<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006193" GROUP_ID="MUSKEL" ID="713106051915550787" MERGED_FROM="" MODIFIED="2012-08-27 19:24:42 +0100" MODIFIED_BY="Elizabeth Tanjong Ghogomu" REVIEW_NO="C115-R" REVMAN_SUB_VERSION="5.1.7" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="4.0">
<COVER_SHEET MODIFIED="2012-08-22 11:22:33 -0400" MODIFIED_BY="Elizabeth Tanjong Ghogomu">
<TITLE MODIFIED="2011-07-25 21:38:09 -0400" MODIFIED_BY="[Empty name]">Cemented, cementless or hybrid fixation options in total knee arthroplasty for osteoarthritis and other non-traumatic diseases</TITLE>
<CONTACT>
<PERSON ID="12FEEE8C82E26AA200CFA52E5C969A40" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Gilberto Yoshinobu</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Nakama</LAST_NAME>
<SUFFIX/>
<POSITION>Orthopaedist</POSITION>
<EMAIL_1>gilberto_nakama@yahoo.com.br</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Orthopaedic and Trauma Department</DEPARTMENT>
<ORGANISATION>Universidade Federal de São Paulo</ORGANISATION>
<ADDRESS_1>Rua Astarté, 297</ADDRESS_1>
<ADDRESS_2/>
<CITY>São Paulo</CITY>
<ZIP>03446-090</ZIP>
<REGION>São Paulo</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>+55 11 69416296</PHONE_1>
<PHONE_2>+55 11 84563850</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2012-08-22 11:22:33 -0400" MODIFIED_BY="Elizabeth Tanjong Ghogomu">
<PERSON ID="12FEEE8C82E26AA200CFA52E5C969A40" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Gilberto Yoshinobu</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Nakama</LAST_NAME>
<SUFFIX/>
<POSITION>Orthopaedist</POSITION>
<EMAIL_1>gilberto_nakama@yahoo.com.br</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Orthopaedic and Trauma Department</DEPARTMENT>
<ORGANISATION>Universidade Federal de São Paulo</ORGANISATION>
<ADDRESS_1>Rua Astarté, 297</ADDRESS_1>
<ADDRESS_2/>
<CITY>São Paulo</CITY>
<ZIP>03446-090</ZIP>
<REGION>São Paulo</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>+55 11 69416296</PHONE_1>
<PHONE_2>+55 11 84563850</PHONE_2>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="12185" ROLE="AUTHOR">
<PREFIX>A/Prof</PREFIX>
<FIRST_NAME>Maria Stella</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Peccin</LAST_NAME>
<SUFFIX/>
<POSITION>Adjunt Professor and Researcher</POSITION>
<EMAIL_1>stella.peccin@gmail.com</EMAIL_1>
<EMAIL_2>stella@webtvinterativa.com</EMAIL_2>
<URL>www.centrocochranedobrasil.org.br</URL>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Human Movement Sciences</DEPARTMENT>
<ORGANISATION>Universidade Federal de São Paulo</ORGANISATION>
<ADDRESS_1>R. Silva Jardim, 136 - Vl. Mathias -</ADDRESS_1>
<ADDRESS_2/>
<CITY>Santos</CITY>
<ZIP>11015-020</ZIP>
<REGION>São Paulo</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>(13) 3878-3763</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="12FEF04182E26AA200CFA52ED970A608" ROLE="AUTHOR">
<PREFIX/>
<FIRST_NAME>Gustavo</FIRST_NAME>
<MIDDLE_INITIALS>JM</MIDDLE_INITIALS>
<LAST_NAME>Almeida</LAST_NAME>
<SUFFIX/>
<POSITION>Research Coordinator</POSITION>
<EMAIL_1>gja4@pitt.edu</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of Physical Therapy</DEPARTMENT>
<ORGANISATION>University of Pittsburgh</ORGANISATION>
<ADDRESS_1>6035 Forbes Tower</ADDRESS_1>
<ADDRESS_2/>
<CITY>Pittsburgh</CITY>
<ZIP>15260</ZIP>
<REGION>Pennsylvania</REGION>
<COUNTRY CODE="US">USA</COUNTRY>
<PHONE_1>+1 412 648 2215</PHONE_1>
<PHONE_2>+1 412 378 1951</PHONE_2>
<FAX_1>+1 412 648 5970</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="12FEF32F82E26AA200CFA52EE2098F79" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Ozório de Almeida</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Lira Neto</LAST_NAME>
<SUFFIX/>
<POSITION>Orthopaedist</POSITION>
<EMAIL_1>jolira@terra.com.br</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Orthopaedic and Trauma Department</DEPARTMENT>
<ORGANISATION>Universidade Federal de São Paulo</ORGANISATION>
<ADDRESS_1>Rua Padre Benedito de Jesus B. Laurindo</ADDRESS_1>
<ADDRESS_2/>
<CITY>São Paulo</CITY>
<ZIP>05396-430</ZIP>
<REGION>São Paulo</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>+55 11 37611060</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="6A742B4982E26AA2015EFE344B6BEF55" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Antônio</FIRST_NAME>
<MIDDLE_INITIALS>AB</MIDDLE_INITIALS>
<LAST_NAME>Queiroz</LAST_NAME>
<SUFFIX/>
<POSITION>Head of knee section</POSITION>
<EMAIL_1>bessadequeiroz@yahoo.com.br</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Orthopaedic and Trauma Department</DEPARTMENT>
<ORGANISATION>Universidade Federal de São Paulo</ORGANISATION>
<ADDRESS_1>Rua Borges Lagoa, 783 - 5º Andar,</ADDRESS_1>
<ADDRESS_2>Vila Clementino</ADDRESS_2>
<CITY>São Paulo</CITY>
<ZIP>04038-032</ZIP>
<REGION>São Paulo</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>055 011 55748490</PHONE_1>
<PHONE_2/>
<FAX_1>055 011 55748490</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="12FEF21682E26AA200CFA52EDE05B3C9" ROLE="AUTHOR">
<PREFIX>Prof</PREFIX>
<FIRST_NAME>Ricardo Dizioli</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Navarro</LAST_NAME>
<SUFFIX/>
<POSITION>Professor</POSITION>
<EMAIL_1>navarroepm@terra.com.br</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Orthopaedic and Trauma Department</DEPARTMENT>
<ORGANISATION>Universidade Federal de São Paulo</ORGANISATION>
<ADDRESS_1>Rua José da Silva Ribeiro, 381 apto. 81</ADDRESS_1>
<ADDRESS_2/>
<CITY>São Paulo</CITY>
<ZIP>05726-130</ZIP>
<REGION>São Paulo</REGION>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<PHONE_1>+55 11 37737801</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE>Deceased July 2010</FOOTNOTE>
</PERSON>
</CREATORS>
<DATES MODIFIED="2012-03-09 09:29:15 -0500" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="13" MONTH="2" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="31" MONTH="10" YEAR="2011"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="31" MONTH="10" YEAR="2013"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2006"/>
<REVIEW_PUBLISHED ISSUE="" YEAR=""/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2006"/>
</DATES>
<WHATS_NEW MODIFIED="2011-08-15 11:55:45 -0400" MODIFIED_BY="[Empty name]"/>
<HISTORY MODIFIED="2011-08-15 11:55:45 -0400" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2011-08-15 11:55:45 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="7" YEAR="2011"/>
<DESCRIPTION>
<P>updated search</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-08-27 09:19:08 -0400" MODIFIED_BY="[Empty name]">
<DATE DAY="6" MONTH="1" YEAR="2010"/>
<DESCRIPTION>
<P>CMSG ID: C115-R</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2008-05-14 21:57:27 -0400" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2008-05-14 21:57:27 -0400" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2008-05-11 16:02:51 -0400" MODIFIED_BY="[Empty name]">
<NAME>Brazilian Cochrane Centre</NAME>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<DESCRIPTION>
<P>Technical support</P>
</DESCRIPTION>
</SOURCE>
<SOURCE MODIFIED="2008-05-11 16:02:22 -0400" MODIFIED_BY="[Empty name]">
<NAME>Orthopaedic and Trauma Department, Universidade Federal de São Paulo, São Paulo</NAME>
<COUNTRY CODE="BR">Brazil</COUNTRY>
<DESCRIPTION>
<P>Technical support</P>
</DESCRIPTION>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2012-08-22 11:13:23 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2012-08-22 11:13:23 -0400" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2012-01-30 10:39:07 -0500" MODIFIED_BY="[Empty name]">Fixation options of total knee replacement for osteoarthritis and other non-traumatic diseases</TITLE>
<SUMMARY_BODY MODIFIED="2012-08-22 11:13:23 -0400" MODIFIED_BY="Elizabeth Tanjong Ghogomu">
<P>This summary of a Cochrane review presents previous research about the effects of cemented, cementless or hybrid fixation of total knee replacement (arthroplasty) for osteoarthritis and other non-traumatic diseases. </P>
<P>Through three high quality trials and 216 participants, we observed that:</P>
<P>- The risk of future aseptic loosening with uncemented fixation is approximately half that of cemented fixation in people with knee osteoarthritis and other non-traumatic diseases.</P>
<P>- Sixteen fewer people out of 100 had a future prediction of arthroplasty instability with uncemented fixation (16% fewer, ranging from 27% fewer to 5% fewer).</P>
<P>- Thirteen people out of 100 had a future prediction of arthroplasty instability with uncemented fixation.</P>
<P>- Twenty-nine people out of 100 had a future prediction of arthroplasty instability with cemented fixation.</P>
<P>These conclusions were based on an arthroplasty instability classification inferred from radiographic measures.</P>
<P>We have no available evidence provided by this review regarding the survival rate of the implant (any change of a component), patient global assessments, functional measures, pain and health-related quality of life measures.<B> </B>
</P>
<P>We often do not have precise information about adverse events and complications. This is particularly true for rare but serious adverse events. Possible adverse events may include deep vein thrombosis and rare complications may include infections.</P>
<P>
<B>What is osteoarthritis and other non-traumatic diseases of the knee and what types of knee implant fixation methods are available?</B>
</P>
<P>Osteoarthritis, also known as degenerative joint disease, has a variety of causes. Osteoarthritis can be classified as either primary or secondary, depending on whether there is an identifiable underlying cause. Most cases of the disease have no known cause and are referred to as primary osteoarthritis. Primary osteoarthritis is mostly related to aging. The causes of secondary osteoarthritis include rheumatoid arthritis, a disease in which the immune system attacks the joints (post-traumatic causes were not included in this review).</P>
<P>In some patients, damage and pain in the knee from arthritis may be severe enough for surgery. In these patients, the damaged joint surfaces can be replaced by an artificial joint or knee implant. In total knee replacement surgery, the ends of the long bones of the leg (femur and tibia) are usually replaced with metal ends, and an insert is placed between them. The femoral and tibial components can be fixed to the bone with or without cement. Cementation of the tibial component while leaving the femoral component cementless is a hybrid technique.</P>
<P>It is not clear which fixation obtains the best clinical, functional and radiographic results in people with osteoarthritis and other non-traumatic diseases, such as rheumatoid arthritis. The use of cement in total knee arthroplasty fixation is considered by many authors to be the gold standard but remains a controversial issue.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2012-08-20 16:32:30 -0400" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2012-06-22 15:27:26 -0400" MODIFIED_BY="[Empty name]">
<P>It is not clear which fixation of total knee arthroplasty obtains the best clinical, functional and radiographic results in people with osteoarthritis and other non-traumatic diseases, such as rheumatoid arthritis. </P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2012-06-19 08:10:23 -0400" MODIFIED_BY="[Empty name]">
<P>To assess the benefits and harms of cemented, cementless and hybrid knee prostheses fixation techniques in participants with primary osteoarthritis (osteoarthritis following trauma was not included) and other non-traumatic diseases, such as rheumatoid arthritis.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2012-08-20 16:32:30 -0400" MODIFIED_BY="[Empty name]">
<P>We searched CENTRAL (2011, issue 10), MEDLINE via PubMed, EMBASE, Current Controlled Trials, LILACS, The Cumulative Index to Nursing and Allied Health Literature, SPORTDiscus, Health Technology Assessment Database and the Database of Abstracts of Reviews of Effectiveness, all from implementation to October 2011, along with handsearches of high-yield journals and reference lists of articles. No language restrictions were applied.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2012-08-18 06:44:35 -0400" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trials (RCTs) evaluating cemented, cementless and hybrid fixation. Participants included patients that were 18 years or older with osteoarthritis and other non-traumatic diseases who were undergoing primary total knee arthroplasty.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2012-02-14 01:49:56 -0500" MODIFIED_BY="[Empty name]">
<P>Three authors independently selected the eligible trials, assessed the trial quality, risk of bias and extracted data. Researchers were contacted to obtain missing information.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2012-08-20 16:20:48 -0400" MODIFIED_BY="[Empty name]">
<P>Five RCTs and 297 participants were included in this review. Using meta-analysis on roentgen stereophotogrammetric analysis (RSA) we observed that cemented fixation of the tibial components demonstrated smaller displacement in relation to cementless fixation (with and without hydroxyapatite) after a follow-up of two years (maximum total point-motion, N = 167, two RCTs, mean difference (MD) = 0.52 mm, 95% confidence interval (CI) 0.31 to 0.74). However, the risk of future aseptic loosening with uncemented fixation was approximately half that of cemented fixation according to the arthroplasty instability classification (moderate quality as assessed by GRADE) inferred from RSA (N = 216, three RCTs, risk ratio (RR) = 0.47, 95% CI 0.24 to 0.92) with a 16% absolute risk difference between groups. The number needed to treat for an additional beneficial outcome (NNTB) to prevent future aseptic loosening was 7 (95% CI 5 to 44). There was a low risk of bias for RSA among the studies included. It was not possible to perform meta-analysis on patient-important outcomes, such as the survival rate of the implant (any change of a component), patient global assessments, functional measures, pain, health-related quality of life measures and adverse events. Almost all included studies recorded functional measures of Knee Society and Hospital for Special Surgery knee scores, but the authors of each study found no significant difference between the groups.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2012-08-16 15:10:04 -0400" MODIFIED_BY="[Empty name]">
<P>There was a smaller displacement of the cemented tibial component in relation to the cementless fixation in studies with osteoarthritis and rheumatoid arthritis participants who underwent primary total knee prosthesis with a follow-up of two years; however, the cemented fixation presented a greater risk of future aseptic loosening than cementless fixation.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2012-08-20 16:54:01 -0400" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2012-08-17 06:11:36 -0400" MODIFIED_BY="Elizabeth Tanjong Ghogomu">
<CONDITION MODIFIED="2012-08-16 15:15:38 -0400" MODIFIED_BY="[Empty name]">
<P>After many years of suffering from the knee joint pain due to disabling diseases, such as rheumatoid arthritis (RA) and osteoarthritis (OA), the only remaining treatment for many patients is surgery and replacement of the joint surfaces with a total knee arthroplasty (TKA). Approximately 20,000 patients undergo TKA in the UK with an annual hospital cost of £70 million showing the economic impact of this disease (<LINK REF="REF-McCormack-2009" TYPE="REFERENCE">McCormack 2009</LINK>).</P>
<P>The major reason for prosthesis failure is aseptic loosening of the implant (<LINK REF="REF-Huiskes-1998" TYPE="REFERENCE">Huiskes 1998</LINK>). Aseptic loosening of the prosthesis can be related to the type of fixation of the implants, since the quality of fixation of the prosthesis and the load transfer characteristics between the implant and bone are important factors that affect the durability of the arthroplasty (<LINK REF="REF-Whiteside-2006" TYPE="REFERENCE">Whiteside 2006</LINK>). Continued developments are aimed at improving the results of TKA.</P>
</CONDITION>
<INTERVENTION MODIFIED="2012-08-16 15:17:06 -0400" MODIFIED_BY="[Empty name]">
<P>Prosthesis systems can be crudely divided into two groups: cemented and cementless systems. Additionally, two hybrid techniques are currently used: 1) cementation of the tibial component while leaving the femoral component cementless, and 2) partial cementation of the tibial component (i.e. cementing the base plate and leaving the tibial stem cementless). While some studies have reported outcomes of fully cemented or fully cementless total knee arthroplasties, some studies have simply reported the outcomes of tibial or femoral components from fully cemented, fully cementless, or hybrid systems. Early implants for TKA were fixed to the bone with cement. To improve the survival of the arthroplasty, the cementless implant was developed to proportionate biologic fixation by osseous ingrowth in the implant with a potentially more durable bond of the prosthesis to the bone than the cemented implant (<LINK REF="REF-Fehring-2006" TYPE="REFERENCE">Fehring 2006</LINK>).</P>
</INTERVENTION>
<THEORY MODIFIED="2012-08-16 15:20:43 -0400" MODIFIED_BY="[Empty name]">
<P>Roentgenographic (X-ray) and histological evaluation of the bone-cement interface in loosened arthroplasties indicate a pathologic response to foreign materials. Therefore, bone cement has been implicated to be involved in the pathogenesis of implant failure (<LINK REF="REF-Harris-1976" TYPE="REFERENCE">Harris 1976</LINK>; <LINK REF="REF-Mirra-1976" TYPE="REFERENCE">Mirra 1976</LINK>). Cement has not been confirmed to be the initiator of osteolytic problems, and osteolysis has been reported with uncemented arthroplasties (<LINK REF="REF-Maloney-1996" TYPE="REFERENCE">Maloney 1996</LINK>). Aseptic loosening is mainly related to wear particles of the prosthetic components, but it remains doubtful whether the use of cement affects the durability of the prosthesis (<LINK REF="STD-Khaw-2002" TYPE="STUDY">Khaw 2002</LINK>). The fixation of the prosthesis without cement has the advantage of having a shorter surgical time and ease of arthroplasty revision as the cement is not interlocked with the bone (<LINK REF="REF-Fehring-2006" TYPE="REFERENCE">Fehring 2006</LINK>). Because cement fixation is not present to help protect against excessive point loading, alignment is more crucial in cementless knee replacements (<LINK REF="REF-Brassard-2006" TYPE="REFERENCE">Brassard 2006</LINK>).</P>
<P>On the other hand, the cemented fixation of the total knee replacement is considered to be the gold standard by many orthopedic surgeons (<LINK REF="REF-Fehring-2006" TYPE="REFERENCE">Fehring 2006</LINK>). Cementation potentially creates a barrier against wear debris preventing osteolysis and loosening (<LINK REF="REF-McCaskie-1998" TYPE="REFERENCE">McCaskie 1998</LINK>). Additionally, cement may help to better distribute stresses and strains to the surrounding bone, thereby adding longevity to the implant.</P>
<P>The survival rate of the implant is one of the most important outcomes to be analyzed, and aseptic loosening is the major cause of arthroplasty failure. Most randomized controlled trials comparing the cemented total knee arthroplasty with uncemented total knee arthroplasty have a follow-up of up to five years, which may be insufficient to show a difference in survival rate. Roentgen stereophotogrammetric analysis (RSA), a radiological method that can predict the risk of future aseptic loosening (predictive power of approximately 85%) through the analysis of small movements of the implant, has been used in studies with a follow-up of two years (<LINK REF="REF-K_x00e4_rrholm-2006" TYPE="REFERENCE">Kärrholm 2006</LINK>; <LINK REF="REF-Ryd-1995" TYPE="REFERENCE">Ryd 1995</LINK>).</P>
<P>In addition to the ability to maintain mechanical contact to the implantation site, various attributes, such as knee function, knee pain, susceptibility to certain complications, ease of re-operation and cost consumption, are also of interest.</P>
</THEORY>
<IMPORTANCE MODIFIED="2012-08-17 06:11:36 -0400" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="REF-Gandhi-2009" TYPE="REFERENCE">Gandhi 2009</LINK> conducted meta-analyses to verify clinical function and survival of fully cemented and fully uncemented prostheses in total knee replacement. These meta-analyses included randomized and quasi-randomized controlled trials and observational studies. <LINK REF="REF-Gandhi-2009" TYPE="REFERENCE">Gandhi 2009</LINK> excluded studies with hybrid fixation of the arthroplasty and did not exclude the studies with post-traumatic participants. The survival rate of the implant free of aseptic loosening was based on studies with a minimum follow-up of two years, and in a subgroup analysis of data only from RCTs showed no differences between the groups for odds of aseptic loosening (Odds ratio (OR) 1.9, 95% CI 0.55 to 6.40; P = 0.314).</P>
<P>Our systematic review included only randomized controlled studies. Studies with hybrid fixation were included and post-traumatic studies were excluded. In addition to clinical function and survival of implants studied by <LINK REF="REF-Gandhi-2009" TYPE="REFERENCE">Gandhi 2009</LINK>, our systematic review included RSA to provide an idea of aseptic loosening even with a short follow-up of two years. Other outcomes were foreseen in our systematic review like health-related quality of life measures and total adverse events (<LINK TAG="CRIT_OUTCOMES" TYPE="SECTION">Types of outcome measures</LINK>).</P>
<P>A number of RCTs have been performed with conflicting results. The use of cement in TKA fixation is considered by many authors to be the gold standard but remains a controversial issue. There are other issues that can potentially affect the results of a total knee arthroplasty but remain inconclusive (mobile bearing versus fixed bearing, and posterior cruciate ligament sacrifice versus posterior cruciate ligament retention) and are analyzed in other systematic reviews (<LINK REF="REF-Wilco-2001" TYPE="REFERENCE">Wilco 2001</LINK>; <LINK REF="REF-Wilco-2005" TYPE="REFERENCE">Wilco 2005</LINK>).</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2012-02-28 12:09:18 -0500" MODIFIED_BY="[Empty name]">
<P>To assess the effects (benefits and harms) of cemented, cementless and hybrid knee prostheses fixation techniques in participants with primary osteoarthritis (osteoarthritis following trauma was not included) and other non-traumatic diseases.</P>
</OBJECTIVES>
<METHODS MODIFIED="2012-08-20 16:37:35 -0400" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2012-08-20 16:20:50 -0400" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2012-04-25 14:39:29 -0400" MODIFIED_BY="[Empty name]">
<P>We included reports of randomized controlled trials. In the case of multiple publications of a given data set, we included the first published article in our analysis. Exceptions to this rule were made if a more recent publication corroborated the results of a longer follow-up.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2012-02-28 12:10:44 -0500" MODIFIED_BY="[Empty name]">
<P>Patients aged 18 years or older who were undergoing implantation of a primary knee arthroplasty were eligible. We considered all of the diagnostic indications for the implantation of a TKA, especially osteoarthritis and rheumatoid arthritis. Participants that received a TKA following trauma or revision arthroplasties were excluded.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2011-07-25 21:52:22 -0400" MODIFIED_BY="[Empty name]">
<P>The intervention of interest was the primary implantation of a cemented, cementless or hybrid total knee prosthesis.</P>
<P>- Cemented fixation of the arthroplasty components versus cementless fixation of the arthroplasty components (with or without hydroxyapatite).</P>
<P>- Cemented fixation of the arthroplasty components versus hybrid fixation (cementless fixation with or without hydroxyapatite of one arthroplasty component and cemented fixation of the other component).</P>
<P>- Cementless fixation of the arthroplasty components (with or without hydroxyapatite) versus hybrid fixation (cementless fixation with or without hydroxyapatite of one arthroplasty component and cemented fixation of the other component).</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2012-08-20 16:20:50 -0400" MODIFIED_BY="[Empty name]">
<P>The major outcomes considered were the survival rate of the implant, roentgen stereophotogrammetric analysis (absolute values of rotation in three orthogonal axes (transverse, longitudinal and sagittal), maximum total point-motion (MTPM), subsidence, lift-off, induced displacement and arthroplasty instability (indirect outcome)), functional measures with validated instruments (e.g. OXFORD, IKDC), knee pain (e.g. VAS), range of motion (with validated methods), general functional abilities (e.g. WOMAC), health-related quality of life measures (e.g. SF36), global assessment (patient), total adverse event (e.g. deep vein thrombosis).</P>
<P>Minor outcomes considered included length of surgery (in minutes), operative blood loss (in milliliters), red blood cell count, hemoglobin level, hematocrit, postoperative blood transfusion (in units), rate of lateral release, days to mobilization, length of hospital stay (days), discharge destination, walking aids at discharge, extensor mechanism function, gait analysis results and costs.</P>
<P>The outcomes were evaluated with validated instruments, and although all of the scales were reported in the review, the pooling of instruments that have not been validated in the next update of the review will be examined in a sensitivity analysis.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2012-08-20 16:35:55 -0400" MODIFIED_BY="[Empty name]">
<P>The following databases were searched to identify randomized controlled trials from inception until 31 October 2011:</P>
<UL>
<LI>the Cochrane Central Register of Controlled Trials (CENTRAL in <I>The Cochrane Library</I> 2011, issue 10);</LI>
<LI>Current Controlled Trials (www.controlled-trials.com);</LI>
<LI>MEDLINE via PubMed;</LI>
<LI>EMBASE;</LI>
<LI>LILACS (Latin American and Caribbean Health Science Literature available at http://bases.bvs.br);</LI>
<LI>Cumulative Index to Nursing and Allied Health Literature (CINAHL);</LI>
<LI>SPORTDiscus;</LI>
<LI>Health Technology Assessment Database (HTA);</LI>
<LI>Database of Abstracts of Reviews of Effectiveness (DARE).</LI>
</UL>
<P>
<BR/>The "optimal" sensitivity search strategies designed to identify clinical trials were used, as described by Dickersin et al (<LINK REF="REF-Dickersin-1994" TYPE="REFERENCE">Dickersin 1994</LINK>) and Castro et al (<LINK REF="REF-Castro-1999" TYPE="REFERENCE">Castro 1999</LINK>).</P>
<P>Complete strategies are described for CENTRAL (<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>), MEDLINE via PubMed (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>), EMBASE via OVID (<LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK>) and LILACS (<LINK REF="APP-04" TYPE="APPENDIX">Appendix 4</LINK>).</P>
<P>In addition to these electronic search strategies, we performed handsearches of high-yield journals (The Journal of Bone and Joint Surgery - American Volume (1980 to October 2011), The Journal of Bone and Joint Surgery - British Volume (1980 to October 2011), The Journal of Arthroplasty (1986 to October 2011) and Clinical Orthopaedics and Related Research (1980 to October 2011)), and additionally, we surveyed the reference lists of relevant articles. Researchers were contacted personally to retrieve information that was not presented in the original articles. No language restrictions were applied.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2012-08-20 16:37:35 -0400" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2012-02-28 13:04:44 -0500" MODIFIED_BY="[Empty name]">
<P>Two authors (GYN and OAL) independently selected trials for inclusion, extracted data, assessed trial quality and analyzed results. When there were disagreements, a third author (MSP) was consulted, and in situations where a consensus was not reached, the data were not included in the review until the author of the trial resolved the question.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2011-07-25 21:57:12 -0400" MODIFIED_BY="[Empty name]">
<P>The review authors screened the titles and abstracts of publications obtained by the search strategy. If a study fulfilled the inclusion criteria, the data concerning methodological issues, characteristics of participants, interventions and outcome measures were independently extracted using a standard extraction form. A one year follow-up was considered a short-term follow-up and five years or more was considered a long-term follow-up.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2012-08-16 15:34:33 -0400" MODIFIED_BY="[Empty name]">
<P>The risk of bias in included studies was assessed by two authors (GYN and OAL) according to the Cochrane Handbook (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). When there were disagreements a third author (MSP) was consulted.</P>
<P>The domains used in the risk of bias tool were:</P>
<P>- random sequence generation;</P>
<P>- allocation concealment;</P>
<P>- blinding of participants and personnel (surgeons);</P>
<P>- blinding of outcome assessment;</P>
<P>- incomplete outcome data;</P>
<P>- selective reporting.</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2012-08-20 16:37:35 -0400" MODIFIED_BY="[Empty name]">
<P>For dichotomous data, risk ratios (RR) and 95% confidence intervals (CI) were estimated according to the intention-to-treat principles. For pooled data, the random-effects model was used. For all statistically significant results, the number needed to treat for an additional beneficial outcome (NNTB) and/or the number needed to treat for an additional harmful outcome (NNTH) were also calculated using the Cates calculator for dichotomous data (<LINK REF="REF-Cates-2004" TYPE="REFERENCE">Cates 2004</LINK>).</P>
<P>Continuous outcomes were analyzed with the mean and standard deviation of endpoint measures. For the meta-analysis of continuous outcomes, mean differences (MDs) between groups were estimated, and when different scales were used, standardized mean differences (SMDs) were estimated. A random-effects model was used for all of the analyses in this review.</P>
<P>Data on continuous outcomes are frequently skewed with the mean being different from the center of the distribution. The statistics for meta-analysis are thought to be able to cope with some skew but were actually formulated for parametric data. To avoid this potential pitfall, the following standards were applied to all of the data before inclusion: (1) standard deviations and means were reported or obtained from authors, and (2) for data with finite limits, such as endpoint scale data, the standard deviation (SD), when multiplied by two, had to be less than the mean. Otherwise, the mean would be unlikely to be an appropriate measure of the center of the distribution. In such circumstances, skewness must be handled through transforming the data, if possible, or through a sensitivity analysis (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). For skewed data, the analysis suggested by Altman (<LINK REF="REF-Altman-1995" TYPE="REFERENCE">Altman 1995</LINK>; <LINK REF="REF-Altman-1996" TYPE="REFERENCE">Altman 1996</LINK>) must be used. However, we found no skewed data.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2012-08-16 15:39:05 -0400" MODIFIED_BY="[Empty name]">
<P>There was no unit of analysis error. The number of observations matched the number of participants knees randomized.</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2012-06-19 10:17:24 -0400" MODIFIED_BY="[Empty name]">
<P>We performed an analysis of data based on available data and intention-to-treat principles (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
<P>For dichotomous data, we assumed either poor outcomes or good outcomes for withdrawn participants. For arthroplasty instability classification, we assumed either that all missing participants were stable, or that all missing participants were unstable.</P>
<P>For continuous data, when participants were lost to follow-up and the individual data of all participants were available, the last available observation outcome of each participant withdrawn from the study was imputed in the intention-to-treat analysis. The mean value of the first evaluation outcome of the randomized group was attributed to each randomized participant withdrawn from the study before the first evaluation.</P>
<P>For continuous data, when participants were withdrawn from the study and the individual data of all participants were not available, the mean and standard deviation of all the randomized participants were calculated using the mean and standard deviation of the analyzed participant groups and the mean and standard deviation of the participants withdrawn from the study based on the known last evaluation outcome. The mean and standard deviation of all the randomized participants were calculated according to the formulas in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> (<LINK REF="REF-Morais-2012" TYPE="REFERENCE">Morais 2012</LINK>).</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2012-08-20 16:06:18 -0400" MODIFIED_BY="[Empty name]">
<P>Heterogeneity was assessed using the Chi<SUP>2</SUP> test in conjunction with the I<SUP>2 </SUP>statistic<SUP> </SUP>(a value greater than 50% was considered to demonstrate substantial heterogeneity). The significance for the Chi<SUP>2</SUP> test was set at P &lt; 0.10 due to the low power of this test (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We also assessed the heterogeneity of estimate effects between the included studies by visual inspection of the forest plot analysis. When significant heterogeneity was present, we attempted to explain the differences based on the clinical characteristics of the included studies.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2012-08-16 15:44:34 -0400" MODIFIED_BY="[Empty name]">
<P>When possible, we plotted data on a funnel graph in order to assess publication bias.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2012-08-20 16:09:06 -0400" MODIFIED_BY="[Empty name]">
<P>Statistical analyses were conducted using Review Manager 5 (RevMan) software.</P>
<P>Continuous data were entered as means and standard deviations.</P>
<P>Dichotomous data were entered as events and number of participants.</P>
<P>The intention-to-treat analysis for dichotomous data assumed either that all of the missing participants experienced the event or that all of the missing participants did not experience the event.</P>
<P>In the absence of significant heterogeneity and given sufficient included trials, the results were combined for the meta-analysis using the random-effects model.</P>
<P>We used the grading system described in the GRADE handbook for grading the quality of evidence (<LINK REF="REF-Sch_x00fc_nemann-2009" TYPE="REFERENCE">Schünemann 2009</LINK>) recommended by the Cochrane Handbook (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>).</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2012-08-16 15:45:28 -0400" MODIFIED_BY="[Empty name]">
<P>It is possible that the treatment effects might differ not because of statistical heterogeneity, but rather clinical heterogeneity (e.g. cemented or cementless endoprosthesis may be more effective in osteoarthritis than in rheumatoid arthritis or vice versa). To evaluate this possibility, we carried out stratification for the most important clinical parameters (effect modifiers) that could influence the effect of the knee endoprosthesis technique on the selected clinical outcomes.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2012-06-19 11:53:10 -0400" MODIFIED_BY="[Empty name]">
<P>It was not possible to perform a sensitivity analysis.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2012-08-20 16:54:01 -0400" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2012-08-20 16:42:48 -0400" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2012-08-20 16:40:30 -0400" MODIFIED_BY="[Empty name]">
<P>The database search resulted in 551 references. Of these, 533 studies were considered to be irrelevant based on the title, abstract and full text. After personal communication with at least one of the authors, six studies were withdrawn because they did not meet the systematic review inclusion criteria (<LINK REF="STD-Albrektsson-1992" TYPE="STUDY">Albrektsson 1992</LINK>; <LINK REF="STD-Beaupr_x00e9_-2007" TYPE="STUDY">Beaupré 2007</LINK>; <LINK REF="STD-Ishii-2005a" TYPE="STUDY">Ishii 2005a</LINK>; <LINK REF="STD-Keblish-1993" TYPE="STUDY">Keblish 1993</LINK>; <LINK REF="STD-Khaw-2002" TYPE="STUDY">Khaw 2002</LINK>; <LINK REF="STD-Nilsson-2006" TYPE="STUDY">Nilsson 2006</LINK>). The studies by <LINK REF="STD-_x00d6_nsten-1998" TYPE="STUDY">Önsten 1998</LINK> and <LINK REF="STD-Khaw-2002" TYPE="STUDY">Khaw 2002</LINK> were the same as the studies by <LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK> and <LINK REF="STD-Baker-2007" TYPE="STUDY">Baker 2007</LINK> with a shorter follow-up, respectively. Two studies (<LINK REF="STD-Nilsson-1992" TYPE="STUDY">Nilsson 1992</LINK>; <LINK REF="STD-Parker-2001" TYPE="STUDY">Parker 2001</LINK>) are awaiting classification because one author of each study was contacted, but there has not been a reply to our request concerning the etiology of osteoarthritis (i.e. post-traumatic or not). Three studies (<LINK REF="STD-Demey-2010" TYPE="STUDY">Demey 2010</LINK>; <LINK REF="STD-Dunbar-2009" TYPE="STUDY">Dunbar 2009</LINK>; <LINK REF="STD-Nelissen-1998" TYPE="STUDY">Nelissen 1998</LINK>) are awaiting classification depending on participant characteristics (there was no feedback from authors to know if they included post-traumatic osteoarthritis). For more information, see the table '<LINK TAG="CHARACTERISTICS_OF_AWAITING_STUDIES" TYPE="SECTION">Characteristics of studies awaiting classification</LINK>'. Five studies met the inclusion criteria. Full details of the included studies are given in the table '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>'. The studies by <LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK>, <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK> and <LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK> included 238 tibial components of participants that were evaluated in this systematic review. <LINK REF="STD-Uvehammer-2007" TYPE="STUDY">Uvehammer 2007</LINK> studied the femoral components. <LINK REF="STD-Ishii-2005b" TYPE="STUDY">Ishii 2005b</LINK> studied the perioperative blood loss in cementless and hybrid total knee arthroplasty. The study flow diagram is summarized in <LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2012-08-20 16:42:05 -0400" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK> analyzed the total knee arthroplasty tibial components randomized to cemented or uncemented without hydroxyapatite (HA) fixation. A follow-up of two years was used for 27 OA participants (28 knees) that were included in this study. The following measures were evaluated: roentgen stereophotogrammetric analysis (RSA), induced displacement, maximum total point-motion (MTPM) and subsidence, hip-knee-ankle-angle (HKA), Hospital for Special Surgery knee score (HSS), extension, flexion and walking distance.</P>
<P>
<LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK> analyzed the tibial components randomized to cemented or uncemented with hydroxyapatite fixation, and 43 OA participants (45 knees) and 13 RA (15 knees) were included in this study with a follow-up of five years. The following measures were evaluated: RSA (absolute values of rotation in three orthogonal axes, MTPM, subsidence, and lift-off), Knee Society knee score, range of motion and radiolucent line analysis at the interface of the tibial component as described by the Knee Society.</P>
<P>
<LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK> analyzed the tibial components randomized to cemented, uncemented without hydroxyapatite, or uncemented with hydroxyapatite fixation, and 120 OA participants (150 knees) were included in this study with a follow-up of five years. The following measures were evaluated: RSA (absolute values of rotation in three orthogonal axes, MTPM, subsidence, and lift-off), the Knee Society clinical rating system and the method of Ewald (the radiographs were evaluated for any osteolytic lesions or any progressive implant bone or cement-bone lucencies using the method of Ewald, in which the interface around the tibial component was analyzed in 10 zones on antero-posterior and lateral radiographs).</P>
<P>
<LINK REF="STD-Ishii-2005b" TYPE="STUDY">Ishii 2005b</LINK> randomized participants (54 OA and 3 RA participants) to the prosthesis fixed without cement or hybrid (cemented tibia and femur without cement) and analyzed total blood loss. Red blood cell count, hemoglobin level, and hematocrit were recorded preoperatively and one week, four weeks, and three months postoperatively. Torniquet time and operation time were recorded too.</P>
<P>
<LINK REF="STD-Uvehammer-2007" TYPE="STUDY">Uvehammer 2007</LINK> analyzed the femoral components randomized to cemented or uncemented with hydroxyapatite fixation, and 50 OA participants (54 knees) were included in this study with a follow-up of two years. The following measures were evaluated: RSA (absolute values of rotation in three orthogonal axes), HKA, and HSS.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2012-08-20 16:42:48 -0400" MODIFIED_BY="[Empty name]">
<P>The following exclusion criteria were used for these eight studies (<LINK REF="STD-Albrektsson-1992" TYPE="STUDY">Albrektsson 1992</LINK>; <LINK REF="STD-Baker-2007" TYPE="STUDY">Baker 2007</LINK>; <LINK REF="STD-Beaupr_x00e9_-2007" TYPE="STUDY">Beaupré 2007</LINK>; <LINK REF="STD-Ishii-2005a" TYPE="STUDY">Ishii 2005a</LINK>; <LINK REF="STD-Keblish-1993" TYPE="STUDY">Keblish 1993</LINK>; <LINK REF="STD-Khaw-2002" TYPE="STUDY">Khaw 2002</LINK>; <LINK REF="STD-Nilsson-2006" TYPE="STUDY">Nilsson 2006</LINK>; <LINK REF="STD-_x00d6_nsten-1998" TYPE="STUDY">Önsten 1998</LINK>): two studies evaluated post-traumatic osteoarthritis participants (<LINK REF="STD-Albrektsson-1992" TYPE="STUDY">Albrektsson 1992</LINK>; <LINK REF="STD-Nilsson-2006" TYPE="STUDY">Nilsson 2006</LINK>); in one study, the prosthesis was always cemented (<LINK REF="STD-Keblish-1993" TYPE="STUDY">Keblish 1993</LINK>); the study by <LINK REF="STD-_x00d6_nsten-1998" TYPE="STUDY">Önsten 1998</LINK> was the same as the study by <LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK> with a shorter follow-up; two studies did not differentiate whether arthritis was post-traumatic or not (<LINK REF="STD-Beaupr_x00e9_-2007" TYPE="STUDY">Beaupré 2007</LINK>; <LINK REF="STD-Khaw-2002" TYPE="STUDY">Khaw 2002</LINK>); one study was not randomized (<LINK REF="STD-Ishii-2005a" TYPE="STUDY">Ishii 2005a</LINK>); and the study by <LINK REF="STD-Baker-2007" TYPE="STUDY">Baker 2007</LINK> was the same as the study by <LINK REF="STD-Khaw-2002" TYPE="STUDY">Khaw 2002</LINK> with a longer follow-up. For exclusion details, see the table '<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>'.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2012-08-20 16:44:51 -0400" MODIFIED_BY="[Empty name]">
<P>We assessed the risk of bias of the trials included in this review (see table '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>') according to the criteria in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) and generated risk of bias figures (<LINK REF="FIG-04" TYPE="FIGURE">Figure 4</LINK> and <LINK REF="FIG-05" TYPE="FIGURE">Figure 5</LINK>).</P>
<ALLOCATION MODIFIED="2012-08-16 15:55:27 -0400" MODIFIED_BY="[Empty name]">
<P>Allocation concealment was considered adequate in four studies (<LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK>; <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK>; <LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK>; <LINK REF="STD-Uvehammer-2007" TYPE="STUDY">Uvehammer 2007</LINK>). <LINK REF="STD-Ishii-2005b" TYPE="STUDY">Ishii 2005b</LINK> was the only study that did not describe the allocation concealment.</P>
</ALLOCATION>
<BLINDING MODIFIED="2012-08-16 15:56:04 -0400" MODIFIED_BY="[Empty name]">
<P>Only <LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK> reported that participants were blinded for the intervention. In this type of study, the surgeon cannot be blinded to the fixation. The clinical measures were assessed by the surgeons in the studies by <LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK>, <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK> and <LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK>. <LINK REF="STD-Uvehammer-2007" TYPE="STUDY">Uvehammer 2007</LINK> did not comment on whether the outcome assessors were blinded.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2012-08-20 16:44:51 -0400" MODIFIED_BY="[Empty name]">
<P>The withdrawal/drop-out rate was described, acceptable (&lt; 20%) and comparable in both groups in <LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK> and <LINK REF="STD-Ishii-2005b" TYPE="STUDY">Ishii 2005b</LINK> studies. The rate of drop-out in the studies by <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK> and <LINK REF="STD-Uvehammer-2007" TYPE="STUDY">Uvehammer 2007</LINK> was described and was comparable in both groups, but was not acceptable (missing outcome data were balanced in numbers across intervention groups with similar reasons for missing data across groups). In the study by <LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK>, the withdrawal/drop-out rate was described, was not acceptable and was not comparable between the groups.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2011-11-08 10:06:45 -0500" MODIFIED_BY="[Empty name]">
<P>All of the included studies were considered to be free of selective reporting.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2012-06-19 11:55:20 -0400" MODIFIED_BY="[Empty name]">
<P>None known.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2012-08-20 16:54:01 -0400" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Meta-analysis</HEADING>
<P>
<LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK> provided us with the individual results of all of the participants (<LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK>), which facilitated the intention-to-treat analysis. In the study by <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK>, we collected the mean and standard deviation of the analyzed participants group and the individual outcomes of the last evaluation of participants withdrawn from study. We have described the calculation of the mean and standard deviation of all of the randomized participants from the studies by <LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK> and <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK> in the<B>
<I> </I>
</B>
<LINK TAG="DATA_COLLECTION" TYPE="SECTION">Data collection and analysis</LINK> section (statistical analyses).</P>
<P>A meta-analysis was performed on the measures presented for more than one study comparing the same follow-up. An intention-to-treat analysis and the study available data analysis were performed. Comparable data included the following: absolute values around the three orthogonal axes (transverse, longitudinal and sagittal), maximum total point motion (MTPM) and arthroplasty instability (<LINK REF="REF-Ryd-1995" TYPE="REFERENCE">Ryd 1995</LINK>).</P>
<P>We could not perform a meta-analysis on clinical outcomes presented in the included studies (Knee Society knee score, Hospital for Special Surgery knee score, Range of Motion and Satisfaction) because the combination of tibial and femoral fixation was not comparable among the studies. For example, in the study by <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK>, if a patient was randomized to cemented tibial fixation, the femoral component should have been cemented as well. However, in the study by <LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK>, if a patient was randomized to the cemented fixation, the femoral fixation was performed according to the preference of the surgeons.</P>
<P>It was not possible to include the study by <LINK REF="STD-Uvehammer-2007" TYPE="STUDY">Uvehammer 2007</LINK> in the meta-analysis because it did not have comparable data.</P>
<SUBSECTION>
<HEADING LEVEL="4">Cemented fixation of the tibial arthroplasty component versus cementless fixation of the tibial component with hydroxyapatite</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Major outcomes</HEADING>
<P>1. Roentgen stereophotogrammetric analysis</P>
<P>1a. Absolute values of rotation in three orthogonal axes (transverse, longitudinal, and sagittal)</P>
<P>The absolute rotation around the longitudinal and sagittal axes (five year follow-up) in an intention-to-treat analysis of the studies by <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK> and <LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK> revealed a MD of 0.26 degrees (95% CI 0.04 to 0.47; P = 0.02) and 0.22 degrees (95% CI 0.01 to 0.42; P = 0.04), respectively, which favored the cemented fixation over the uncemented fixation with hydroxyapatite.</P>
<P>We found no differences among the groups in the transverse axis in available data analyses of the three orthogonal axes.</P>
<P>1b. Arthroplasty instability</P>
<P>According to instability classification, uncemented fixation with hydroxyapatite was superior to cemented fixation according to available data (arthroplasty instability was considered an event), an intention-to-treat analysis (missing participants were categorized as unstable), and an intention-to-treat analysis (missing participants were categorized as stable), which revealed a RR of 0.34 (95% CI 0.15 to 0.74; P = 0.007), a RR of 0.47 (95% CI 0.26 to 0.85; P = 0.01), and a RR of 0.34 (95% CI 0.15 to 0.74; P = 0.008), respectively (<LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK>; <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK>). A NNTH of 6 was found for available data, an intention-to-treat analysis (missing participants were categorized as unstable), and an intention-to-treat analysis (missing participants were categorized as stable). One additional person will likely incur arthroplasty instability for every six participants receiving cemented fixation rather than uncemented fixation with hydroxyapatite.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Cemented fixation of the tibial arthroplasty component versus cementless fixation of the tibial component with and without hydroxyapatite</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Major outcomes</HEADING>
<P>1. Roentgen stereophotogrammetric analysis</P>
<P>1a. Absolute values of rotation in three orthogonal axes (transverse, longitudinal, and sagittal)</P>
<P>A meta-analysis of <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK> and <LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK> demonstrated that cemented fixation was superior to uncemented fixation with and without hydroxyapatite (uncemented types of fixation were grouped together). The MD was 0.33 degrees (95% CI 0.09 to 0.58; P = 0.008) for absolute rotation around the longitudinal axis (five year follow-up) through an intention-to-treat analysis. For absolute rotation around the sagittal axis (five year follow-up), the MD was 0.15 degrees (95% CI 0.01 to 0.29; P = 0.03) through available data analysis and 0.20 degrees (95% CI 0.04 to 0.36; P = 0.02) through an intention-to-treat analysis.</P>
<P>We found no differences among the groups in the transverse axis.</P>
<P>1b. Maximum total point-motion (MTPM)</P>
<P>Regarding the 12-month MTPM (<LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK>; <LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK>), cemented fixation was superior to uncemented fixation with or without hydroxyapatite according to the available data and an intention-to-treat analysis, revealing MTPMs of 0.61 mm (MD) (95% CI 0.37 to 0.84; P &lt; 0.00001) and 0.60 mm (MD) (95% CI 0.38 to 0.82; P &lt; 0.00001), respectively. The 24-month MTPM data confirmed the superiority of cemented fixation to uncemented fixation with or without hydroxyapatite according to the available data and an intention-to-treat analysis, which revealed MTPMs of 0.52 mm (MD) (95% CI 0.31 to 0.74; P &lt; 0.00001) and 0.52 mm (MD) (95% CI 0.31 to 0.72; P &lt; 0.00001), respectively.</P>
<P>1c. Arthroplasty instability</P>
<P>Concerning arthroplasty instability (<LINK REF="REF-Ryd-1995" TYPE="REFERENCE">Ryd 1995</LINK>), uncemented fixation with and without hydroxyapatite was found to be superior to cemented fixation through available data (arthroplasty instability was considered an event) and an intention-to-treat analysis (missing participants were categorized as stable), revealing an RR of 0.47 (95% CI 0.24 to 0.92; P = 0.03) and an RR of 0.40 (95% CI 0.22 to 0.73; P = 0.003), respectively. We found no difference with the same comparison using an intention-to-treat analysis when missing participants were categorized as unstable, which revealed an RR of 0.78 (95% CI 0.36 to 1.68; P = 0.53 (<LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK>; <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK>; <LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK>). Numbers needed to treat for an additional harmful outcome (NNTH) were 7 and 8 for available data analysis and an intention-to-treat analysis, respectively (missing participants were categorized as stable).</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Cemented fixation of the tibial arthroplasty component versus cementless fixation of the tibial component without hydroxyapatite</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Major outcomes</HEADING>
<P>1. Roentgen stereophotogrammetric analysis</P>
<P>1a. Maximum total point-motion (MTPM)</P>
<P>Regarding the 12-month MTPM (<LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK>; <LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK>), cemented fixation was superior to uncemented fixation without hydroxyapatite according to available data and an intention-to-treat analysis, which reported MTPMs of 0.64 mm (MD) (95% CI 0.43 to 0.85; P &lt; 0.00001) and 0.62 mm (MD) (95% CI 0.42 to 0.81; P &lt; 0.00001), respectively. The 24-month MTPM data confirmed the superiority of cemented fixation to uncemented fixation with or without hydroxyapatite according to the available data and an intention-to-treat analysis, which revealed MTPMs of 0.54 mm (MD) (95% CI 0.33 to 0.75; P &lt; 0.00001) and 0.52 mm (MD) (95% CI 0.33 to 0.72; P &lt; 0.00001), respectively.</P>
<P>1b. Arthroplasty instability</P>
<P>We found no differences regarding arthroplasty instability when uncemented fixation without hydroxyapatite was compared to cemented fixation using available data (arthroplasty instability was considered an event), an intention-to-treat analysis (missing participants were categorized as unstable), and another intention-to-treat analysis (missing participants were categorized as stable), which revealed RRs of 0.54 (95% CI 0.24 to 1.22; P = 0.14), 0.66 (95% CI 0.37 to 1.17; P = 0.15), and 0.61 (95% CI 0.20 to 1.90; P = 0.4), respectively (<LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK>; <LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK>).</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Outcomes not analyzed by meta-analysis</HEADING>
<P>A meta-analysis and an intention-to-treat analysis were performed on the available data when outcomes were observed in more than one study with the same follow-up time. The tibial component was randomized in all of the studies except the study by <LINK REF="STD-Uvehammer-2007" TYPE="STUDY">Uvehammer 2007</LINK> (randomization of the femoral component). We could not perform a meta-analysis on the following outcomes.</P>
<P>The Hospital for Special Surgery knee score (HSS) results were reported in the studies by <LINK REF="STD-Uvehammer-2007" TYPE="STUDY">Uvehammer 2007</LINK> and <LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK>. This rating system generates a maximum score of 100 points. The resultant score was classified in the following ranges: &gt; 85 was excellent, 70 to 84 was good, 60 to 69 was fair and &lt; 60 was poor. According to <LINK REF="STD-Uvehammer-2007" TYPE="STUDY">Uvehammer 2007</LINK>, at the two year follow-up, the median HSS scores for the cemented (N = 27) and uncemented with hydroxyapatite (N = 21) femoral component groups were 92 (no SD; range 66 to 98) and 94 (no SD; range 70 to 98), respectively (P = 0.4) (the preoperative score was not reported). In the study by <LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK>, the median HSS preoperative scores for the cemented (N = 9) and uncemented without hydroxyapatite (N = 14) groups were 59 (no SD; range 46 to 79) and 59 (no SD; range 42 to 87), respectively. The postoperative scores at two years for the cemented and uncemented groups were 93 (no SD; range 90 to 97) and 88 (no SD; range 74 to 98), respectively. No significant differences were detected between the groups.</P>
<P>The Knee Society clinical rating system results were reported by <LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK> and <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK>. The Knee Society clinical rating score consists of two scores: a knee score and a functional score, which range from 0 to 100 points, with 100 points being the best score. Fifty of the 100 points in the knee score reflect pain assessment. In the study by <LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK>, knee osteoarthritis cases were stratified into two series. Series I comprised 90 patients submitted to unilateral total knee replacement, and Series II comprised 30 patients with bilateral, simultaneous knee replacements. The knees were randomized with respect to the fixation of the tibial component: cemented, uncemented with hydroxyapatite and uncemented without hydroxyapatite. The study did not individualize the preoperative and postoperative results to the type of tibial fixation but found no difference between the groups (five year follow-up). In the study by <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK>, the median Knee Society knee scores for the cemented (N = 26) and uncemented with hydroxyapatite (N = 27) groups were 15 (no SD; range 0 to 59) and 11 (no SD; range 0 to 43), respectively. At the five year follow-up, the median Knee Society knee scores for the cemented and uncemented with hydroxyapatite groups were 93 (no SD; range 69 to 99) and 93 (no SD; range 74 to 99), respectively. No significant difference was detected between the groups.</P>
<P>According to the study by <LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK>, all of the patients (9 cemented and 14 uncemented without hydroxyapatite) were satisfied with the results at a two year follow-up.</P>
<P>Total blood loss, red blood cell count, hemoglobin level, and hematocrit were reported by <LINK REF="STD-Ishii-2005b" TYPE="STUDY">Ishii 2005b</LINK>. Total blood loss did not differ between the two groups (cemented tibial component, 731 ± 288 mL; cementless tibial component, 731 ± 331 mL; P = 0.9117). The red blood cell count, hemoglobin level, and hematocrit returned to the preoperative levels within three months in both groups. There were no significant differences in tourniquet time (mean 65 ± 13 versus 60 ± 12 minutes in cementless and hybrid, respectively) or operation time (59 ± 12 and 55 ± 13 minutes, respectively) between the groups. No patient needed an additional transfusion. No significant difference was detected between the groups.</P>
<SUBSECTION>
<HEADING LEVEL="4">Complications</HEADING>
<P>Complications are summarized in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>.</P>
<P>Two deaths not related to surgical intervention and one myocardial infarction before the first roentgen stereophotogrammetric analysis (RSA) occurred in the study by <LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK> (all of the participants underwent tibial component fixation with cement).</P>
<P>During the study by <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK>, eight deaths not related to surgical intervention occurred (three from the cemented group and five from the uncemented with hydroxyapatite group). Before RSA, three participants were excluded: one due to myocardial infarction on the third postoperative day, one due to hemorrhage on the fifth postoperative day, and one participant was not treated according to the protocol. From these participants, two belonged to the cemented group and one belonged to the uncemented with hydroxyapatite group. However, it was not possible to correlate these participants to the events from the study description. Three participants were revised (loosening of the tibial component with uncemented fixation with hydroxyapatite occurred to one participant in the seventh postoperative month, and two participants with rheumatoid arthritis from the uncemented with hydroxyapatite group were revised between the first and second year due to infection).</P>
<P>Three participants were submitted to osteosynthesis due to a supracondylar femoral fracture (one uncemented with hydroxyapatite and two cemented) and remained in the analysis. Patellar aseptic necrosis occurred in one participant treated nonoperatively that evolved painlessly in a five year follow-up. A participant from the cemented group was excluded due to cerebral infarction after two years. In the study by <LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK>, one participant from the uncemented without hydroxyapatite group was revised due to infection, another due to instability (cemented group), and six participants died due to causes not related to the intervention (one from the cemented group, four from the uncemented without hydroxyapatite group and one from the uncemented with hydroxyapatite group).</P>
<P>In the study by <LINK REF="STD-Uvehammer-2007" TYPE="STUDY">Uvehammer 2007</LINK>, three unrelated deaths occurred (two from the cemented group and one from the uncemented with hydroxyapatite group).</P>
<P>
<LINK REF="STD-Ishii-2005b" TYPE="STUDY">Ishii 2005b</LINK> reported no complications like persistent drainage, dehiscence or infection.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Heterogeneity</HEADING>
<P>Except for rotation about the longitudinal axis, the data for the cemented fixation group versus the uncemented with and without hydroxyapatite groups comparison demonstrated no statistically significant heterogeneity using the Chi<SUP>2</SUP> test in conjunction with I<SUP>2</SUP> for all of the meta-analyses, including rotation about the transversal and sagittal axes in the same studies. The heterogeneity was also assessed by visual inspection of the forest plots (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>; <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>; <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>; <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>; <LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>; <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>; <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>; <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>; <LINK REF="CMP-003.03" TYPE="ANALYSIS">Analysis 3.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analysis</HEADING>
<P>Since <LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK> evaluated three types of tibial fixation (cemented, uncemented without hydroxyapatite and uncemented with hydroxyapatite), a comparison between the cemented group and the two types of uncemented fixation was possible (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>; <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>; <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>; <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>; <LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>; <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>). While migration analysis through the MTPM demonstrated that the cemented fixation migrated less than the uncemented types of fixation in 24 months, the uncemented types of fixation appeared to be more stable.</P>
<P>All of the studies included in this review evaluated osteoarthritis participants. <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK> included rheumatoid arthritis participants, and because there was no significant difference between these diagnoses, this author did not present separated results. Therefore, it was not possible to analyze subgroups according to the diagnosis. <LINK REF="STD-Ishii-2005b" TYPE="STUDY">Ishii 2005b</LINK> also included three rheumatoid arthritis participants but separated results were not provided.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessing publication bias</HEADING>
<P>A funnel plot with three and four studies was not considered useful and, therefore, was not produced.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Grading of the evidence<I> and summary of findings table</I>
</HEADING>
<P>The meta-analysis outcome was graded (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>) according to the GRADE approach (<LINK REF="REF-Sch_x00fc_nemann-2009" TYPE="REFERENCE">Schünemann 2009</LINK>).</P>
<P>The following seven important outcomes were selected for the summary of findings table: arthroplasty instability, survival of the implant, global assessment (patient), functional measures with validated instruments, pain, health-related quality of life, and total adverse events.</P>
<P>The quality of evidence was classified as moderate for arthroplasty instability because of the indirectness of the evidence.</P>
<P>We could not perform an analysis on the other patient-important outcomes.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2012-08-18 06:24:23 -0400" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2012-08-18 06:08:53 -0400" MODIFIED_BY="[Empty name]">
<P>Four of the five included studies (<LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK>; <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK>; <LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK>; <LINK REF="STD-Uvehammer-2007" TYPE="STUDY">Uvehammer 2007</LINK>) evaluated clinical and radiographic measures, with a particular focus on roentgen stereophotogrammetric analyses (RSA).</P>
<P>Roentgen stereophotogrammetric analysis allows the accurate three-dimensional measurement of micromotion between an implant and the host bone using roentgen rays (<LINK REF="REF-K_x00e4_rrholm-2006" TYPE="REFERENCE">Kärrholm 2006</LINK>; <LINK REF="REF-Valstar-2005" TYPE="REFERENCE">Valstar 2005</LINK>).<B> </B>Usually tantalum markers are fixed into the arthroplasty implant and into the bone where this implant is placed. After the surgery, control radiographs capture the distances between markers inside the implant and those in the bone. During follow-up, new radiographs are performed to measure the distance between markers, and consequently between the implant and bone. The most commonly used variables are absolute rotation around the three axes, maximum total point-motion (MTPM), lift-off, and subsidence. The rotations are measured around the transverse (flexion/extension), longitudinal (internal/external rotation) and sagittal (varus/valgus) axes. The MTPM is the total three-dimensional vector translation of the marker with the greatest motion.</P>
<P>Using high resolution analyses, small movements of the knee implants in relatively low numbers of participants measured by RSA after a short follow-up can predict the risk of future aseptic loosening (<LINK REF="REF-K_x00e4_rrholm-2006" TYPE="REFERENCE">Kärrholm 2006</LINK>; <LINK REF="REF-Ryd-1995" TYPE="REFERENCE">Ryd 1995</LINK>). <LINK REF="REF-Ryd-1995" TYPE="REFERENCE">Ryd 1995</LINK> showed that migration of the tibial component (MTPM) of more than 0.2 mm between one and two years predicted the risk for future aseptic loosening (predictive power of approximately 85%). Therefore, cases migrating at a higher rate were considered unstable, while those migrating at a lower rate were classified as stable.</P>
<P>For radiographic measures (using RSA), the risk of bias was considered low for most of the key domains among the studies. The blinding of outcome assessor was at high risk or unclear risk of bias in all of the studies, but there is no importance of blinding for RSA since this is an objective outcome. The quality of evidence was considered high for analyses of absolute values of rotation in the three orthogonal axes (transverse, longitudinal, and sagittal) but was considered moderate for arthroplasty instability because it was an indirect outcome. We considered there to be a high risk of attrition bias in the study by <LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK> because the withdrawal/drop-out rate was described, was unacceptable and was not comparable between the groups.</P>
<P>Using the available means and standard deviations from the selected studies, we were able to execute the meta-analysis and verify that tibial component fixation with cement presented a smaller displacement than fixation without cement (with or without hydroxyapatite) when evaluating MTPM through two years of follow-up data (MTPM, N = 167, two RCTs, MD = 0.52 mm, 95% CI 0.31 to 0.74). Furthermore, the intention-to-treat analysis verified the superiority in this previously analyzed variable (24-months MTPM, N = 173, two RCTs, MD = 0.52 mm, 95% CI 0.31 to 0.72).</P>
<P>These results were statistically significant; however, it is important to note that the MDs of the studied variables were less than one degree and less than one millimeter.</P>
<P>
<LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK> study demonstrated the superiority of cemented fixation over uncemented fixation concerning displacement at five years and is in agreement with our systematic review. <LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK> showed that cemented tibial components had lesser subsidence than uncemented components at two years.</P>
<P>Contrary to the previously mentioned findings, cementless components demonstrated 4.7 times lower risk of future aseptic loosening compared to cemented fixation according to the arthroplasty instability classification inferred from RSA (N = 216, three RCTs, RR = 0.47, 95% CI 0.24 to 0.92). The quality of this evidence is moderate and was downgraded by one level because of indirectness of evidence. Probably uncemented total knee arthroplasties are more stable and durable than cemented arthroplasties, but this information must be confirmed through RCTs with longer follow-up. Although aseptic loosening is mainly related to wear debris, the role of bone cement as initiator of osteolysis remains controversial (<LINK REF="REF-Harris-1976" TYPE="REFERENCE">Harris 1976</LINK>; <LINK REF="STD-Khaw-2002" TYPE="STUDY">Khaw 2002</LINK>; <LINK REF="REF-Mirra-1976" TYPE="REFERENCE">Mirra 1976</LINK>). On the other side, the cemented system can provide a more effective seal from wear particles improving arthroplasty durability (<LINK REF="REF-McCaskie-1998" TYPE="REFERENCE">McCaskie 1998</LINK>).</P>
<P>Although <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK> observed no difference between the hydroxyapatite-coated and cemented implants concerning displacement at five years, he noted distinct migration patterns. The uncemented components stabilized after an initial period of early and larger migration, whereas the cemented components did not show a tendency toward stabilization over time. This presumably reflected the different biological reactions at the implant-bone interface. A small difference at the level of the tibial cut implied that the uncemented component initially rests on only a small area of bone and gradually migrates until stronger bone and an equilibrium are reached. According to <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK>, because hydroxyapatite is osteoconductive, even in partially unstable conditions, it can be expected to shorten this period. The continuous migration pattern of cemented components suggests the presence of long-lasting bone remodeling at the interface when cement is used.</P>
<P>Other issues that remain inconclusive in total knee arthroplasty (mobile bearing versus fixed bearing, and posterior cruciate ligament sacrifice versus posterior cruciate ligament retention) are analyzed in other systematic reviews (<LINK REF="REF-Wilco-2001" TYPE="REFERENCE">Wilco 2001</LINK>; <LINK REF="REF-Wilco-2005" TYPE="REFERENCE">Wilco 2005</LINK>). <LINK REF="REF-Wilco-2001" TYPE="REFERENCE">Wilco 2001</LINK> systematic review included two studies and found no superiority between mobile and fixed bearing for total knee arthroplasty with regard to range of motion or functional performance of the participants. <LINK REF="REF-Wilco-2005" TYPE="REFERENCE">Wilco 2005</LINK> systematic review included studies with variable methodological quality and concluded that there was no solid base to decide whether or not to retain or sacrifice the posterior cruciate ligament in total knee replacement.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2012-08-18 06:16:50 -0400" MODIFIED_BY="[Empty name]">
<P>This systematic review has external validity for patients with osteoarthritis of the knee and other non-traumatic diseases, for example, rheumatoid arthritis. The exclusion criteria used in included studies did not affect the external validity of the meta-analyses performed (<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>). It is important to remember that: 1) The results of this systematic review do not apply to patients with post-traumatic osteoarthritis, and 2) The most common type of knee osteoarthritis is primary osteoarthritis (no known cause and is not a result of trauma). The included studies were insufficient to address all of the objectives of the review. We could not perform a meta-analysis on clinical and functional outcomes presented in the included studies because the combination of tibial and femoral fixation was not comparable among the studies.</P>
<P>Primary studies have reported some complications or adverse outcomes, and we could not investigate whether there was any possible correlation with the type of fixation.</P>
<P>
<LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK> was the only study to report revision due to loosening (one participant with uncemented fixation with hydroxyapatite). Any significant difference between the types of fixation could be presented in studies with follow-ups longer than five years.</P>
<P>Some complications were occasionally influenced by the type of fixation of both components, but the studies were designed to evaluate tibial or femoral components, and it was not possible to compare studies analyzing the total knee prosthesis with both components (femoral and tibial) fixed with cement, cementless or hybrid. <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK> and <LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK> analyzed the same follow-up period, but we could not perform a meta-analysis on the adverse outcomes because the femoral component was cemented or was not consistent with the preference of the surgeon in the study of Carlsson. As there were not two comparable groups between the studies by <LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK> (uncemented femur/cemented tibia or uncemented femur/uncemented tibia) and <LINK REF="STD-Uvehammer-2007" TYPE="STUDY">Uvehammer 2007</LINK> (uncemented femur/cemented tibia or cemented femur/uncemented tibia), we could not perform a meta-analysis on these studies.</P>
<P>Other comparisons were not possible because the means and standard deviations of other outcomes were not available.</P>
<P>The results of the review suggest that cementless total knee arthroplasty is more durable than a cemented one, but this supposition must be confirmed through RCTs with longer follow-up. We must bear in mind that cementless total knee arthroplasty is not available in all countries because it has a higher cost.</P>
<P>Future research must focus on major outcomes, such as health-related quality of life measures.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2012-08-18 06:18:38 -0400" MODIFIED_BY="[Empty name]">
<P>Through available data, uncemented fixation with and without hydroxyapatite was found to be superior to cemented fixation according to arthroplasty instability classification inferred from RSA (N = 216, three RCTs, RR = 0.47, 95% CI 0.24 to 0.92). The quality of this evidence is moderate and was downgraded one level because this is an indirect outcome that predicts arthroplasty instability. We found no key methodological limitations of the studies and their results were consistent. Arthroplasty instability is an important outcome for the surgeon and is something the patient can understand. Taking into account the methodological quality and power of included studies, the results of the review suggest higher durability of cementless total knee arthroplasty.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2012-06-19 14:29:34 -0400" MODIFIED_BY="[Empty name]">
<P>The strengths of this systematic review are: there were no language restrictions in search strategy, two authors independently selected studies and a third author was consulted when there were disagreements, and contact was made with all of the authors of primary studies to obtain missing data.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2012-08-18 06:24:23 -0400" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="REF-Gandhi-2009" TYPE="REFERENCE">Gandhi 2009</LINK> conducted meta-analyses to verify clinical function and survival of fully cemented and fully uncemented prostheses in total knee replacement. In addition to these types of fixation, our systematic review also studied hybrid fixation.<BR/>
<LINK REF="REF-Gandhi-2009" TYPE="REFERENCE">Gandhi 2009</LINK> included studies with participants with knee osteoarthritis and rheumatoid arthritis, without exclusion of studies with post-traumatic arthritis as in our systematic review. This increases the external validity of <LINK REF="REF-Gandhi-2009" TYPE="REFERENCE">Gandhi 2009</LINK>, but increases the heterogeneity of their patients.<BR/>
<LINK REF="REF-Gandhi-2009" TYPE="REFERENCE">Gandhi 2009</LINK> included randomized and quasi-randomized controlled trials and observational studies, while our systematic review aimed to include only randomized controlled trials. The inclusion of unpublished abstracts increased the power of <LINK REF="REF-Gandhi-2009" TYPE="REFERENCE">Gandhi 2009</LINK> meta-analyses.<BR/>
<LINK REF="REF-Gandhi-2009" TYPE="REFERENCE">Gandhi 2009</LINK> assessed only the survival of the implant free of aseptic loosening at a minimum follow-up of two years and joint function measured by the Knee Society Score. In our systematic review the number of outcomes is broader (<LINK TAG="CRIT_OUTCOMES" TYPE="SECTION">Types of outcome measures</LINK>), including RSA that can predict aseptic loosening.<BR/>
</P>
<P>The search strategy of <LINK REF="REF-Gandhi-2009" TYPE="REFERENCE">Gandhi 2009</LINK> resulted in five RCTs (<LINK REF="STD-Khaw-2002" TYPE="STUDY">Khaw 2002</LINK>; <LINK REF="REF-Gicquel-2000" TYPE="REFERENCE">Gicquel 2000</LINK>; <LINK REF="REF-McCaskie-1998" TYPE="REFERENCE">McCaskie 1998</LINK>; <LINK REF="STD-Nilsson-1992" TYPE="STUDY">Nilsson 1992</LINK>; <LINK REF="REF-Nilsson-1993" TYPE="REFERENCE">Nilsson 1993</LINK>) and 10 observational studies while our search strategy resulted in five RCTs (three could be used for meta-analyses). The study of <LINK REF="REF-Gandhi-2009" TYPE="REFERENCE">Gandhi 2009</LINK> should have included the <LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK> study since the authors observed the clinical function of fully cemented and fully uncemented total knee arthroplasties. We did not include <LINK REF="REF-Nilsson-1993" TYPE="REFERENCE">Nilsson 1993</LINK> and <LINK REF="REF-McCaskie-1998" TYPE="REFERENCE">McCaskie 1998</LINK> studies because the authors performed a quasi-randomized method of allocation. We did not include <LINK REF="STD-Khaw-2002" TYPE="STUDY">Khaw 2002</LINK>; <LINK REF="REF-Gicquel-2000" TYPE="REFERENCE">Gicquel 2000</LINK> and <LINK REF="STD-Nilsson-1992" TYPE="STUDY">Nilsson 1992</LINK> studies because there was no differentiation between post-traumatic and non post-traumatic osteoarthritis.</P>
<P>According to <LINK REF="REF-Gandhi-2009" TYPE="REFERENCE">Gandhi 2009</LINK>, the combined odds ratio for aseptic loosening for the uncemented group was 4.2 (95% CI 2.7 to 6.5; P &lt; 0.0001). However, subgroup analysis of data only from RCTs showed no differences between the groups for odds of aseptic loosening (OR 1.9, 95% CI 0.55 to 6.40; P = 0.314). <LINK REF="REF-Gandhi-2009" TYPE="REFERENCE">Gandhi 2009</LINK> found no difference between the groups for the Knee Society Knee Score (MD 0.005, 95% CI -0.26 to 0.26; P = 0.972).</P>
<P>The concept of survival of the implant free of aseptic loosening was based on a minimum follow-up of two years in <LINK REF="REF-Gandhi-2009" TYPE="REFERENCE">Gandhi 2009</LINK> study. This follow-up can be considered short to evaluate implant survival and can explain why <LINK REF="REF-Gandhi-2009" TYPE="REFERENCE">Gandhi 2009</LINK> found no difference when he made a subgroup analysis with only the randomized controlled trials.</P>
<P>There are follow-up limitations in current primary studies, in which case RSA can provide a better idea of risk of future aseptic loosening as in our systematic review, even with a relative low number of participants after a short follow-up of two years (<LINK REF="REF-K_x00e4_rrholm-2006" TYPE="REFERENCE">Kärrholm 2006</LINK>; <LINK REF="REF-Ryd-1995" TYPE="REFERENCE">Ryd 1995</LINK>).</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2012-08-18 06:26:16 -0400" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2012-08-18 06:25:41 -0400" MODIFIED_BY="[Empty name]">
<P>We observed that cemented fixation of the tibial component demonstrated a smaller displacement in relation to cementless fixation in a two to five year follow-up.</P>
<P>The cemented tibial components demonstrated an increased risk of subsequent loosening compared to the cementless components using RSA which has a predictive power of approximately 85%. </P>
<P>Through the included studies, we found no indication that either cemented or uncemented total knee arthroplasty results in better functional performance of the participants.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2012-08-18 06:26:16 -0400" MODIFIED_BY="[Empty name]">
<P>A specific problem related to comparing prostheses is that the differences are small, and consequently, the effect on participant performance for a given parameter can be difficult to detect and can only be detected with large sample sizes with longer follow-ups.</P>
<P>Although RSA in two to five year follow-ups suggested the most stable fixation for total knee prosthesis, to assure the superiority of one type of fixation in relation to another, we must base the results on the following: 1) revision rate, 2) adverse events, and 3) functional status and health-related quality of life.</P>
<P>Some studies failed to present validated instruments, blinding of outcomes, means, standard deviations or an intention-to-treat analysis. In future studies, we suggest that these methodological aspects must be considered to attempt to solve the question of total knee prosthesis fixation.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2012-08-18 06:27:04 -0400" MODIFIED_BY="[Empty name]">
<P>We would like to acknowledge Regis Bruni Andriolo, Jose Fausto de Morais, Elizabeth Ghogomu and Lara J. Maxwell for methodological and statistical support and to Mario Lenza (surgical editor) for his comments.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2012-08-18 06:28:28 -0400" MODIFIED_BY="[Empty name]">
<P>None known.</P>
<P>Ricardo Dizioli Navaro deceased; declarations of interest published in the protocol: "none known".</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-08-18 06:27:50 -0400" MODIFIED_BY="[Empty name]">
<P>Gilberto Yoshinobu Nakama - Protocol and review writing, search procedures, studies selection, inclusion criteria.<BR/>Gustavo JM Almeida - Protocol writing, search procedures, studies selection, inclusion criteria.<BR/>Maria Stella Peccin - Protocol writing, search procedures, inclusion criteria.<BR/>Ozorio A Lira Neto - Protocol writing, search procedures, studies selection, inclusion criteria.</P>
<P>Antônio Altenor B. Queiroz - Protocol writing.<BR/>Ricardo Dizioli Navarro - Protocol writing and review writing. (The author is deceased (July 2010), and the living authors did not make substantive changes to the review beyond the deceased author's contribution).</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2011-09-20 22:11:19 -0400" MODIFIED_BY="[Empty name]">
<P>We included the Current Controlled Trials in the electronic search strategies and the risk of bias and summary of findings tables were completed.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2012-08-22 11:23:36 -0400" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2012-08-17 05:40:27 -0400" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2012-08-17 05:31:38 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="MIX" ID="STD-Carlsson-2005" MODIFIED="2012-02-21 21:40:20 -0500" MODIFIED_BY="[Empty name]" NAME="Carlsson 2005" YEAR="2005">
<REFERENCE MODIFIED="2012-02-21 21:40:02 -0500" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Carlsson A, Björkman A, Besjakov J, Onsten I</AU>
<TI>Cemented tibial component fixation performs better than cementless fixation: a randomized radiostereometric study comparing porous-coated, hydroxyapatite-coated and cemented tibial components over 5 years</TI>
<SO>Acta Orthopaedica</SO>
<YR>2005 Jun</YR>
<VL>76(3)</VL>
<PG>362-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-02-21 21:40:20 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Carlsson A</AU>
<SO>Personal communication</SO>
<YR>July 2008</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2012-02-21 21:27:34 -0500" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Ishii-2005b" MODIFIED="2012-08-17 04:49:05 -0400" MODIFIED_BY="[Empty name]" NAME="Ishii 2005b" YEAR="2005">
<REFERENCE MODIFIED="2012-08-17 04:49:05 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ishii Y, Matsuda Y</AU>
<TI>Perioperative blood loss in cementless or hybrid total knee arthroplasty without patellar resurfacing</TI>
<SO>Journal of Arthroplasty</SO>
<YR>2005</YR>
<VL>20</VL>
<NO>8</NO>
<PG>972-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-02-21 22:00:54 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Ishii Y</AU>
<SO>Personal communication</SO>
<YR>January 2012</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Nilsson-1999" MODIFIED="2012-08-17 04:49:41 -0400" MODIFIED_BY="[Empty name]" NAME="Nilsson 1999" YEAR="1999">
<REFERENCE MODIFIED="2012-08-17 04:49:41 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Nilsson KG, Kärrholm J, Carlsson L, Dalén T</AU>
<TI>Hydroxyapatite coating versus cemented fixation of the tibial component in total knee arthroplasty: prospective randomized comparison of hydroxyapatite-coated and cemented tibial components with 5-year follow-up using radiostereometry</TI>
<SO>Journal of Arthroplasty</SO>
<YR>1999</YR>
<VL>14</VL>
<NO>1</NO>
<PG>9-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-02-21 22:10:06 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Nilsson KG</AU>
<SO>Personal communication</SO>
<YR>May 2008</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Toksvig_x002d_Larsen-1998" MODIFIED="2012-08-17 05:31:38 -0400" MODIFIED_BY="[Empty name]" NAME="Toksvig-Larsen 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-08-17 05:31:38 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Toksvig-Larsen S, Ryd L, Lindstrand A</AU>
<TI>Early inducible displacement of tibial components in total knee prostheses inserted with and without cement: a randomized study with roentgen stereophotogrammetric analysis</TI>
<SO>Journal of Bone and Joint Surgery - American Volume</SO>
<YR>1998 Jan</YR>
<VL>80</VL>
<NO>1</NO>
<PG>83-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-02-21 22:16:33 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Toksvig-Larsen S</AU>
<SO>Personal communication</SO>
<YR>May 2008</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Uvehammer-2007" MODIFIED="2008-06-24 18:31:34 -0400" MODIFIED_BY="[Empty name]" NAME="Uvehammer 2007" YEAR="2006">
<REFERENCE MODIFIED="2008-06-24 18:31:34 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Uvehammer J, Kärrholm J, Carlsson L</AU>
<TI>Cemented versus hydroxyapatite fixation of the femoral component of the Freeman-Samuelson total knee replacement: a radiostereometric analysis</TI>
<SO>Journal of Bone and Joint Surgery - British Volume</SO>
<YR>2007 Jan</YR>
<VL>89</VL>
<NO>1</NO>
<PG>39-44</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2008-05-11 16:44:40 -0400" MODIFIED_BY="[Empty name]"/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2012-08-17 05:34:52 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="MIX" ID="STD-Albrektsson-1992" MODIFIED="2012-02-21 22:21:12 -0500" MODIFIED_BY="[Empty name]" NAME="Albrektsson 1992" YEAR="1992">
<REFERENCE MODIFIED="2012-02-21 22:21:12 -0500" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Albrektsson BE, Carlsson LV, Freeman MA, Herberts P, Ryd L</AU>
<TI>Proximally cemented versus uncemented Freeman-Samuelson knee arthroplasty. A prospective randomised study</TI>
<SO>Journal of Bone and Joint Surgery - British Volume</SO>
<YR>1992 Mar</YR>
<VL>74</VL>
<NO>2</NO>
<PG>233-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-02-21 21:50:05 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Albrektsson BE</AU>
<SO>Personal communication</SO>
<YR>November 2007</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Baker-2007" MODIFIED="2012-08-17 05:32:49 -0400" MODIFIED_BY="[Empty name]" NAME="Baker 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-08-17 05:32:49 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Baker PN, Khaw FM, Kirk LM, Esler CN, Gregg PJ</AU>
<TI>A randomised controlled trial of cemented versus cementless press-fit condylar total knee replacement: 15-year survival analysis</TI>
<SO>Journal of Bone and Joint Surgery - British Volume</SO>
<YR>2007</YR>
<VL>89</VL>
<NO>12</NO>
<PG>1608-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-02-21 22:20:35 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Khaw FM</AU>
<SO>Personal communication</SO>
<YR>October 2007</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Beaupr_x00e9_-2007" MODIFIED="2012-08-17 05:33:26 -0400" MODIFIED_BY="[Empty name]" NAME="Beaupré 2007" YEAR="2007">
<REFERENCE MODIFIED="2012-08-17 05:33:26 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Beaupré LA, al-Yamani M, Huckell JR, Johnston DW</AU>
<TI>Hydroxyapatite-coated tibial implants compared with cemented tibial fixation in primary total knee arthroplasty. A randomized trial of outcomes at five years</TI>
<SO>Journal of Bone and Joint Surgery - American Volume</SO>
<YR>2007</YR>
<VL>89</VL>
<NO>10</NO>
<PG>2204-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-02-21 21:53:08 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Beaupré LA</AU>
<SO>Personal communication</SO>
<YR>July 2008</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Ishii-2005a" MODIFIED="2012-08-17 05:34:52 -0400" MODIFIED_BY="[Empty name]" NAME="Ishii 2005a" YEAR="2005">
<REFERENCE MODIFIED="2012-08-17 05:34:52 -0400" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Ishii Y, Matsuda Y, Sakata S, Onda N, Omori G</AU>
<TI>Primary total knee arthroplasty using the Genesis I total knee prosthesis: a 5- to 10-year follow-up study</TI>
<SO>The Knee</SO>
<YR>2005 Oct</YR>
<VL>12</VL>
<NO>5</NO>
<PG>341-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-02-21 21:57:54 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Ishii Y</AU>
<SO>Personal communication</SO>
<YR>September 2007</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Keblish-1993" MODIFIED="2012-02-21 22:22:02 -0500" MODIFIED_BY="[Empty name]" NAME="Keblish 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-02-21 22:22:02 -0500" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Keblish P, Udvarhelyi I, Váczi G</AU>
<TI>Low contact stress knee prosthesis system. Results and complications</TI>
<SO>Magyar traumatológia, ortopédia, kézsebészet, plasztikai sebészet</SO>
<YR>1993</YR>
<VL>36</VL>
<NO>3</NO>
<PG>243-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-02-21 22:19:35 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Váczi G</AU>
<SO>Personal communication</SO>
<YR>October 2007</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Khaw-2002" MODIFIED="2012-02-21 22:22:30 -0500" MODIFIED_BY="[Empty name]" NAME="Khaw 2002" YEAR="2002">
<REFERENCE MODIFIED="2012-02-21 22:22:30 -0500" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Khaw FM, Kirk LM, Morris RW, Gregg PJ</AU>
<TI>A randomised, controlled trial of cemented versus cementless press-fit condylar total knee replacement. Ten-year survival analysis</TI>
<SO>Journal of Bone and Joint Surgery - British Volume</SO>
<YR>2002</YR>
<VL>84</VL>
<NO>5</NO>
<PG>658-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-02-21 22:04:18 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Khaw FM</AU>
<SO>Personal communication</SO>
<YR>October 2007</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="MIX" ID="STD-Nilsson-2006" MODIFIED="2012-02-21 22:22:52 -0500" MODIFIED_BY="[Empty name]" NAME="Nilsson 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-02-21 22:22:52 -0500" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Nilsson KG, Henricson A, Norgren B, Dalén T</AU>
<TI>Uncemented HA-coated implant is the optimum fixation for TKA in the young patient</TI>
<SO>Clinical Orthopaedics and Related Research</SO>
<YR>2006 Jul</YR>
<VL>448</VL>
<PG>129-39</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-02-21 22:07:06 -0500" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CORRESPONDENCE">
<AU>Nilsson KG</AU>
<SO>Personal communication</SO>
<YR>September 2007</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-_x00d6_nsten-1998" MODIFIED="2008-06-24 18:28:35 -0400" MODIFIED_BY="[Empty name]" NAME="Önsten 1998" YEAR="1998">
<REFERENCE MODIFIED="2008-06-24 18:28:35 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Önsten I, Nordqvist A, Carlsson AS, Besjakov J, Shott S</AU>
<TI>Hydroxyapatite augmentation of the porous coating improves fixation of tibial components. A randomised RSA study in 116 patients</TI>
<SO>Journal of Bone and Joint Surgery - British Volume</SO>
<YR>1998</YR>
<VL>80-B</VL>
<PG>417-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2012-08-17 05:40:27 -0400" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Demey-2010" MODIFIED="2012-08-17 05:38:20 -0400" MODIFIED_BY="[Empty name]" NAME="Demey 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-08-17 05:38:20 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Demey G, Servien E, Pinaroli A, Lustig S, Aït Si Selmi T, Neyret P</AU>
<TI>The influence of femoral cementing on perioperative blood loss in total knee arthroplasty: a prospective randomized study</TI>
<SO>Journal of Bone and Joint Surgery - American Volume</SO>
<YR>2010</YR>
<VL>92</VL>
<NO>3</NO>
<PG>536-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dunbar-2009" MODIFIED="2012-08-17 05:39:12 -0400" MODIFIED_BY="[Empty name]" NAME="Dunbar 2009" YEAR="2009">
<REFERENCE MODIFIED="2012-08-17 05:39:12 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dunbar MJ, Wilson DA, Hennigar AW, Amirault JD, Gross M, Reardon GP</AU>
<TI>Fixation of a trabecular metal knee arthroplasty component. A prospective randomized study</TI>
<SO>Journal of Bone and Joint Surgery - American Volume</SO>
<YR>2009</YR>
<VL>91</VL>
<NO>7</NO>
<PG>1578-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Nelissen-1998" MODIFIED="2012-08-17 05:39:37 -0400" MODIFIED_BY="[Empty name]" NAME="Nelissen 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-08-17 05:39:37 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nelissen RG, Valstar ER, Rozing PM</AU>
<TI>The effect of hydroxyapatite on the micromotion of total knee prostheses. A prospective, randomized, double-blind study</TI>
<SO>Journal of Bone and Joint Surgery - American Volume</SO>
<YR>1998</YR>
<VL>80</VL>
<NO>11</NO>
<PG>1665-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Nilsson-1992" MODIFIED="2012-08-17 05:40:14 -0400" MODIFIED_BY="[Empty name]" NAME="Nilsson 1992" YEAR="1992">
<REFERENCE MODIFIED="2012-08-17 05:40:14 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nilsson KG, Björnebrink J, Hietala SO, Kärrholm J</AU>
<TI>Scintimetry after total knee arthroplasty. Prospective 2-year study of 18 cases of arthrosis and 15 cases of rheumatoid arthritis</TI>
<SO>Acta Orthopaedica Scandinavica</SO>
<YR>1992 Apr</YR>
<VL>63</VL>
<NO>2</NO>
<PG>159-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Parker-2001" MODIFIED="2012-08-17 05:40:27 -0400" MODIFIED_BY="[Empty name]" NAME="Parker 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-08-17 05:40:27 -0400" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Parker DA, Rorabeck CH, Bourne RB</AU>
<TI>Long-term follow up of cementless versus hybrid fixation for total knee arthroplasty</TI>
<SO>Clinical Orthopaedics and Related Research</SO>
<YR>2001 Jul</YR>
<VL>388</VL>
<PG>68-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2012-08-22 11:23:36 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2012-08-22 11:23:36 -0400" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Altman-1995" MODIFIED="2012-08-17 05:46:16 -0400" MODIFIED_BY="[Empty name]" NAME="Altman 1995" TYPE="JOURNAL_ARTICLE">
<AU>Altman DG, Bland JM</AU>
<TI>Statistics notes: The normal distribution</TI>
<SO>BMJ</SO>
<YR>1995</YR>
<VL>310</VL>
<PG>298</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Altman-1996" MODIFIED="2012-08-17 05:46:49 -0400" MODIFIED_BY="[Empty name]" NAME="Altman 1996" TYPE="JOURNAL_ARTICLE">
<AU>Altman DG, Bland JM</AU>
<TI>Detecting skewness from summary information</TI>
<SO>BMJ</SO>
<YR>1996</YR>
<VL>313</VL>
<PG>1200</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Brassard-2006" MODIFIED="2012-08-17 05:54:55 -0400" MODIFIED_BY="[Empty name]" NAME="Brassard 2006" TYPE="BOOK_SECTION">
<AU>Brassard MF, Insall JN, Scuderi GR, Faris PM</AU>
<TI>Complications of total knee arthroplasty</TI>
<SO>Surgery of the knee</SO>
<YR>2006</YR>
<VL>2</VL>
<PG>1716-60</PG>
<EN>4th</EN>
<ED>Insall JN, Scott WN</ED>
<PB>Churchill Livingstone</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Castro-1999" NAME="Castro 1999" TYPE="JOURNAL_ARTICLE">
<AU>Castro AA, Clark OA, Atallah AN</AU>
<TI>Optimal search strategy for clinical trials in the Latin American and Caribbean Health Science Literature Database (LILACS database): Update [Letter]</TI>
<SO>São Paulo Medical Journal = Revista Paulista de Medicina</SO>
<YR>1999</YR>
<VL>117</VL>
<NO>3</NO>
<PG>138-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cates-2004" MODIFIED="2010-08-27 11:08:48 -0400" MODIFIED_BY="[Empty name]" NAME="Cates 2004" TYPE="OTHER">
<AU>Cates C</AU>
<TI>Visual Rx 2.0 NNT Calculator</TI>
<SO>Dr Chris Cates EBM Website - www.nntonline.net</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dickersin-1994" MODIFIED="2012-08-17 05:54:03 -0400" MODIFIED_BY="Charlotte Archibald" NAME="Dickersin 1994" TYPE="JOURNAL_ARTICLE">
<AU>Dickersin K, Scherer R, Levefre C</AU>
<TI>Identifying relevant studies for systematic reviews</TI>
<SO>BMJ</SO>
<YR>1994</YR>
<VL>309</VL>
<PG>1286-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fehring-2006" NAME="Fehring 2006" TYPE="BOOK_SECTION">
<AU>Fehring TK, Mason JB</AU>
<TI>Cemented total knee replacement: The gold standard</TI>
<SO>Surgery of the knee</SO>
<YR>2006</YR>
<PG>1626-30</PG>
<EN>4th</EN>
<ED>Insall JN, Scott WN</ED>
<PB>Churchill Livingstone</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gandhi-2009" MODIFIED="2012-02-14 02:01:34 -0500" MODIFIED_BY="[Empty name]" NAME="Gandhi 2009" TYPE="JOURNAL_ARTICLE">
<AU>Gandhi R, Tsvetkov D, Davey JR, Mahomed NN</AU>
<TI>Survival and clinical function of  cemented and uncemented prostheses in total knee replacement: a meta-analysis</TI>
<SO>Journal of Bone and Joint Surgery - British Volume</SO>
<YR>2009</YR>
<VL>91</VL>
<NO>7</NO>
<PG>889-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gicquel-2000" MODIFIED="2012-06-19 20:01:48 -0400" MODIFIED_BY="[Empty name]" NAME="Gicquel 2000" TYPE="JOURNAL_ARTICLE">
<AU>Gicquel P, Kempf JF, Gastaud F, Schlemmer B, Bonnomet F</AU>
<TI>Comparative study of fixation mode in total knee arthroplasty with preservation of the posterior cruciate ligament</TI>
<SO>Revue de Chirurgie Orthopédique et Réparatrice de l'Appareil Moteur</SO>
<YR>2000</YR>
<VL>86</VL>
<PG>240-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Harris-1976" NAME="Harris 1976" TYPE="JOURNAL_ARTICLE">
<AU>Harris WH, Schiller AL, Scholler JM, Freiberg RA, Scott R</AU>
<TI>Extensive localized bone resorption in the femur following total hip replacement</TI>
<SO>Journal of Bone and Joint Surgery - American Volume</SO>
<YR>1976</YR>
<VL>58</VL>
<NO>5</NO>
<PG>612-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2012-08-17 05:56:09 -0400" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Altman DG, Sterne JAC (editors)</AU>
<TI>Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS MODIFIED="2011-09-20 21:16:03 -0400" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE ID="REF-Huiskes-1998" NAME="Huiskes 1998" TYPE="JOURNAL_ARTICLE">
<AU>Huiskes R</AU>
<TI>The causes of failure for hip and knee arthroplasties</TI>
<TO>Oorzaken van falen van heup- en knieartroplastieken</TO>
<SO>Nederlands Tijdschrift voor Geneeskunde</SO>
<YR>1998</YR>
<VL>142</VL>
<NO>37</NO>
<PG>2035-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-K_x00e4_rrholm-2006" MODIFIED="2009-04-09 22:28:22 -0400" MODIFIED_BY="[Empty name]" NAME="Kärrholm 2006" TYPE="JOURNAL_ARTICLE">
<AU>Kärrholm J, Gill RH, Valstar ER</AU>
<TI>The history and future of radiostereometric analysis</TI>
<SO>Clinical Orthopaedics and Related Research</SO>
<YR>2006</YR>
<VL>448</VL>
<PG>10-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Maloney-1996" MODIFIED="2012-08-17 05:57:55 -0400" MODIFIED_BY="Charlotte Archibald" NAME="Maloney 1996" TYPE="JOURNAL_ARTICLE">
<AU>Maloney WJ, Woolson ST</AU>
<TI>Increasing incidence of femoral osteolysis in association with uncemented Harris-Galante total hip arthroplasty: a follow-up report</TI>
<SO>Journal of Arthroplasty</SO>
<YR>1996</YR>
<VL>11</VL>
<PG>130-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McCaskie-1998" NAME="McCaskie 1998" TYPE="JOURNAL_ARTICLE">
<AU>McCaskie AW, Deehan DJ, Green TP, Lock KR, Thompson JR, Harper WM, et al</AU>
<TI>Randomised, prospective study comparing cemented and cementless total knee replacement: results of press-fit condylar total knee replacement at five years</TI>
<SO>Journal of Bone and Joint Surgery - British Volume</SO>
<YR>1998</YR>
<VL>80</VL>
<NO>6</NO>
<PG>971-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McCormack-2009" MODIFIED="2012-08-22 11:23:36 -0400" MODIFIED_BY="[Empty name]" NAME="McCormack 2009" TYPE="COCHRANE_PROTOCOL">
<AU>McCormack K, Cody DJ, Murray D, Ramsay CR, Campbell MK</AU>
<TI>Metal versus non-metal backing of the tibial component for total knee replacement for osteoarthritis and/or rheumatoid arthritis</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2010-08-27 10:49:24 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-08-27 10:49:24 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004801"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Mirra-1976" NAME="Mirra 1976" TYPE="JOURNAL_ARTICLE">
<AU>Mirra JM, Amstutz HC, Matos M, Gold R</AU>
<TI>The pathology of the joint tissues and its clinical relevance in prosthesis failure</TI>
<SO>Clinical Orthopaedics and Related Research</SO>
<YR>1976</YR>
<VL>117</VL>
<PG>221-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Morais-2012" MODIFIED="2012-08-17 06:00:05 -0400" MODIFIED_BY="[Empty name]" NAME="Morais 2012" TYPE="OTHER">
<AU>Morais JF</AU>
<TI>The relationship among the standard deviation of a dataset and the standard deviation and average two part of this set</TI>
<SO>arXiv: 1202.0850v1[stat.ME]</SO>
<YR>2012</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nilsson-1993" MODIFIED="2012-08-17 06:00:19 -0400" MODIFIED_BY="[Empty name]" NAME="Nilsson 1993" TYPE="JOURNAL_ARTICLE">
<AU>Nilsson KG, Karrholm J</AU>
<TI>Increased varus-valgus tilting of screw-fixated knee prostheses: stereoradiographic study of uncemented versus cemented tibial components</TI>
<SO>The Journal of Arthroplasty</SO>
<YR>1993</YR>
<VL>8</VL>
<PG>529-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ryd-1995" MODIFIED="2009-04-09 22:47:01 -0400" MODIFIED_BY="[Empty name]" NAME="Ryd 1995" TYPE="JOURNAL_ARTICLE">
<AU>Ryd L, Albrektsson BE, Carlsson L, Dansgård F, Herberts P, Lindstrand A, et al</AU>
<TI>Roentgen stereophotogrammetric analysis as a predictor of mechanical loosening of knee prostheses</TI>
<SO>Journal of Bone and Joint Surgery - British Volume</SO>
<YR>1995</YR>
<VL>77</VL>
<NO>3</NO>
<PG>377-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sch_x00fc_nemann-2009" MODIFIED="2012-08-17 06:01:52 -0400" MODIFIED_BY="[Empty name]" NAME="Schünemann 2009" TYPE="OTHER">
<AU>Schünemann H, Bro&#380;ek J, Oxman A, editors</AU>
<TI>GRADE handbook for grading quality of evidence and strength of recommendation</TI>
<SO>Version 3.2 [updated March 2009]. The GRADE Working Group, 2009. Available from http://www.cc-ims.net/gradepro</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Valstar-2005" MODIFIED="2009-04-09 22:45:30 -0400" MODIFIED_BY="[Empty name]" NAME="Valstar 2005" TYPE="JOURNAL_ARTICLE">
<AU>Valstar ER, Gill R, Ryd L, Flivik G, Börlin N, Kärrholm J</AU>
<TI>Guidelines for standardization of radiostereometry (RSA) of implants</TI>
<SO>Acta Orthopaedica</SO>
<YR>2005</YR>
<VL>76</VL>
<NO>4</NO>
<PG>563-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Whiteside-2006" NAME="Whiteside 2006" TYPE="BOOK_SECTION">
<AU>Whiteside LA</AU>
<TI>Cementless total knee designs</TI>
<SO>Surgery of the knee</SO>
<YR>2006</YR>
<PG>1613-25</PG>
<EN>4</EN>
<ED>Insall JN, Scott WN</ED>
<PB>Churchill Livingstone</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wilco-2001" MODIFIED="2012-08-17 06:11:36 -0400" MODIFIED_BY="[Empty name]" NAME="Wilco 2001" TYPE="COCHRANE_REVIEW">
<AU>Jacobs W, Anderson PG, van Limbeek J, Wymenga AAB</AU>
<TI>Mobile bearing vs fixed bearing prostheses for total knee arthroplasty for post-operative functional status in patients with osteoarthritis and rheumatoid arthritis</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2012-07-19 18:14:54 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-07-19 18:14:54 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD003130.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Wilco-2005" MODIFIED="2012-08-17 06:11:27 -0400" MODIFIED_BY="[Empty name]" NAME="Wilco 2005" TYPE="COCHRANE_REVIEW">
<AU>Jacobs W, Clement DJ, Wymenga AAB</AU>
<TI>Retention versus sacrifice of the posterior cruciate ligament in total knee replacement for treatment of osteoarthritis and rheumatoid arthritis</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2012-08-17 06:11:22 -0400" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-08-17 06:11:22 -0400" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004803.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2012-08-21 14:57:48 -0400" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2012-08-21 14:40:37 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2012-08-18 06:29:33 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Carlsson-2005">
<CHAR_METHODS MODIFIED="2012-08-18 06:29:33 -0400" MODIFIED_BY="[Empty name]">
<P>RCT, computer generated randomization. The primary outcome measure in this study was RSA, which is a radiographic "measuring tool", and was not influenced by the assessor. For the secondary outcome measure, i.e. the clinical data, the assessor was not blinded.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-07-25 22:21:09 -0400" MODIFIED_BY="[Empty name]">
<P>Inclusion: Osteoarthrosis: 120 participants (150 knees). Exclusion: Revision, history of joint sepsis, recent systemic corticosteroids, primary or secondary carcinoma in the last five years, metabolic bone disease, such as Paget&#8217;s disease, psychosocial disorders limiting rehabilitation, previous intraarticular knee fracture, over 20° valgus or varus deformity, extension loss over 30°, unsuitable for cruciate-retaining arthroplasty, unsuitable for cementless fixation of the tibial component, need for augmentation wedges or bone grafts, previous proximal tibial osteotomy, and greater than 80 years old. Average age: 73 years. Average weight: 79 kg. Seven participants lost.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-07-25 22:21:09 -0400" MODIFIED_BY="[Empty name]">
<P>Randomized tibial component fixation: Cemented (only under the tibial plateau), uncemented porous, or uncemented porous hydroxyapatite. According to the preference of the surgeons, the femoral component was cemented or not, although according to the protocol, the patella should not be resurfaced, and a surgeon chose to implant a patellar component in 2 participants.</P>
<P>The Press-Fit Condylar (PFC) modular, posterior-cruciate-retaining prosthesis with a posterior lipped polyethylene insert (Johnson and Johnson Orthopaedics) was used in all cases.</P>
<P>Vacuum-mixed, gentamicin-loaded cement (Palacos cum Gentamicin; Schering-Plough, Kenilworth, NJ) was used.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-07-25 22:21:09 -0400" MODIFIED_BY="[Empty name]">
<P>RSA (absolute values of rotation around the three orthogonal axes, MTPM, lift-off, subsidence), Knee Society clinical rating system and method of Ewald. Individual data were sent for the systematic review by the author (Åke Carlsson).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-25 22:21:09 -0400" MODIFIED_BY="[Empty name]">
<P>Duration of follow-up: 5 years. The cemented knees rotated less than uncemented knees with or without hydroxyapatite and migrated less than uncemented knees without hydroxyapatite.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-08-18 06:34:18 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ishii-2005b">
<CHAR_METHODS MODIFIED="2012-08-18 06:32:12 -0400" MODIFIED_BY="[Empty name]">
<P>RCT</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-08-18 06:32:22 -0400" MODIFIED_BY="[Empty name]">
<P>Osteoarthritis: 54 participants (56 knees), Rheumathoid arthritis: 3 participants (4 knees). Exclusion criteria: Peripherical vascular diseases or neurological problems. Average age of cementless group: 72 years. Average weight of cementless group: 59 kg. Average age of hybrid group: 72 years. Average weight of hybrid group: 61 kg. None participant lost.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-08-18 06:33:20 -0400" MODIFIED_BY="[Empty name]">
<P>The participants were randomly assigned to either the cementless or hybrid (cemented tibia and uncemented femur) group with a tourniquet pressure of 100 mm Hg above systolic blood pressure.</P>
<P>The tourniquet used was the MT-720 tourniquet system (Mizuho-Ika, Tokyo, Japan). All the patients had spinal anesthesia. Esmarch&#8217;s bandage was used. A straight longitudinal midline skin incision was used with a medial parapatellar capsulotomy. In all cases, intramedullary femoral and extramedullary tibial resection guides were used. Each hole in the distal femur made for the intramedullary guides was filled with an autogenous bone plug. No lateral retinacular release or patellar arthroplasty was performed. During the arthroplasty, an effort was made to collect all the fluid lost in closed canisters using continuous wall suction. The amount of fluid that was administered for irrigation, using a bulb syringe, was recorded, and its volume was then subtracted from the total suction-fluid volume to estimate the intraoperative blood loss. A Stryker CBCII Consta Vac Blood Conservation System (Stryker, Kalamazoo, Mich) was used in all the patients after surgery. The volume of blood collected was returned to the patients within 3 hours of surgery. No patient received medication for thromboembolism.</P>
<P>The New Jersey LCS total knee system (DePuy, Warsaw, Ind) was used in all cases.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-18 06:34:18 -0400" MODIFIED_BY="[Empty name]">
<P>The red blood cell count, hemoglobin level, and hematocrit were recorded preoperatively and 1 week, 4 weeks, and 3 months postoperatively for each patient. The volumes of postoperative suction drainage within 3 hours and upon removal (first operative day) were recorded. Both the measured and calculated blood losses were evaluated using the maximum decrease in the hemoglobin level (1 week after surgery) and were normalized using each patient&#8217;s weight and height.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-13 08:06:25 -0500" MODIFIED_BY="[Empty name]">
<P>The authors found no difference between the groups.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-08-18 06:36:29 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nilsson-1999">
<CHAR_METHODS MODIFIED="2012-08-18 06:35:05 -0400" MODIFIED_BY="[Empty name]">
<P>RCT and opaque envelopes. The primary outcome measure in this study was RSA. For the secondary outcome measure, i.e. the clinical data, the assessor was not blinded.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-07-25 22:23:34 -0400" MODIFIED_BY="[Empty name]">
<P>Inclusion: Osteoarthrosis: 43 participants (45 knees). RA: 13 participants (15 knees). No exclusion criteria were specified. Average age: 69 years. Twenty-four participants were lost.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-02-21 22:08:11 -0500" MODIFIED_BY="[Empty name]">
<P>Randomized tibial component fixation: Cemented (only under the tibial plateau) or uncemented with hydroxyapatite. The femoral components were fixed identically to the corresponding tibial components (<LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK>); however, the uncemented bones were not hydroxyapatite coated. A cemented all-polyethylene patellar component was used in all of the knees.</P>
<P>All of the knees received a Tricon II (Smith &amp; Nephew) total knee prosthesis.</P>
<P>Bone cement (Palacos cum Gentamicin, Shering-Plough, Kenilworth, NJ) was used. The cut proximal tibia was cleaned with a high-pressure lavage before the bone cement was injected via a delivery nozzle to improve the penetration of the cement into the trabecular bone.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-18 06:36:29 -0400" MODIFIED_BY="[Empty name]">
<P>RSA (absolute values of rotation around the three orthogonal axes, MTPM, lift-off and subsidence), Knee Society knee score, Knee Society pain score, Knee Society function score, HKA, range of motion and radiolucent lines analysis at the tibial component interface, as described by the Knee Society.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-21 22:08:33 -0500" MODIFIED_BY="[Empty name]">
<P>Duration of follow-up: 5 years. No difference between the two types of fixation. Some data were obtained by personal communication (<LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK>).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-08-18 06:38:17 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Toksvig_x002d_Larsen-1998">
<CHAR_METHODS MODIFIED="2012-08-18 06:37:20 -0400" MODIFIED_BY="[Empty name]">
<P>RCT, sealed envelopes. The primary outcome measure in this study was RSA. For the secondary outcome measure, i.e. the clinical data, the assessor was not blinded.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-07-25 22:25:21 -0400" MODIFIED_BY="[Empty name]">
<P>Inclusion: Osteoarthrosis: 27 participants (28 knees). No exclusion criteria were specified. Average age: 71 years. Average body weight: 79 kg. Five participants were lost.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-07-25 22:25:21 -0400" MODIFIED_BY="[Empty name]">
<P>Randomized tibial component fixation: Cemented or uncemented without hydroxyapatite. The femoral component was inserted without cement, and the patella was not resurfaced. The cement was applied to the horizontal cut surface but not around the stem. All knees received a porous-coated anatomic total knee prosthesis (PCA Universal; Howmedica) with a porous-coated anatomic modular cruciform stem tibial component. The cementing technique included vacuum-mixing of the cement, lavage, and pressurization.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2008-06-08 18:17:49 -0400" MODIFIED_BY="[Empty name]">
<P>RSA (MTPM, subsidence and inducible displacement), HKA, Hospital for Special Surgery, extension, flexion, and walking distance.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-18 06:38:17 -0400" MODIFIED_BY="[Empty name]">
<P>Duration of follow-up: 2 years. The prostheses that was inserted with cement subsided 0.0 ± 0.1 millimeter, and the prostheses that was inserted without cement subsided 0.5 ± 0.1 millimeter at the two year follow-up evaluation (P = 0.008). Some data were obtained by personal communication (<LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK>).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-08-20 16:20:53 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Uvehammer-2007">
<CHAR_METHODS MODIFIED="2011-07-25 22:27:21 -0400" MODIFIED_BY="[Empty name]">
<P>RCT. Unknown randomization technique. Blinding not stated. </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-07-25 22:27:21 -0400" MODIFIED_BY="[Empty name]">
<P>Inclusion: Osteoarthrosis: 50 participants (54 knees). All of the femoral components were manufactured with an 80 mm stem and were only available in one size (size 2/medium). This made the series more homogeneous regarding biomechanical factors but excluded selection of participants with larger or smaller knees. Average age: 72 years. Fifteen participants were lost (16 knees).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-08-20 16:20:53 -0400" MODIFIED_BY="[Empty name]">
<P>The femoral component fixation (cemented or uncemented with hydroxyapatite) and prosthesis design (three variations of the Freeman-Samuelson knee replacement (Finsbury Orthopaedics Ltd): one with a rotating tibial insert, one with a medial femoral condyle representing part of a sphere articulating against a corresponding concave tibial polyethylene insert (FS1000), and the original standard version) were randomized, and the participants were randomized into one of the six treatment options. All of the tibial components were cemented. In 44 of the knees, a patellar component was inserted.</P>
<P>Refobacin-Palacos R bone cement (Biomet Orthopaedics Inc., Warsaw, Indiana) was prepared by vacuum mixing.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-07-25 22:27:21 -0400" MODIFIED_BY="[Empty name]">
<P>RSA (absolute values of rotation around the three orthogonal axes), HKA, and Hospital for Special Surgery knee score.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-25 22:27:21 -0400" MODIFIED_BY="[Empty name]">
<P>Duration of follow-up: 2 years. No difference between the two types of fixation.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>RCT = randomoized controlled trial </P>
<P>RSA = roentgen stereophotogrammetric analysis</P>
<P>MTPM = maximum total point motion</P>
<P>RA = rheumatoid arthritis</P>
<P>HKA = hip-knee-ankle-angle</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2012-08-17 06:21:16 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2012-08-17 06:20:36 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Albrektsson-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-17 06:20:36 -0400" MODIFIED_BY="[Empty name]">
<P>Personal communication (<LINK REF="STD-Albrektsson-1992" TYPE="STUDY">Albrektsson 1992</LINK>) - The author included post-traumatic osteoarthritis participants</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-17 06:20:40 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Baker-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-17 06:20:40 -0400" MODIFIED_BY="[Empty name]">
<P>Personal communication (<LINK REF="STD-Khaw-2002" TYPE="STUDY">Khaw 2002</LINK>) - The author did not differentiate between post-traumatic and non post-traumatic osteoarthritis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-17 06:20:42 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Beaupr_x00e9_-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-17 06:20:42 -0400" MODIFIED_BY="[Empty name]">
<P>Personal communication (<LINK REF="STD-Beaupr_x00e9_-2007" TYPE="STUDY">Beaupré 2007</LINK>) - The author did not differentiate between post-traumatic and non post-traumatic osteoarthritis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-17 06:20:47 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ishii-2005a">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-17 06:20:47 -0400" MODIFIED_BY="[Empty name]">
<P>Personal communication (<LINK REF="STD-Ishii-2005a" TYPE="STUDY">Ishii 2005a</LINK>) - Non-randomized controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-17 06:20:53 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Keblish-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-17 06:20:53 -0400" MODIFIED_BY="[Empty name]">
<P>Personal communication (<LINK REF="STD-Keblish-1993" TYPE="STUDY">Keblish 1993</LINK>) - Non-randomized controlled trial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-17 06:21:05 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Khaw-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-17 06:21:05 -0400" MODIFIED_BY="[Empty name]">
<P>Personal communication (<LINK REF="STD-Khaw-2002" TYPE="STUDY">Khaw 2002</LINK>) - The author did not differentiate between post-traumatic and non post-traumatic osteoarthritis</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-17 06:21:11 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nilsson-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-17 06:21:11 -0400" MODIFIED_BY="[Empty name]">
<P>Personal communication (<LINK REF="STD-Nilsson-2006" TYPE="STUDY">Nilsson 2006</LINK>) - The author included post-traumatic osteoarthritis participants</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-08-17 06:21:16 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-_x00d6_nsten-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-08-17 06:21:16 -0400" MODIFIED_BY="[Empty name]">
<P>The study by Önsten 1998 is the same as the study by <LINK REF="STD-Carlsson-2005" TYPE="STUDY">Carlsson 2005</LINK> with a shorter follow-up</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2012-08-21 14:57:48 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2012-08-21 14:57:48 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Demey-2010">
<CHAR_METHODS MODIFIED="2012-08-17 06:23:10 -0400" MODIFIED_BY="[Empty name]">
<P>RCT. Computer-generated randomization. Single-blind.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-01-31 11:35:50 -0500" MODIFIED_BY="[Empty name]">
<P>Osteoarthritis and chondrocalcinosis: 107 participants. There were no significant differences between the two groups with respect to anthropometric or demographic data (sex, age, body mass index, weight, height, diagnosis). No patient was lost. </P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-08-21 14:57:48 -0400" MODIFIED_BY="[Empty name]">
<P>The operations were performed using the HLS Noetos® prosthesis (Tornier, Saint-Ismier, France) and were randomized to cemented or hybrid (cementless femoral implant and cemented tibial implant) fixation of the components.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-01-31 11:46:15 -0500" MODIFIED_BY="[Empty name]">
<P>Hemoglobin and hematocrit levels, volumes of postoperative suction drainage and the rate of blood transfusion</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-28 12:58:39 -0500" MODIFIED_BY="[Empty name]">
<P>No differences were found between the two groups</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2012-08-17 06:26:28 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Dunbar-2009">
<CHAR_METHODS MODIFIED="2012-08-17 06:23:37 -0400" MODIFIED_BY="[Empty name]">
<P>RCT, computer-generated randomization. The primary outcome measured in this study was RSA, which is a radiographic "measuring tool" and is not influenced by the assessor. For the secondary outcome measure, i.e. the clinical data, blinding was not stated.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-08-17 06:26:28 -0400" MODIFIED_BY="[Empty name]">
<P>Seventy participants. Inclusion and exclusion criteria were not described. Age: 60.2 ± 8.3 years (trabecular metal group) and 61.1 ± 9.4 years (cemented group). Twenty-one participants (21 knees) were lost.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-08-17 06:24:55 -0400" MODIFIED_BY="[Empty name]">
<P>Participants were randomized to receive either the trabecular metal or the cemented tibial component of the same design (Zimmer, Warsaw, Indiana).</P>
<P>The surgery was performed using a standardized protocol consisting of a resection of the posterior cruciate ligament, patellar resurfacing with a cemented inlay component, cementing of the femoral component, and placement of 0.8 mm marker beads for the radiostereometric analysis. Four, five, or six tantalum markers were placed around the periphery of the polyethylene component, and eight to twenty tantalum markers were inserted into the proximal part of the tibia.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-07-25 22:30:49 -0400" MODIFIED_BY="[Empty name]">
<P>RSA and WOMAC.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-25 22:30:49 -0400" MODIFIED_BY="[Empty name]">
<P>Duration of follow-up: 2 years. No significant difference with regard to WOMAC was found between the groups. A subset of the trabecular metal components migrated extensively in the postoperative period but stabilized by one year, and the proportion considered to be at risk for early aseptic loosening was 0.0 (95% CI, 0.0 to 0.12) in the entire group. Four cemented components were considered to be at risk for early aseptic loosening (proportion at risk, 0.19; 95% confidence interval, 0.08 to 0.4).</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2012-08-17 06:27:35 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nelissen-1998">
<CHAR_METHODS MODIFIED="2011-07-25 22:31:13 -0400" MODIFIED_BY="[Empty name]">
<P>RCT. Unknown randomization technique. Double-blind.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-07-25 22:31:13 -0400" MODIFIED_BY="[Empty name]">
<P>Twenty-one participants: osteoarthrosis (5 knees) and rheumatoid arthritis (26 knees). Average age: 68 years. Three participants (3 knees) were lost.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-07-25 22:31:13 -0400" MODIFIED_BY="[Empty name]">
<P>Fixation with cement, without cement, or with a hydroxyapatite coating (without cement) was randomly chosen during the operation. All of the prostheses were posterior cruciate ligament-retaining total condylar implants (Interax; Howmedica, Rutherford, New Jersey). A patellar component made of ultra-high molecular weight polyethylene was used in all but one total knee arthroplasty. No patellar components were used in one knee because the remaining patellar bone was too thin.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-07-25 22:31:13 -0400" MODIFIED_BY="[Empty name]">
<P>RSA, Knee Society score, conventional roentgenograms, length of surgery (in minutes) and femorotibial angle.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-08-17 06:27:35 -0400" MODIFIED_BY="[Empty name]">
<P>Duration of follow-up: 2 years. A significant difference with regard to micromotion was found between the non-coated components fixed without cement and the hydroxyapatite-coated components fixed without cement and between the non-coated components fixed without cement and the components fixed with cement (P &lt; 0.001, analysis of variance). The hydroxyapatite-coated components fixed without cement and the components fixed with cement both had far less micromotion along the longitudinal axis (subsidence) throughout the follow-up period than the non-coated components fixed without cement.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2012-08-17 06:29:38 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Nilsson-1992">
<CHAR_METHODS MODIFIED="2011-07-25 22:31:41 -0400" MODIFIED_BY="[Empty name]">
<P>RCT. Unknown randomization technique. Blinding not stated. </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-07-25 22:31:41 -0400" MODIFIED_BY="[Empty name]">
<P>Osteoarthrosis and rheumatoid arthritis: 39 participants. Average age: 68 years. Eleven participants&#8217; knees were lost to follow-up.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-07-25 22:31:41 -0400" MODIFIED_BY="[Empty name]">
<P>The operations were performed using the Tricon-M knee prosthesis (Smith and Nephew Richards) and were randomized to cemented or cementless fixation of the components.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-17 06:29:38 -0400" MODIFIED_BY="[Empty name]">
<P>Scintimetry, RSA, HKA and HSS knee score.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2008-06-24 17:38:45 -0400" MODIFIED_BY="[Empty name]">
<P>Duration of follow-up: 2 years. No difference between the two types of fixation.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<AWAITING_CHAR MODIFIED="2012-08-17 06:29:47 -0400" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Parker-2001">
<CHAR_METHODS MODIFIED="2011-07-25 22:31:56 -0400" MODIFIED_BY="[Empty name]">
<P>RCT. Unknown randomization technique. Blinding not stated. </P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-07-25 22:31:56 -0400" MODIFIED_BY="[Empty name]">
<P>Osteoarthrosis: 99 participants (100 knees). Average age: 66.7 years. Thirty-three participants were lost.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-08-17 06:28:57 -0400" MODIFIED_BY="[Empty name]">
<P>One hundred MGI total knee replacements (Zimmer, Warsaw, Indiana) were performed in 99 participants randomized to either cementless or hybrid fixation. In all of the cases, femoral fixation was a cementless porous design. Tibial fixation was randomized to either cemented or cementless, and patellar fixation paralleled the tibial component.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-08-17 06:29:47 -0400" MODIFIED_BY="[Empty name]">
<P>HSS knee score, Knee Society knee score, failure rate and reasons for failure.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-25 22:31:56 -0400" MODIFIED_BY="[Empty name]">
<P>Duration of follow-up: 12 years. Differences in the outcome between the two groups were not sufficiently significant to recommend one method of fixation over another.</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES>
<P>RCT = randomoized controlled trial</P>
<P>RSA = roentgen stereophotogrammetric analysis</P>
<P>WOMAC = Western Ontario and McMaster Universities Osteoarthritis Index </P>
<P>HKA = hip-knee-ankle-angle</P>
<P>HSS = Hospital for Special Surgery knee score</P>
<P>MGI total knee replacement = Miller-Galante I total knee replacement</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2012-08-21 14:41:45 -0400" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2012-08-18 06:38:32 -0400" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2012-08-18 06:38:32 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 22:22:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carlsson-2005">
<DESCRIPTION>
<P>Computer generated randomization.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-21 21:59:28 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ishii-2005b">
<DESCRIPTION>
<P>Personal communication (<LINK REF="STD-Ishii-2005b" TYPE="STUDY">Ishii 2005b</LINK>) - Random number table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-13 07:28:44 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nilsson-1999">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-18 06:38:32 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toksvig_x002d_Larsen-1998">
<DESCRIPTION>
<P>In a personal communication (<LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK>), the author stated: "All knees were randomized, patients with bilateral surgery were operated with an interval of more than 3 months."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-31 08:41:08 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Uvehammer-2007">
<DESCRIPTION>
<P>This item was not mentioned in the trial report.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2012-08-18 06:36:51 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 22:22:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carlsson-2005">
<DESCRIPTION>
<P>The type of component to be used was written down on a piece of stiff paper that was folded and put inside another piece of stiff paper in a sealed envelope. What was written on the paper could not be read even if held against a lamp. During the operation, the envelope was opened in sequential order after the tibial resection.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-21 21:59:34 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ishii-2005b">
<DESCRIPTION>
<P>Personal communication (<LINK REF="STD-Ishii-2005b" TYPE="STUDY">Ishii 2005b</LINK>) - The author used an open random number table.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-18 06:36:51 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nilsson-1999">
<DESCRIPTION>
<P>After cutting the proximal tibia and prior to inserting the tibial component, a telephone call was made from the operating room to a secretary at the orthopedic department. She opened a sealed envelope and read the contents, i.e. to use a cemented component or an uncemented component. The envelopes were placed in a locked location.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-21 22:14:49 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Toksvig_x002d_Larsen-1998">
<DESCRIPTION>
<P>Personal communication (<LINK REF="STD-Toksvig_x002d_Larsen-1998" TYPE="STUDY">Toksvig-Larsen 1998</LINK>) - The allocation was performed using sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 22:28:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Uvehammer-2007">
<DESCRIPTION>
<P>Sealed envelopes were opened before the operation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2008-06-06 08:15:05 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-11" LEVEL="GROUP" NO="11">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-12" LEVEL="GROUP" NO="12">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2012-01-30 14:36:50 -0500" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="STUDY" MODIFIED="2012-02-13 23:52:38 -0500" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Was the patient blinded?</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 22:22:20 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carlsson-2005">
<DESCRIPTION>
<P>Single-blind study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-13 23:52:38 -0500" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ishii-2005b">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-30 13:31:13 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nilsson-1999">
<DESCRIPTION>
<P>This item was not mentioned in the trial report.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-30 13:31:48 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toksvig_x002d_Larsen-1998">
<DESCRIPTION>
<P>This item was not mentioned in the trial report.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-30 13:32:03 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Uvehammer-2007">
<DESCRIPTION>
<P>This item was not mentioned in the trial report.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="STUDY" MODIFIED="2012-02-13 07:29:55 -0500" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Was the surgeon blinded?</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 22:22:09 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Carlsson-2005">
<DESCRIPTION>
<P>It is impossible to blind the surgeon to prosthesis fixation</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-13 07:29:55 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ishii-2005b">
<DESCRIPTION>
<P>It is impossible to blind the surgeon to prosthesis fixation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 22:24:48 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Nilsson-1999">
<DESCRIPTION>
<P>It is impossible to blind the surgeon to prosthesis fixation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 22:26:11 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Toksvig_x002d_Larsen-1998">
<DESCRIPTION>
<P>It is impossible to blind the surgeon to prosthesis fixation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 22:28:00 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Uvehammer-2007">
<DESCRIPTION>
<P>It is impossible to blind the surgeon to prosthesis fixation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-09" LEVEL="STUDY" MODIFIED="2012-02-14 00:07:26 -0500" MODIFIED_BY="[Empty name]" NO="9">
<NAME>Was the outcome assessor blinded?</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 22:22:09 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Carlsson-2005">
<DESCRIPTION>
<P>Single-blind study</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-14 00:07:26 -0500" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Ishii-2005b">
<DESCRIPTION>
<P>The outcome assessor was the surgeon.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 22:24:48 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nilsson-1999">
<DESCRIPTION>
<P>This item was not mentioned in the trial report.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 22:26:11 -0400" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Toksvig_x002d_Larsen-1998">
<DESCRIPTION>
<P>This item was not mentioned in the trial report.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-12-30 13:31:59 -0500" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Uvehammer-2007">
<DESCRIPTION>
<P>This item was not mentioned in the trial report.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-10" LEVEL="STUDY" MODIFIED="2012-08-18 06:34:55 -0400" MODIFIED_BY="[Empty name]" NO="10">
<NAME>Was the withdrawal/drop-out rate described, acceptable (&lt;20%), and comparable in both groups?</NAME>
<DESCRIPTION/>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-18 06:31:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carlsson-2005">
<DESCRIPTION>
<P>Seven participants were lost (&lt; 20%).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-18 06:34:55 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ishii-2005b">
<DESCRIPTION>
<P>There were no withdrawals.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 22:24:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nilsson-1999">
<DESCRIPTION>
<P>The withdrawal/drop-out rate was described and comparable in both groups but was not acceptable. Missing outcome data were balanced in numbers among intervention groups with similar reasons for missing data among groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 22:26:11 -0400" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Toksvig_x002d_Larsen-1998">
<DESCRIPTION>
<P>The withdrawal/drop-out rate was described, was not acceptable and was not comparable between the groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 22:28:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Uvehammer-2007">
<DESCRIPTION>
<P>The withdrawal/drop-out rate was described, was comparable in both groups and was not acceptable. Missing outcome data were balanced in numbers among intervention groups with similar reasons for missing data among the groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2012-08-18 06:34:58 -0400" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 22:22:09 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carlsson-2005">
<DESCRIPTION>
<P>The study protocol was available, and all of the study&#8217;s prespecified (primary and secondary) outcomes that were of interest in the review were reported in the prespecified manner.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-08-18 06:34:58 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Ishii-2005b">
<DESCRIPTION>
<P>The study protocol is available, and all of the study&#8217;s prespecified outcomes that were of interest in the review were reported in the prespecified manner.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 22:24:48 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nilsson-1999">
<DESCRIPTION>
<P>The study protocol is available, and all of the study&#8217;s prespecified (primary and secondary) outcomes that were of interest in the review were reported in the prespecified manner.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 22:26:11 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Toksvig_x002d_Larsen-1998">
<DESCRIPTION>
<P>The study protocol is available, and all of the study&#8217;s prespecified (primary and secondary) outcomes that were of interest in the review were reported in the prespecified manner.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-25 22:28:00 -0400" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Uvehammer-2007">
<DESCRIPTION>
<P>The study protocol is available, and all of the study&#8217;s prespecified (primary and secondary) outcomes that were of interest in the review were reported in the prespecified manner.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2012-08-20 16:55:13 -0400" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2012-08-20 16:55:13 -0400" MODIFIED_BY="[Empty name]" NO="1" READONLY="YES">
<TITLE MODIFIED="2012-07-24 16:37:31 -0400" MODIFIED_BY="[Empty name]">Uncemented fixation with and without hydroxyapatite compared to cemented fixation for osteoarthritis and other non-traumatic diseases</TITLE>
<TABLE COLS="7" ROWS="14">
<TR>
<TD COLSPAN="7">
<P>
<B>Uncemented fixation with and without hydroxyapatite</B> <B>compared to cemented fixation for osteoarthritis and other non-traumatic diseases</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population: </B>Patients with osteoarthritis and other non-traumatic diseases<BR/>
<B>Settings: </B>Osteoarthritis (non-post-traumatic patients)<BR/>
<B>Intervention:</B> Uncemented with and without hydroxyapatite<BR/>
<B>Comparison: </B>Cemented</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Cemented</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Uncemented with and without </B>hydroxyapatite</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Arthroplasty instability - </B>
</P>
<P>
<B>inferred from roentgen stereophotogrammetric analysis </B>
</P>
<P>
<B>(Available data analysis)</B>
<BR/>
<BR/>Follow-up: 1 to 2 years</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>287 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>135 per 1000</B>
<BR/>(69 to 264)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.47 </B>
<BR/>(0.24 to 0.92)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>216<BR/>(3 studies)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8853;<BR/>
<B>moderate</B>
<SUP>1</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Arthroplasty instability was considered an event. This outcome predicts knee arthroplasty revision rates because of aseptic loosening (provides indirect evidence).</P>
<P>Absolute risk difference = 16% (95% CI -0.27 to -0.05)</P>
<P>Relative percent change = 53% (95% CI 8 to 76%)</P>
<P>NNTH = 7 (95% CI 5 to 44)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Survival rate of the implant (any change of a component)</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>0<BR/>(0)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Survival rate of the implant is a long term outcome not available in included studies (2 to 5 year follow-up).</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Global Assessment (Patient)</B>
</P>
</TD>
<TD ROWSPAN="1">
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>27<BR/>(1)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Toksvig-Larsen 1988 reported that all of the patients were satisfied with the results at a 2 year follow-up. We found no mention of degrees of satisfaction.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Functional measures with validated instruments </B>
</P>
</TD>
<TD ROWSPAN="1">
<P>See comment</P>
</TD>
<TD>
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<BR/>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>240<BR/>(4)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Knee Society and HSS knee scores were recorded. The SD of the mean of the results was not reported. The authors found no significant difference between the groups.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Pain</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>
<BR/>
</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>0<BR/>(0)</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Not reported.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Health-related quality of life measures </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>0<BR/>(0)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>Not reported.</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Total adverse event </B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>See comment<BR/>
<BR/>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>0<BR/>(0)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>See comment</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>No evidence available<SUP>2</SUP>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk among studies) is provided in the footnotes. The <B>corresponding risk</B> (and its 95% CI) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio;</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect.<BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Roentgen stereophotogrammetric analysis predicts the arthroplasty instability. We downgraded for indirectness of evidence.</P>
<P>
<SUP>2</SUP>The type of fixation of the femoral component was different from the tibial component in 3 out of 4 studies. It was not possible to correlate some adverse events to the cementation of the arthroplasty from the study description even when the type of fixation of the femoral and tibial components was the same (<LINK REF="STD-Nilsson-1999" TYPE="STUDY">Nilsson 1999</LINK>).</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2012-08-18 06:43:05 -0400" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2012-08-18 06:43:05 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2012-06-19 12:00:23 -0400" MODIFIED_BY="[Empty name]">Complications</TITLE>
<TABLE COLS="5" ROWS="10">
<TR>
<TD>
<P>Complications</P>
</TD>
<TD ALIGN="CENTER">
<P>Toksvig-Larsen 1998</P>
</TD>
<TD ALIGN="CENTER">
<P>Nilsson 1999</P>
</TD>
<TD ALIGN="CENTER">
<P>Carlsson 2005</P>
</TD>
<TD ALIGN="CENTER">
<P>Uvehammer 2007</P>
</TD>
</TR>
<TR>
<TD>
<P>Unrelated deaths</P>
<P>(N and fixation)</P>
</TD>
<TD ALIGN="CENTER">
<P>2 cemented</P>
</TD>
<TD ALIGN="CENTER">
<P>3 cemented, 5 uncemented with hydroxyapatite</P>
</TD>
<TD ALIGN="CENTER">
<P>1 cemented, 4 uncemented without hydroxyapatite,</P>
<P>1 uncemented with hydroxyapatite</P>
</TD>
<TD ALIGN="CENTER">
<P>2 cemented, 1 uncemented with hydroxyapatite</P>
</TD>
</TR>
<TR>
<TD>
<P>Cardiac infarction</P>
<P>(N and fixation)</P>
</TD>
<TD ALIGN="CENTER">
<P>1 cemented</P>
</TD>
<TD ALIGN="CENTER">
<P>1?</P>
<P>(5-day PO)</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Revision because of loosening</P>
<P>(N and fixation)</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="CENTER">
<P>1 uncemented with hydroxyapatite</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Revision because of infection</P>
<P>(N and fixation)</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="CENTER">
<P>2 uncemented with hydroxyapatite</P>
</TD>
<TD ALIGN="CENTER">
<P>1 uncemented without hydroxyapatite</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Revision because of instability</P>
<P>(N and fixation)</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="CENTER">
<P>1 cemented</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Cerebral hemorrhage</P>
<P>(N and fixation)</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="CENTER">
<P>1 ?</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Cerebral infarction</P>
<P>(N and fixation)</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="CENTER">
<P>1 cemented (2-year PO)</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Periprosthetic fractures</P>
<P>(N and fixation)</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="CENTER">
<P>2 cemented, 1 uncemented with hydroxyapatite</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
</TR>
<TR>
<TD>
<P>Aseptic necrosis of the patella</P>
<P>(N and fixation)</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="CENTER">
<P>1?</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
<TD ALIGN="CENTER">
<P>-</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>? = Type of fixation not described</P>
<P>PO = postoperative</P>
<P>N = number of participants</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2012-08-17 06:14:15 -0400" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2012-08-17 06:12:54 -0400" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Cemented versus uncemented with HA</NAME>
<CONT_OUTCOME CHI2="4.349904857149313" CI_END="0.37798077887578263" CI_START="-0.020756640397835813" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.1786120692389734" ESTIMABLE="YES" I2="31.032974317373135" I2_Q="0.0" ID="CMP-001.01" MODIFIED="2008-07-22 22:59:07 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.22607577009345048" P_Q="0.895854590194968" P_Z="0.07910402392492388" Q="0.01713475356102731" RANDOM="YES" SCALE="2.569375642769909" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0076582501005697965" TOTALS="SUB" TOTAL_1="147" TOTAL_2="147" UNITS="" WEIGHT="200.0" Z="1.755908555310872">
<NAME>Absolute rotation about transverse axis in degrees (60 months)</NAME>
<GROUP_LABEL_1>Uncemented with HA</GROUP_LABEL_1>
<GROUP_LABEL_2>Cemented</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Uncemented HA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Cemented</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.5986198372643923" CI_END="0.44673242792734474" CI_START="-0.11603127850205747" DF="1" EFFECT_SIZE="0.16535057471264364" ESTIMABLE="YES" I2="61.51803408640505" ID="CMP-001.01.01" MODIFIED="2008-06-23 15:21:40 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.10695686627127565" P_Z="0.24942439153445495" STUDIES="2" TAU2="0.025868333333333323" TOTAL_1="80" TOTAL_2="80" WEIGHT="99.99999999999999" Z="1.151748655989195">
<NAME>Intention-to-treat analysis</NAME>
<CONT_DATA CI_END="0.48872140467683794" CI_START="0.0912785953231619" EFFECT_SIZE="0.2899999999999999" ESTIMABLE="YES" MEAN_1="0.69" MEAN_2="0.4" MODIFIED="2008-05-22 16:13:40 -0400" MODIFIED_BY="[Empty name]" ORDER="1" SD_1="0.62" SD_2="0.36" SE="0.1013903348450926" STUDY_ID="STD-Carlsson-2005" TOTAL_1="50" TOTAL_2="50" WEIGHT="57.01743955608402"/>
<CONT_DATA CI_END="0.29125970477163843" CI_START="-0.29125970477163843" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.46" MEAN_2="0.46" MODIFIED="2008-06-23 15:21:40 -0400" MODIFIED_BY="[Empty name]" ORDER="2" SD_1="0.55" SD_2="0.6" SE="0.14860462083439174" STUDY_ID="STD-Nilsson-1999" TOTAL_1="30" TOTAL_2="30" WEIGHT="42.982560443915965"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.6825378550273533" CI_END="0.4745026686591643" CI_START="-0.09054026649399721" DF="1" EFFECT_SIZE="0.19198120108258354" ESTIMABLE="YES" I2="40.56597318080889" ID="CMP-001.01.02" MODIFIED="2008-05-22 19:15:41 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.19458765234370257" P_Z="0.1829094569407324" STUDIES="2" TAU2="0.019491950113378658" TOTAL_1="67" TOTAL_2="67" WEIGHT="100.0" Z="1.3318500822547645">
<NAME>Available data analysis</NAME>
<CONT_DATA CI_END="0.49456877085696405" CI_START="0.08543122914303583" EFFECT_SIZE="0.2899999999999999" ESTIMABLE="YES" MEAN_1="0.69" MEAN_2="0.4" MODIFIED="2008-05-21 09:08:57 -0400" MODIFIED_BY="[Empty name]" ORDER="6" SD_1="0.63" SD_2="0.37" SE="0.10437373975775904" STUDY_ID="STD-Carlsson-2005" TOTAL_1="49" TOTAL_2="49" WEIGHT="68.38103260728504"/>
<CONT_DATA CI_END="0.401379595219844" CI_START="-0.44137959521984405" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.49" MEAN_2="0.51" MODIFIED="2008-05-21 08:56:31 -0400" MODIFIED_BY="[Empty name]" ORDER="5" SD_1="0.56" SD_2="0.72" SE="0.214993539954628" STUDY_ID="STD-Nilsson-1999" TOTAL_1="18" TOTAL_2="18" WEIGHT="31.618967392714968"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="3.559720664472394" CI_END="0.39835614262718816" CI_START="0.05448239500544616" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.22641926881631716" ESTIMABLE="YES" I2="15.72372433766101" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2008-06-23 15:22:42 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.31309890497086623" P_Q="0.6356041606936904" P_Z="0.009850704533395802" Q="0.22453745658197438" RANDOM="YES" SCALE="2.841750065650712" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.003865519249154576" TOTALS="SUB" TOTAL_1="147" TOTAL_2="147" UNITS="" WEIGHT="200.0" Z="2.5810264107396854">
<NAME>Absolute rotation about longitudinal axis in degrees (60 months)</NAME>
<GROUP_LABEL_1>Uncemented with HA</GROUP_LABEL_1>
<GROUP_LABEL_2>Cemented</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours uncemented HA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours cemented</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.5436077497021756" CI_END="0.4702089236515976" CI_START="0.04365025247229726" DF="1" EFFECT_SIZE="0.25692958806194743" ESTIMABLE="YES" I2="0.0" ID="CMP-001.02.01" MODIFIED="2008-06-23 15:22:42 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4609414807275861" P_Z="0.0182210699945839" STUDIES="2" TAU2="0.0" TOTAL_1="80" TOTAL_2="80" WEIGHT="100.0" Z="2.3610948419916507">
<NAME>Intention-to-treat analysis</NAME>
<CONT_DATA CI_END="0.7385566223794442" CI_START="0.0014433776205557414" EFFECT_SIZE="0.37" ESTIMABLE="YES" MEAN_1="0.72" MEAN_2="0.35" MODIFIED="2008-05-23 07:04:21 -0400" MODIFIED_BY="[Empty name]" ORDER="7" SD_1="1.28" SD_2="0.36" SE="0.18804254837669052" STUDY_ID="STD-Carlsson-2005" TOTAL_1="50" TOTAL_2="50" WEIGHT="33.487992977616145"/>
<CONT_DATA CI_END="0.46151629370096825" CI_START="-0.06151629370096823" EFFECT_SIZE="0.2" ESTIMABLE="YES" MEAN_1="0.45" MEAN_2="0.25" MODIFIED="2008-06-23 15:22:42 -0400" MODIFIED_BY="[Empty name]" ORDER="8" SD_1="0.7" SD_2="0.21" SE="0.1334291322512941" STUDY_ID="STD-Nilsson-1999" TOTAL_1="30" TOTAL_2="30" WEIGHT="66.51200702238386"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="2.065171151020766" CI_END="0.4603654964666417" CI_START="-0.12079670120660224" DF="1" EFFECT_SIZE="0.16978439763001973" ESTIMABLE="YES" I2="51.57786319522606" ID="CMP-001.02.02" MODIFIED="2008-05-23 07:42:37 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.15069805500084354" P_Z="0.25212943030220825" STUDIES="2" TAU2="0.02478316326530611" TOTAL_1="67" TOTAL_2="67" WEIGHT="100.0" Z="1.1451925325630548">
<NAME>Available data analysis</NAME>
<CONT_DATA CI_END="0.7484490670048733" CI_START="-0.008449067004873412" EFFECT_SIZE="0.37" ESTIMABLE="YES" MEAN_1="0.73" MEAN_2="0.36" MODIFIED="2008-05-23 07:42:37 -0400" MODIFIED_BY="[Empty name]" ORDER="7" SD_1="1.3" SD_2="0.37" SE="0.19308980674646645" STUDY_ID="STD-Carlsson-2005" TOTAL_1="49" TOTAL_2="49" WEIGHT="35.414321816135406"/>
<CONT_DATA CI_END="0.24850329994835813" CI_START="-0.12850329994835813" EFFECT_SIZE="0.06" ESTIMABLE="YES" MEAN_1="0.34" MEAN_2="0.28" MODIFIED="2008-05-23 07:34:57 -0400" MODIFIED_BY="[Empty name]" ORDER="8" SD_1="0.33" SD_2="0.24" SE="0.09617692030835673" STUDY_ID="STD-Nilsson-1999" TOTAL_1="18" TOTAL_2="18" WEIGHT="64.5856781838646"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.550936153022276" CI_END="0.29885843370336096" CI_START="0.04521749453348933" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.17203796411842515" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.03" MODIFIED="2008-07-22 22:59:57 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9075666305319547" P_Q="0.5787316970950702" P_Z="0.007842326339677663" Q="0.3082897032245222" RANDOM="YES" SCALE="2.008858689777396" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="147" TOTAL_2="147" UNITS="" WEIGHT="200.0" Z="2.6587838284251224">
<NAME>Absolute rotation about sagittal axis in degrees (60 months)</NAME>
<GROUP_LABEL_1>Uncemented with HA</GROUP_LABEL_1>
<GROUP_LABEL_2>Cemented</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours uncemented HA</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours cemented</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.0823886608791175" CI_END="0.4213420728184728" CI_START="0.013287101921774097" DF="1" EFFECT_SIZE="0.21731458737012344" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.01" MODIFIED="2008-06-23 15:23:27 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.774086105948567" P_Z="0.03683349574092337" STUDIES="2" TAU2="0.0" TOTAL_1="80" TOTAL_2="80" WEIGHT="100.0" Z="2.0876048323815226">
<NAME>Intention-to-treat analysis</NAME>
<CONT_DATA CI_END="0.4664313637437828" CI_START="-0.0864313637437828" EFFECT_SIZE="0.19" ESTIMABLE="YES" MEAN_1="0.48" MEAN_2="0.29" MODIFIED="2008-05-23 10:43:18 -0400" MODIFIED_BY="[Empty name]" ORDER="9" SD_1="0.89" SD_2="0.45" SE="0.14103900169811187" STUDY_ID="STD-Carlsson-2005" TOTAL_1="50" TOTAL_2="50" WEIGHT="54.475687716460946"/>
<CONT_DATA CI_END="0.5523896902926022" CI_START="-0.052389690292602153" EFFECT_SIZE="0.25" ESTIMABLE="YES" MEAN_1="0.51" MEAN_2="0.26" MODIFIED="2008-06-23 15:23:27 -0400" MODIFIED_BY="[Empty name]" ORDER="10" SD_1="0.79" SD_2="0.3" SE="0.154283289222564" STUDY_ID="STD-Nilsson-1999" TOTAL_1="30" TOTAL_2="30" WEIGHT="45.524312283539054"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.16025778891863635" CI_END="0.30542565424011886" CI_START="-0.018365827335439955" DF="1" EFFECT_SIZE="0.14352991345233945" ESTIMABLE="YES" I2="0.0" ID="CMP-001.03.02" MODIFIED="2008-05-23 10:54:25 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6889194964970912" P_Z="0.0822775930228812" STUDIES="2" TAU2="0.0" TOTAL_1="67" TOTAL_2="67" WEIGHT="100.0" Z="1.7376211363058363">
<NAME>Available data analysis</NAME>
<CONT_DATA CI_END="0.46923784547981995" CI_START="-0.08923784547981994" EFFECT_SIZE="0.19" ESTIMABLE="YES" MEAN_1="0.48" MEAN_2="0.29" MODIFIED="2008-05-23 10:54:25 -0400" MODIFIED_BY="[Empty name]" ORDER="11" SD_1="0.89" SD_2="0.45" SE="0.14247090644645127" STUDY_ID="STD-Carlsson-2005" TOTAL_1="49" TOTAL_2="49" WEIGHT="33.614162074770654"/>
<CONT_DATA CI_END="0.318699924764904" CI_START="-0.078699924764904" EFFECT_SIZE="0.12" ESTIMABLE="YES" MEAN_1="0.37" MEAN_2="0.25" MODIFIED="2008-05-23 10:50:49 -0400" MODIFIED_BY="[Empty name]" ORDER="12" SD_1="0.35" SD_2="0.25" SE="0.10137937550497032" STUDY_ID="STD-Nilsson-1999" TOTAL_1="18" TOTAL_2="18" WEIGHT="66.38583792522935"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.092642180432109" CI_END="0.5933477244154284" CI_START="0.2647582413052828" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.39635047621861186" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="69" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="-0.22669071888534983" LOG_CI_START="-0.5771505124378444" LOG_EFFECT_SIZE="-0.40192061566159715" METHOD="MH" MODIFIED="2012-08-17 06:12:54 -0400" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.8361835045562274" P_Q="0.7269824547502002" P_Z="6.93993417632255E-6" Q="0.6377060094740433" RANDOM="YES" SCALE="140.14" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="235" TOTAL_2="234" WEIGHT="300.0" Z="4.4955224298669805">
<NAME>Arthroplasty instability (arthroplasty instability was considered an event)</NAME>
<GROUP_LABEL_1>Uncemented with HA</GROUP_LABEL_1>
<GROUP_LABEL_2>Cemented</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours uncemented</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours cemented</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.9580108760228818" CI_END="0.8466018051859051" CI_START="0.2623009415833675" DF="1" EFFECT_SIZE="0.47123714905177155" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="27" I2="0.0" ID="CMP-001.04.01" LOG_CI_END="-0.07232080982675981" LOG_CI_START="-0.5812001504171691" LOG_EFFECT_SIZE="-0.32676048012196446" MODIFIED="2009-04-29 19:24:54 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3276887326821588" P_Z="0.011834018490357876" STUDIES="2" TAU2="0.0" TOTAL_1="80" TOTAL_2="80" WEIGHT="100.00000000000001" Z="2.517055504226287">
<NAME>Intention-to-treat analysis (missing participants were categorized unstable)</NAME>
<DICH_DATA CI_END="0.8791529899238495" CI_START="0.10768837426261646" EFFECT_SIZE="0.3076923076923077" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="13" LOG_CI_END="-0.055935542561936565" LOG_CI_START="-0.9678311793958121" LOG_EFFECT_SIZE="-0.5118833609788743" MODIFIED="2009-04-29 19:24:03 -0400" MODIFIED_BY="[Empty name]" ORDER="43" O_E="0.0" SE="0.535652011032421" STUDY_ID="STD-Carlsson-2005" TOTAL_1="50" TOTAL_2="50" VAR="0.2869230769230769" WEIGHT="31.141488286229187"/>
<DICH_DATA CI_END="1.1576728677075563" CI_START="0.2820577568614003" EFFECT_SIZE="0.5714285714285714" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="14" LOG_CI_END="0.06358585488303282" LOG_CI_START="-0.5496619522556218" LOG_EFFECT_SIZE="-0.24303804868629447" MODIFIED="2009-04-29 19:24:54 -0400" MODIFIED_BY="[Empty name]" ORDER="44" O_E="0.0" SE="0.360224797538849" STUDY_ID="STD-Nilsson-1999" TOTAL_1="30" TOTAL_2="30" VAR="0.12976190476190477" WEIGHT="68.85851171377082"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.22212202353074947" CI_END="0.7502538055408179" CI_START="0.15407160185042304" DF="1" EFFECT_SIZE="0.33998941985604436" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="21" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="-0.1247917930091594" LOG_CI_START="-0.8122774021394559" LOG_EFFECT_SIZE="-0.4685345975743076" MODIFIED="2012-08-17 06:12:54 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6374277958178431" P_Z="0.007551174090014122" STUDIES="2" TAU2="0.0" TOTAL_1="80" TOTAL_2="80" WEIGHT="100.0" Z="2.671505918264441">
<NAME>Intention-to-treat analysis (missing participants were categorized stable)</NAME>
<DICH_DATA CI_END="0.9191054618512847" CI_START="0.08092669272080905" EFFECT_SIZE="0.2727272727272727" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="11" LOG_CI_END="-0.03663465306194126" LOG_CI_START="-1.0919082078151838" LOG_EFFECT_SIZE="-0.5642714304385626" MODIFIED="2009-04-29 19:39:56 -0400" MODIFIED_BY="[Empty name]" ORDER="45" O_E="0.0" SE="0.6198729097503973" STUDY_ID="STD-Carlsson-2005" TOTAL_1="50" TOTAL_2="50" VAR="0.38424242424242416" WEIGHT="42.442124375851115"/>
<DICH_DATA CI_END="1.1353940444188015" CI_START="0.14092023891309263" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="10" LOG_CI_END="0.05514661185272456" LOG_CI_START="-0.8510266291967997" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2009-04-29 19:40:19 -0400" MODIFIED_BY="[Empty name]" ORDER="46" O_E="0.0" SE="0.5322906474223771" STUDY_ID="STD-Nilsson-1999" TOTAL_1="30" TOTAL_2="30" VAR="0.2833333333333333" WEIGHT="57.55787562414888"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.25195308123532717" CI_END="0.7395353373851596" CI_START="0.15461211090933924" DF="1" EFFECT_SIZE="0.33814363753465765" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="21" I2="0.0" ID="CMP-001.04.03" LOG_CI_END="-0.13104106917930874" LOG_CI_START="-0.8107564903976883" LOG_EFFECT_SIZE="-0.4708987797884985" MODIFIED="2010-07-22 14:58:47 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.6157032332593092" P_Z="0.0066139893359132415" STUDIES="2" TAU2="0.0" TOTAL_1="75" TOTAL_2="74" WEIGHT="100.0" Z="2.715679591600116">
<NAME>Available data analysis (arthroplasty instability was considered an event)</NAME>
<DICH_DATA CI_END="0.8985813715674444" CI_START="0.07943100231267608" EFFECT_SIZE="0.26716141001855287" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="11" LOG_CI_END="-0.04644258898061168" LOG_CI_START="-1.1000099572023665" LOG_EFFECT_SIZE="-0.573226273091489" MODIFIED="2009-04-29 20:15:00 -0400" MODIFIED_BY="[Empty name]" ORDER="47" O_E="0.0" SE="0.6188706873360418" STUDY_ID="STD-Carlsson-2005" TOTAL_1="49" TOTAL_2="48" VAR="0.38300092764378474" WEIGHT="41.62264017554403"/>
<DICH_DATA CI_END="1.1139619595744543" CI_START="0.14363147558568498" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="10" LOG_CI_END="0.046870360470580755" LOG_CI_START="-0.8427503778146559" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2009-04-29 20:15:49 -0400" MODIFIED_BY="[Empty name]" ORDER="48" O_E="0.0" SE="0.5225676253624244" STUDY_ID="STD-Nilsson-1999" TOTAL_1="26" TOTAL_2="26" VAR="0.2730769230769231" WEIGHT="58.37735982445597"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2012-08-17 06:14:02 -0400" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Cemented versus uncemented with and without HA</NAME>
<CONT_OUTCOME CHI2="3.5810954231553955" CI_END="0.335074496677632" CI_START="0.010296329392238096" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.17268541303493504" ESTIMABLE="YES" I2="16.226750602567787" I2_Q="0.0" ID="CMP-002.01" MODIFIED="2010-08-22 23:53:58 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.31039578667190415" P_Q="0.8397085664382494" P_Z="0.03713869664239561" Q="0.040911698187790134" RANDOM="YES" SCALE="2.07" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0025091332825244745" TOTALS="SUB" TOTAL_1="242" TOTAL_2="147" UNITS="" WEIGHT="200.0" Z="2.0842360989523177">
<NAME>Absolute rotation about transverse axis in degrees (60 months)</NAME>
<GROUP_LABEL_1>Uncemented</GROUP_LABEL_1>
<GROUP_LABEL_2>Cemented</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Uncemented</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Cemented</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="2.133154337982661" CI_END="0.3926976190639174" CI_START="-0.08322828573058405" DF="1" EFFECT_SIZE="0.1547346666666667" ESTIMABLE="YES" I2="53.12106666666665" ID="CMP-002.01.01" MODIFIED="2008-06-23 15:24:29 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.14414392437065138" P_Z="0.2025003025010571" STUDIES="2" TAU2="0.016600333333333328" TOTAL_1="130" TOTAL_2="80" WEIGHT="100.0" Z="1.274460460215659">
<NAME>Intention-to-treat analysis</NAME>
<CONT_DATA CI_END="0.41649314355290673" CI_START="0.08350685644709327" EFFECT_SIZE="0.25" ESTIMABLE="YES" MEAN_1="0.65" MEAN_2="0.4" MODIFIED="2008-05-23 13:02:26 -0400" MODIFIED_BY="[Empty name]" ORDER="13" SD_1="0.68" SD_2="0.36" SE="0.0849470423263812" STUDY_ID="STD-Carlsson-2005" TOTAL_1="100" TOTAL_2="50" WEIGHT="61.89386666666667"/>
<CONT_DATA CI_END="0.29125970477163843" CI_START="-0.29125970477163843" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.46" MEAN_2="0.46" MODIFIED="2008-06-23 15:24:29 -0400" MODIFIED_BY="[Empty name]" ORDER="14" SD_1="0.55" SD_2="0.6" SE="0.14860462083439174" STUDY_ID="STD-Nilsson-1999" TOTAL_1="30" TOTAL_2="30" WEIGHT="38.10613333333333"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="1.379482948028675" CI_END="0.4104873188336416" CI_START="-0.03382599499231104" DF="1" EFFECT_SIZE="0.18833066192066528" ESTIMABLE="YES" I2="27.509071320596476" ID="CMP-002.01.02" MODIFIED="2008-05-23 13:07:11 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.24018943253890113" P_Z="0.09660581652795366" STUDIES="2" TAU2="0.010027056496357411" TOTAL_1="112" TOTAL_2="67" WEIGHT="99.99999999999999" Z="1.6615361415601693">
<NAME>Available data analysis</NAME>
<CONT_DATA CI_END="0.409513433647142" CI_START="0.09048656635285798" EFFECT_SIZE="0.25" ESTIMABLE="YES" MEAN_1="0.65" MEAN_2="0.4" MODIFIED="2008-05-23 13:03:44 -0400" MODIFIED_BY="[Empty name]" ORDER="15" SD_1="0.6" SD_2="0.37" SE="0.08138590040702973" STUDY_ID="STD-Carlsson-2005" TOTAL_1="94" TOTAL_2="49" WEIGHT="77.1595044150612"/>
<CONT_DATA CI_END="0.401379595219844" CI_START="-0.44137959521984405" EFFECT_SIZE="-0.020000000000000018" ESTIMABLE="YES" MEAN_1="0.49" MEAN_2="0.51" MODIFIED="2008-05-23 13:07:11 -0400" MODIFIED_BY="[Empty name]" ORDER="16" SD_1="0.56" SD_2="0.72" SE="0.214993539954628" STUDY_ID="STD-Nilsson-1999" TOTAL_1="18" TOTAL_2="18" WEIGHT="22.84049558493878"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="9.719313432830415" CI_END="0.5177390695965572" CI_START="0.10291995024526188" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.3103295099209096" ESTIMABLE="YES" I2="69.13362223851696" I2_Q="0.0" ID="CMP-002.02" MODIFIED="2008-07-22 23:00:42 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.02110915578383188" P_Q="0.7320047936695843" P_Z="0.0033621292512473998" Q="0.11727885156001899" RANDOM="YES" SCALE="2.569375642769909" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.03042328367090927" TOTALS="SUB" TOTAL_1="242" TOTAL_2="147" UNITS="" WEIGHT="200.0" Z="2.932529550403178">
<NAME>Absolute rotation about longitudinal axis in degrees (60 months)</NAME>
<GROUP_LABEL_1>Uncemented</GROUP_LABEL_1>
<GROUP_LABEL_2>Cemented</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Uncemented</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Cemented</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="1.9758888865470958" CI_END="0.5774500808808117" CI_START="0.08845125245252175" DF="1" EFFECT_SIZE="0.33295066666666673" ESTIMABLE="YES" I2="49.38986666666669" ID="CMP-002.02.01" MODIFIED="2008-06-23 15:25:09 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.15982449769357676" P_Z="0.007607524658706081" STUDIES="2" TAU2="0.015434333333333359" TOTAL_1="130" TOTAL_2="80" WEIGHT="100.0" Z="2.669009729093717">
<NAME>Intention-to-treat analysis</NAME>
<CONT_DATA CI_END="0.6804770977180996" CI_START="0.21952290228190058" EFFECT_SIZE="0.45000000000000007" ESTIMABLE="YES" MEAN_1="0.8" MEAN_2="0.35" MODIFIED="2008-05-23 13:18:07 -0400" MODIFIED_BY="[Empty name]" ORDER="17" SD_1="1.06" SD_2="0.36" SE="0.1175925167687128" STUDY_ID="STD-Carlsson-2005" TOTAL_1="100" TOTAL_2="50" WEIGHT="53.18026666666667"/>
<CONT_DATA CI_END="0.46151629370096825" CI_START="-0.06151629370096823" EFFECT_SIZE="0.2" ESTIMABLE="YES" MEAN_1="0.45" MEAN_2="0.25" MODIFIED="2008-06-23 15:25:09 -0400" MODIFIED_BY="[Empty name]" ORDER="18" SD_1="0.7" SD_2="0.21" SE="0.1334291322512941" STUDY_ID="STD-Nilsson-1999" TOTAL_1="30" TOTAL_2="30" WEIGHT="46.81973333333334"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="6.482131391227096" CI_END="0.6439709266732545" CI_START="-0.13942902480612468" DF="1" EFFECT_SIZE="0.2522709509335649" ESTIMABLE="YES" I2="84.57297546678245" ID="CMP-002.02.02" MODIFIED="2008-05-23 13:18:31 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0108964518019814" P_Z="0.2068417091746665" STUDIES="2" TAU2="0.06765838037342596" TOTAL_1="112" TOTAL_2="67" WEIGHT="100.0" Z="1.2622976992575758">
<NAME>Available data analysis</NAME>
<CONT_DATA CI_END="0.7034874802959866" CI_START="0.21651251970401333" EFFECT_SIZE="0.45999999999999996" ESTIMABLE="YES" MEAN_1="0.82" MEAN_2="0.36" MODIFIED="2008-05-23 13:18:31 -0400" MODIFIED_BY="[Empty name]" ORDER="19" SD_1="1.09" SD_2="0.37" SE="0.1242305890396889" STUDY_ID="STD-Carlsson-2005" TOTAL_1="94" TOTAL_2="49" WEIGHT="48.067737733391226"/>
<CONT_DATA CI_END="0.24850329994835813" CI_START="-0.12850329994835813" EFFECT_SIZE="0.06" ESTIMABLE="YES" MEAN_1="0.34" MEAN_2="0.28" MODIFIED="2008-05-23 13:12:20 -0400" MODIFIED_BY="[Empty name]" ORDER="20" SD_1="0.33" SD_2="0.24" SE="0.09617692030835673" STUDY_ID="STD-Nilsson-1999" TOTAL_1="18" TOTAL_2="18" WEIGHT="51.932262266608774"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.5320075126867012" CI_END="0.2767371824068373" CI_START="0.066614098344877" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.17167564037585717" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2008-07-22 23:01:01 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9118053629059965" P_Q="0.6500878835489257" P_Z="0.0013615710431597564" Q="0.20578935888862113" RANDOM="YES" SCALE="1.1881796426494518" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="242" TOTAL_2="147" UNITS="" WEIGHT="200.0" Z="3.20267593312414">
<NAME>Absolute rotation about sagittal axis in degrees (60 months)</NAME>
<GROUP_LABEL_1>Uncemented</GROUP_LABEL_1>
<GROUP_LABEL_2>Cemented</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Uncemented</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Cemented</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.1483170554524175" CI_END="0.35943235835719156" CI_START="0.03969791850131196" DF="1" EFFECT_SIZE="0.19956513842925175" ESTIMABLE="YES" I2="0.0" ID="CMP-002.03.01" MODIFIED="2008-06-23 15:25:42 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.7001490042006546" P_Z="0.014418740567400392" STUDIES="2" TAU2="0.0" TOTAL_1="130" TOTAL_2="80" WEIGHT="100.0" Z="2.446658446099147">
<NAME>Intention-to-treat analysis</NAME>
<CONT_DATA CI_END="0.36834019950687524" CI_START="-0.008340199506875229" EFFECT_SIZE="0.18" ESTIMABLE="YES" MEAN_1="0.47" MEAN_2="0.29" MODIFIED="2008-05-23 13:30:27 -0400" MODIFIED_BY="[Empty name]" ORDER="21" SD_1="0.72" SD_2="0.45" SE="0.0960937042682818" STUDY_ID="STD-Carlsson-2005" TOTAL_1="100" TOTAL_2="50" WEIGHT="72.04980224392607"/>
<CONT_DATA CI_END="0.5523896902926022" CI_START="-0.052389690292602153" EFFECT_SIZE="0.25" ESTIMABLE="YES" MEAN_1="0.51" MEAN_2="0.26" MODIFIED="2008-06-23 15:25:42 -0400" MODIFIED_BY="[Empty name]" ORDER="22" SD_1="0.79" SD_2="0.3" SE="0.154283289222564" STUDY_ID="STD-Nilsson-1999" TOTAL_1="30" TOTAL_2="30" WEIGHT="27.950197756073933"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.17790109834566273" CI_END="0.2898619516649559" CI_START="0.011085646842354469" DF="1" EFFECT_SIZE="0.15047379925365517" ESTIMABLE="YES" I2="0.0" ID="CMP-002.03.02" MODIFIED="2008-05-23 13:33:52 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6731832482039968" P_Z="0.03435829651507028" STUDIES="2" TAU2="0.0" TOTAL_1="112" TOTAL_2="67" WEIGHT="100.0" Z="2.1158414259185183">
<NAME>Available data analysis</NAME>
<CONT_DATA CI_END="0.3755861894782263" CI_START="-0.015586189478226292" EFFECT_SIZE="0.18" ESTIMABLE="YES" MEAN_1="0.47" MEAN_2="0.29" MODIFIED="2008-05-23 13:31:06 -0400" MODIFIED_BY="[Empty name]" ORDER="23" SD_1="0.74" SD_2="0.45" SE="0.0997907058604062" STUDY_ID="STD-Carlsson-2005" TOTAL_1="94" TOTAL_2="49" WEIGHT="50.78966542275865"/>
<CONT_DATA CI_END="0.318699924764904" CI_START="-0.078699924764904" EFFECT_SIZE="0.12" ESTIMABLE="YES" MEAN_1="0.37" MEAN_2="0.25" MODIFIED="2008-05-23 13:33:52 -0400" MODIFIED_BY="[Empty name]" ORDER="24" SD_1="0.35" SD_2="0.25" SE="0.10137937550497032" STUDY_ID="STD-Nilsson-1999" TOTAL_1="18" TOTAL_2="18" WEIGHT="49.21033457724135"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="1.2615628394198222" CI_END="0.7635495658483149" CI_START="0.44334978324967067" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.6034496745489928" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2012-02-28 13:01:51 -0500" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.7382800494877095" P_Q="0.9780823868822656" P_Z="1.4960331768608017E-13" Q="7.547718289478815E-4" RANDOM="YES" SCALE="1.9068826006981447" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="224" TOTAL_2="120" UNITS="" WEIGHT="200.0" Z="7.3875105035967685">
<NAME>Maximum total point motion in millimeters (12 months)</NAME>
<GROUP_LABEL_1>Uncemented</GROUP_LABEL_1>
<GROUP_LABEL_2>Cemented</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Uncemented</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Cemented</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.6105856038896574" CI_END="0.8226782768111288" CI_START="0.3799350861092231" DF="1" EFFECT_SIZE="0.601306681460176" ESTIMABLE="YES" I2="0.0" ID="CMP-002.04.01" MODIFIED="2008-05-27 18:40:14 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4345675887147925" P_Z="1.016182522458778E-7" STUDIES="2" TAU2="0.0" TOTAL_1="115" TOTAL_2="61" WEIGHT="100.0" Z="5.323806053151665">
<NAME>Intention-to-treat analysis</NAME>
<CONT_DATA CI_END="0.8817121163780108" CI_START="0.39828788362198947" EFFECT_SIZE="0.6400000000000001" ESTIMABLE="YES" MEAN_1="1.09" MEAN_2="0.45" MODIFIED="2008-05-27 18:40:14 -0400" MODIFIED_BY="[Empty name]" ORDER="25" SD_1="1.11" SD_2="0.38" SE="0.12332477447779908" STUDY_ID="STD-Carlsson-2005" TOTAL_1="100" TOTAL_2="50" WEIGHT="83.87778394173996"/>
<CONT_DATA CI_END="0.9513273361795064" CI_START="-0.15132733617950656" EFFECT_SIZE="0.3999999999999999" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="1.0" MODIFIED="2008-05-27 17:32:20 -0400" MODIFIED_BY="[Empty name]" ORDER="28" SD_1="0.77" SD_2="0.66" SE="0.2812946260892068" STUDY_ID="STD-Toksvig_x002d_Larsen-1998" TOTAL_1="15" TOTAL_2="11" WEIGHT="16.122216058260044"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.6502224637012168" CI_END="0.8376202837553209" CI_START="0.3739792054003982" DF="1" EFFECT_SIZE="0.6057997445778596" ESTIMABLE="YES" I2="0.0" ID="CMP-002.04.02" MODIFIED="2008-05-27 18:40:54 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.42003342587019343" P_Z="3.025826276998065E-7" STUDIES="2" TAU2="0.0" TOTAL_1="109" TOTAL_2="59" WEIGHT="100.0" Z="5.121831246830298">
<NAME>Available data analysis</NAME>
<CONT_DATA CI_END="0.9055050570210516" CI_START="0.3944949429789487" EFFECT_SIZE="0.6500000000000001" ESTIMABLE="YES" MEAN_1="1.1" MEAN_2="0.45" MODIFIED="2008-05-27 18:40:54 -0400" MODIFIED_BY="[Empty name]" ORDER="29" SD_1="1.14" SD_2="0.39" SE="0.13036211840444145" STUDY_ID="STD-Carlsson-2005" TOTAL_1="94" TOTAL_2="48" WEIGHT="82.31989783114378"/>
<CONT_DATA CI_END="0.9513273361795064" CI_START="-0.15132733617950656" EFFECT_SIZE="0.3999999999999999" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="1.0" MODIFIED="2008-05-27 17:31:21 -0400" MODIFIED_BY="[Empty name]" ORDER="30" SD_1="0.77" SD_2="0.66" SE="0.2812946260892068" STUDY_ID="STD-Toksvig_x002d_Larsen-1998" TOTAL_1="15" TOTAL_2="11" WEIGHT="17.680102168856223"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.021940061401318486" CI_END="0.6695150757694539" CI_START="0.36837657000541196" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.518945822887433" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.05" MODIFIED="2012-02-28 13:02:09 -0500" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.9991413447919432" P_Q="0.962458076171061" P_Z="1.4270563658925604E-11" Q="0.0022155108957977723" RANDOM="YES" SCALE="2.7298189452046877" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="222" TOTAL_2="118" UNITS="" WEIGHT="200.0" Z="6.755131630916932">
<NAME>Maximum total point motion in millimeters (24 months)</NAME>
<GROUP_LABEL_1>Uncemented</GROUP_LABEL_1>
<GROUP_LABEL_2>Cemented</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Uncemented</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Cemented</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.006159287986308862" CI_END="0.7247894999169325" CI_START="0.30611692730008133" DF="1" EFFECT_SIZE="0.5154532136085069" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.01" MODIFIED="2009-06-26 07:52:50 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9374453390216522" P_Z="1.3925971328745867E-6" STUDIES="2" TAU2="0.0" TOTAL_1="114" TOTAL_2="59" WEIGHT="99.99999999999999" Z="4.826061225236527">
<NAME>Intention-to-treat analysis</NAME>
<CONT_DATA CI_END="0.7581497386702916" CI_START="0.28185026132970875" EFFECT_SIZE="0.5200000000000001" ESTIMABLE="YES" MEAN_1="1.09" MEAN_2="0.57" MODIFIED="2009-06-26 07:52:50 -0400" MODIFIED_BY="[Empty name]" ORDER="60" SD_1="1.06" SD_2="0.42" SE="0.1215072014326723" STUDY_ID="STD-Carlsson-2005" TOTAL_1="100" TOTAL_2="50" WEIGHT="77.26606804253427"/>
<CONT_DATA CI_END="0.9390431821861216" CI_START="0.06095681781387835" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="1.0" MODIFIED="2009-06-26 07:49:52 -0400" MODIFIED_BY="[Empty name]" ORDER="61" SD_1="0.75" SD_2="0.3" SE="0.22400573972238175" STUDY_ID="STD-Toksvig_x002d_Larsen-1998" TOTAL_1="14" TOTAL_2="9" WEIGHT="22.733931957465717"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.013565262519211852" CI_END="0.7394198311000101" CI_START="0.30595920185116265" DF="1" EFFECT_SIZE="0.5226895164755864" ESTIMABLE="YES" I2="0.0" ID="CMP-002.05.02" MODIFIED="2009-06-26 07:57:40 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9072800574792388" P_Z="2.280247168822567E-6" STUDIES="2" TAU2="0.0" TOTAL_1="108" TOTAL_2="59" WEIGHT="100.0" Z="4.726854335832526">
<NAME>Available data analysis</NAME>
<CONT_DATA CI_END="0.7792112642277447" CI_START="0.2807887357722556" EFFECT_SIZE="0.5300000000000001" ESTIMABLE="YES" MEAN_1="1.1" MEAN_2="0.57" MODIFIED="2009-06-26 07:57:30 -0400" MODIFIED_BY="[Empty name]" ORDER="62" SD_1="1.09" SD_2="0.42" SE="0.1271509406262009" STUDY_ID="STD-Carlsson-2005" TOTAL_1="94" TOTAL_2="50" WEIGHT="75.63172158528762"/>
<CONT_DATA CI_END="0.9390431821861216" CI_START="0.06095681781387835" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="1.0" MODIFIED="2009-06-26 07:57:40 -0400" MODIFIED_BY="[Empty name]" ORDER="63" SD_1="0.75" SD_2="0.3" SE="0.22400573972238175" STUDY_ID="STD-Toksvig_x002d_Larsen-1998" TOTAL_1="14" TOTAL_2="9" WEIGHT="24.368278414712385"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="12.304589070873169" CI_END="0.7336739676344669" CI_START="0.3392831106984339" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4989220239451091" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="81" I2="34.98360689722491" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="-0.13449689037496745" LOG_CI_START="-0.4694377587251577" LOG_EFFECT_SIZE="-0.3019673245500626" METHOD="MH" MODIFIED="2012-08-17 06:14:02 -0400" MODIFIED_BY="[Empty name]" NO="6" NOTES="&lt;p&gt;Arthroplasty instability was considered an event&lt;/p&gt;" NOTES_MODIFIED="2012-08-17 06:14:02 -0400" NOTES_MODIFIED_BY="[Empty name]" P_CHI2="0.13812263958781235" P_Q="0.3928073677289532" P_Z="4.092788550074083E-4" Q="1.8688721969630255" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.1171720081280952" TOTALS="SUB" TOTAL_1="419" TOTAL_2="273" WEIGHT="300.0" Z="3.534027266014307">
<NAME>Arthroplasty instability (arthroplasty instability was considered an event)</NAME>
<GROUP_LABEL_1>Uncemented</GROUP_LABEL_1>
<GROUP_LABEL_2>Cemented</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours uncemented</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours cemented</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.054009430150502" CI_END="1.680630474022267" CI_START="0.3622308232489775" DF="2" EFFECT_SIZE="0.780241091062503" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="31" I2="66.96404220912684" ID="CMP-002.06.01" LOG_CI_END="0.22547223412076783" LOG_CI_START="-0.44101459709930135" LOG_EFFECT_SIZE="-0.10777118148926676" MODIFIED="2010-07-22 14:44:18 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.04846071383865702" P_Z="0.5261761856570968" STUDIES="3" TAU2="0.3064870509942858" TOTAL_1="145" TOTAL_2="93" WEIGHT="100.0" Z="0.633853886966138">
<NAME>Intention-to-treat analysis (missing participants were categorized unstable)</NAME>
<DICH_DATA CI_END="0.996604853792933" CI_START="0.2508516781235175" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="13" LOG_CI_END="-0.0014770020030576072" LOG_CI_START="-0.6005829893249047" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2009-04-28 22:06:59 -0400" MODIFIED_BY="[Empty name]" ORDER="33" O_E="0.0" SE="0.3519178225753192" STUDY_ID="STD-Carlsson-2005" TOTAL_1="100" TOTAL_2="50" VAR="0.12384615384615384" WEIGHT="35.61668471171595"/>
<DICH_DATA CI_END="1.1576728677075563" CI_START="0.2820577568614003" EFFECT_SIZE="0.5714285714285714" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="14" LOG_CI_END="0.06358585488303282" LOG_CI_START="-0.5496619522556218" LOG_EFFECT_SIZE="-0.24303804868629447" MODIFIED="2009-04-28 22:08:16 -0400" MODIFIED_BY="[Empty name]" ORDER="34" O_E="0.0" SE="0.360224797538849" STUDY_ID="STD-Nilsson-1999" TOTAL_1="30" TOTAL_2="30" VAR="0.12976190476190477" WEIGHT="35.133704907594414"/>
<DICH_DATA CI_END="4.864386592141701" CI_START="0.7817018503716064" EFFECT_SIZE="1.95" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="4" LOG_CI_END="0.6870280827453685" LOG_CI_START="-0.10695886002033243" LOG_EFFECT_SIZE="0.290034611362518" MODIFIED="2010-07-22 14:44:18 -0400" MODIFIED_BY="[Empty name]" ORDER="35" O_E="0.0" SE="0.46639186047932646" STUDY_ID="STD-Toksvig_x002d_Larsen-1998" TOTAL_1="15" TOTAL_2="13" VAR="0.21752136752136753" WEIGHT="29.24961038068964"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.7939483963178166" CI_END="0.726734387777239" CI_START="0.2193837184834434" DF="2" EFFECT_SIZE="0.3992914879387731" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="25" I2="0.0" ID="CMP-002.06.02" LOG_CI_END="-0.1386242892789305" LOG_CI_START="-0.6587956066390489" LOG_EFFECT_SIZE="-0.39870994795898973" MODIFIED="2012-08-17 06:14:02 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6723515913221587" P_Z="0.0026591765881713025" STUDIES="3" TAU2="0.0" TOTAL_1="145" TOTAL_2="93" WEIGHT="100.0" Z="3.004614488331931">
<NAME>Intention-to-treat analysis (missing participants were categorized stable)</NAME>
<DICH_DATA CI_END="0.7707468620996705" CI_START="0.13135268451913024" EFFECT_SIZE="0.3181818181818182" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="-0.11308823471766817" LOG_CI_START="-0.8815610468982307" LOG_EFFECT_SIZE="-0.4973246408079494" MODIFIED="2009-04-28 22:47:42 -0400" MODIFIED_BY="[Empty name]" ORDER="36" O_E="0.0" SE="0.4514047338766329" STUDY_ID="STD-Carlsson-2005" TOTAL_1="100" TOTAL_2="50" VAR="0.20376623376623376" WEIGHT="45.81796414176183"/>
<DICH_DATA CI_END="1.1353940444188015" CI_START="0.14092023891309263" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="10" LOG_CI_END="0.05514661185272456" LOG_CI_START="-0.8510266291967997" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2009-04-28 22:48:05 -0400" MODIFIED_BY="[Empty name]" ORDER="37" O_E="0.0" SE="0.5322906474223771" STUDY_ID="STD-Nilsson-1999" TOTAL_1="30" TOTAL_2="30" VAR="0.2833333333333333" WEIGHT="32.95113173648173"/>
<DICH_DATA CI_END="2.3843611851933995" CI_START="0.177196308438367" EFFECT_SIZE="0.65" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.37737204337320523" LOG_CI_START="-0.7515453300874941" LOG_EFFECT_SIZE="-0.1870866433571444" MODIFIED="2010-07-22 14:43:18 -0400" MODIFIED_BY="[Empty name]" ORDER="38" O_E="0.0" SE="0.6631316534019392" STUDY_ID="STD-Toksvig_x002d_Larsen-1998" TOTAL_1="15" TOTAL_2="13" VAR="0.4397435897435897" WEIGHT="21.230904121756453"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="2.5390967560153026" CI_END="0.9151142800032455" CI_START="0.2403836593405544" DF="2" EFFECT_SIZE="0.4690186769649764" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="25" I2="21.231831939375436" ID="CMP-002.06.03" LOG_CI_END="-0.03852466759946713" LOG_CI_START="-0.6190950578815637" LOG_EFFECT_SIZE="-0.3288098627405154" MODIFIED="2010-07-22 14:58:00 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.2809585887362973" P_Z="0.026413540351486183" STUDIES="3" TAU2="0.07527793559037933" TOTAL_1="129" TOTAL_2="87" WEIGHT="100.0" Z="2.2200770122631672">
<NAME>Available data analysis (arthroplasty instability was considered an event)</NAME>
<DICH_DATA CI_END="0.7846303865000746" CI_START="0.13457746834746132" EFFECT_SIZE="0.32495164410058025" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="-0.10533487689247788" LOG_CI_START="-0.8710276458436816" LOG_EFFECT_SIZE="-0.4881812613680797" MODIFIED="2009-04-28 22:53:01 -0400" MODIFIED_BY="[Empty name]" ORDER="39" O_E="0.0" SE="0.4497717227222716" STUDY_ID="STD-Carlsson-2005" TOTAL_1="94" TOTAL_2="48" VAR="0.20229460256056" WEIGHT="41.89946450570093"/>
<DICH_DATA CI_END="1.1139619595744543" CI_START="0.14363147558568498" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="10" LOG_CI_END="0.046870360470580755" LOG_CI_START="-0.8427503778146559" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2009-04-28 22:53:45 -0400" MODIFIED_BY="[Empty name]" ORDER="40" O_E="0.0" SE="0.5225676253624244" STUDY_ID="STD-Nilsson-1999" TOTAL_1="26" TOTAL_2="26" VAR="0.2730769230769231" WEIGHT="33.385900671820416"/>
<DICH_DATA CI_END="3.7148092435830664" CI_START="0.3159276921522681" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5699365175350146" LOG_CI_START="-0.5004123050165907" LOG_EFFECT_SIZE="0.03476210625921191" MODIFIED="2010-01-01 16:42:54 -0500" MODIFIED_BY="[Empty name]" ORDER="41" O_E="0.0" SE="0.6287281966789348" STUDY_ID="STD-Toksvig_x002d_Larsen-1998" TOTAL_1="9" TOTAL_2="13" VAR="0.3952991452991452" WEIGHT="24.714634822478658"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2012-08-17 06:14:15 -0400" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Cemented versus uncemented without HA</NAME>
<CONT_OUTCOME CHI2="1.557747325607517" CI_END="0.7712409077760451" CI_START="0.48524110286021727" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.6282410053181312" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2012-02-28 13:02:50 -0500" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6690078544741397" P_Q="0.887670951313999" P_Z="7.261364838558385E-18" Q="0.019952100654992467" RANDOM="YES" SCALE="1.91" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="125" TOTAL_2="120" UNITS="" WEIGHT="200.0" Z="8.610703384201008">
<NAME>Maximum total point motion in millimeters (12 months)</NAME>
<GROUP_LABEL_1>Uncemented without HA</GROUP_LABEL_1>
<GROUP_LABEL_2>Cemented</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Uncemented</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Cemented</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.6908774696566627" CI_END="0.813848648730676" CI_START="0.4234860012615864" DF="1" EFFECT_SIZE="0.6186673249961312" ESTIMABLE="YES" I2="0.0" ID="CMP-003.01.01" MODIFIED="2008-05-27 18:53:55 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.40586647697647193" P_Z="5.214528620944753E-10" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="61" WEIGHT="100.0" Z="6.21250871857646">
<NAME>Intention-to-treat analysis</NAME>
<CONT_DATA CI_END="0.8586970534268035" CI_START="0.4413029465731968" EFFECT_SIZE="0.6500000000000001" ESTIMABLE="YES" MEAN_1="1.1" MEAN_2="0.45" MODIFIED="2008-05-27 18:53:55 -0400" MODIFIED_BY="[Empty name]" ORDER="29" SD_1="0.65" SD_2="0.38" SE="0.10648004507887851" STUDY_ID="STD-Carlsson-2005" TOTAL_1="50" TOTAL_2="50" WEIGHT="87.46692999845243"/>
<CONT_DATA CI_END="0.9513273361795064" CI_START="-0.15132733617950656" EFFECT_SIZE="0.3999999999999999" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="1.0" MODIFIED="2008-05-27 17:35:32 -0400" MODIFIED_BY="[Empty name]" ORDER="30" SD_1="0.77" SD_2="0.66" SE="0.2812946260892068" STUDY_ID="STD-Toksvig_x002d_Larsen-1998" TOTAL_1="15" TOTAL_2="11" WEIGHT="12.533070001547566"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.8469177552958617" CI_END="0.8494423017564171" CI_START="0.42922754765341986" DF="1" EFFECT_SIZE="0.6393349247049185" ESTIMABLE="YES" I2="0.0" ID="CMP-003.01.02" MODIFIED="2008-05-27 18:54:50 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.3574258326799862" P_Z="2.4618674291489877E-9" STUDIES="2" TAU2="0.0" TOTAL_1="60" TOTAL_2="59" WEIGHT="99.99999999999999" Z="5.963966825273019">
<NAME>Available data analysis</NAME>
<CONT_DATA CI_END="0.9072570046544131" CI_START="0.4527429953455868" EFFECT_SIZE="0.6799999999999999" ESTIMABLE="YES" MEAN_1="1.13" MEAN_2="0.45" MODIFIED="2008-05-27 18:54:50 -0400" MODIFIED_BY="[Empty name]" ORDER="31" SD_1="0.68" SD_2="0.39" SE="0.11594958195507027" STUDY_ID="STD-Carlsson-2005" TOTAL_1="45" TOTAL_2="48" WEIGHT="85.47675882318521"/>
<CONT_DATA CI_END="0.9513273361795064" CI_START="-0.15132733617950656" EFFECT_SIZE="0.3999999999999999" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="1.0" MODIFIED="2008-05-27 17:36:04 -0400" MODIFIED_BY="[Empty name]" ORDER="32" SD_1="0.77" SD_2="0.66" SE="0.2812946260892068" STUDY_ID="STD-Toksvig_x002d_Larsen-1998" TOTAL_1="15" TOTAL_2="11" WEIGHT="14.523241176814784"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.06384062838810292" CI_END="0.6725369876086777" CI_START="0.38969863268619437" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="MD" EFFECT_SIZE="0.5311178101474361" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.02" MODIFIED="2012-02-28 13:03:17 -0500" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9957911671704963" P_Q="0.9180864381407372" P_Z="1.8268061085911818E-13" Q="0.010576978061383515" RANDOM="YES" SCALE="4.422698220684536" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="123" TOTAL_2="117" UNITS="" WEIGHT="200.0" Z="7.360895446602726">
<NAME>Maximum total point motion in millimeters (24 months)</NAME>
<GROUP_LABEL_1>Uncemented without HA</GROUP_LABEL_1>
<GROUP_LABEL_2>Cemented</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Uncemented</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Cemented</GRAPH_LABEL_2>
<CONT_SUBGROUP CHI2="0.014418785617833652" CI_END="0.7185371780855453" CI_START="0.3296970928503028" DF="1" EFFECT_SIZE="0.524117135467924" ESTIMABLE="YES" I2="0.0" ID="CMP-003.02.01" MODIFIED="2009-06-26 07:16:05 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.90442116608325" P_Z="1.2662351998778217E-7" STUDIES="2" TAU2="0.0" TOTAL_1="64" TOTAL_2="59" WEIGHT="100.0" Z="5.283666721634218">
<NAME>Intention-to-treat analysis</NAME>
<CONT_DATA CI_END="0.7468397010819194" CI_START="0.31316029891808084" EFFECT_SIZE="0.5300000000000001" ESTIMABLE="YES" MEAN_1="1.1" MEAN_2="0.57" MODIFIED="2009-06-26 06:59:21 -0400" MODIFIED_BY="[Empty name]" ORDER="56" SD_1="0.66" SD_2="0.42" SE="0.11063453348751465" STUDY_ID="STD-Carlsson-2005" TOTAL_1="50" TOTAL_2="50" WEIGHT="80.39045155974641"/>
<CONT_DATA CI_END="0.9390431821861216" CI_START="0.06095681781387835" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="1.0" MODIFIED="2009-06-26 07:16:05 -0400" MODIFIED_BY="[Empty name]" ORDER="57" SD_1="0.75" SD_2="0.3" SE="0.22400573972238175" STUDY_ID="STD-Toksvig_x002d_Larsen-1998" TOTAL_1="14" TOTAL_2="9" WEIGHT="19.609548440253587"/>
</CONT_SUBGROUP>
<CONT_SUBGROUP CHI2="0.03884486470888573" CI_END="0.7450665903431826" CI_START="0.33290060239393776" DF="1" EFFECT_SIZE="0.5389835963685602" ESTIMABLE="YES" I2="0.0" ID="CMP-003.02.02" MODIFIED="2009-06-26 07:29:06 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8437564079053177" P_Z="2.9590916737719955E-7" STUDIES="2" TAU2="0.0" TOTAL_1="59" TOTAL_2="58" WEIGHT="100.0" Z="5.126034015549764">
<NAME>Available data analysis</NAME>
<CONT_DATA CI_END="0.7833921294248003" CI_START="0.31660787057519996" EFFECT_SIZE="0.5500000000000002" ESTIMABLE="YES" MEAN_1="1.12" MEAN_2="0.57" MODIFIED="2009-06-26 07:26:13 -0400" MODIFIED_BY="[Empty name]" ORDER="58" SD_1="0.69" SD_2="0.42" SE="0.11907980517283355" STUDY_ID="STD-Carlsson-2005" TOTAL_1="45" TOTAL_2="49" WEIGHT="77.96719273712016"/>
<CONT_DATA CI_END="0.9390431821861216" CI_START="0.06095681781387835" EFFECT_SIZE="0.5" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="1.0" MODIFIED="2009-06-26 07:29:06 -0400" MODIFIED_BY="[Empty name]" ORDER="59" SD_1="0.75" SD_2="0.3" SE="0.22400573972238175" STUDY_ID="STD-Toksvig_x002d_Larsen-1998" TOTAL_1="14" TOTAL_2="9" WEIGHT="22.032807262879842"/>
</CONT_SUBGROUP>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.947465291373753" CI_END="0.9514273720157331" CI_START="0.40118278639773086" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6178157364136513" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="48" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="-0.021624358335087704" LOG_CI_START="-0.39665770958197555" LOG_EFFECT_SIZE="-0.20914103395853165" METHOD="MH" MODIFIED="2010-08-23 00:15:16 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.70808519203187" P_Q="0.9291436271379715" P_Z="0.028816603628418026" Q="0.14698393236277296" RANDOM="YES" SCALE="385.37" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="189" TOTAL_2="183" WEIGHT="300.0" Z="2.1859863550020315">
<NAME>Arthroplasty instability (arthroplasty instability was considered an event)</NAME>
<GROUP_LABEL_1>Uncemented without HA</GROUP_LABEL_1>
<GROUP_LABEL_2>Cemented</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours uncemented</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours cemented</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.03681047728491306" CI_END="1.1686021751118019" CI_START="0.3728397623798034" DF="1" EFFECT_SIZE="0.6600767813559311" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="20" I2="0.0" ID="CMP-003.03.01" LOG_CI_END="0.06766669032456016" LOG_CI_START="-0.42847777748415394" LOG_EFFECT_SIZE="-0.18040554357979685" MODIFIED="2009-04-29 20:39:31 -0400" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8478514979715531" P_Z="0.1540576731491956" STUDIES="2" TAU2="0.0" TOTAL_1="65" TOTAL_2="63" WEIGHT="100.0" Z="1.4253443945044542">
<NAME>Intention-to-treat analysis (missing participants were categorized unstable)</NAME>
<DICH_DATA CI_END="1.471637171617545" CI_START="0.32568485634376343" EFFECT_SIZE="0.6923076923076923" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="13" LOG_CI_END="0.16780074900449615" LOG_CI_START="-0.48720243473951985" LOG_EFFECT_SIZE="-0.1597008428675119" MODIFIED="2009-04-29 20:39:03 -0400" MODIFIED_BY="[Empty name]" ORDER="53" O_E="0.0" SE="0.38475211244928603" STUDY_ID="STD-Carlsson-2005" TOTAL_1="50" TOTAL_2="50" VAR="0.14803418803418805" WEIGHT="57.37589649838279"/>
<DICH_DATA CI_END="1.4848928798541157" CI_START="0.2580791920062111" EFFECT_SIZE="0.6190476190476191" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="7" LOG_CI_END="0.17169512478706633" LOG_CI_START="-0.5882470096412313" LOG_EFFECT_SIZE="-0.20827594242708247" MODIFIED="2009-04-29 20:39:31 -0400" MODIFIED_BY="[Empty name]" ORDER="54" O_E="0.0" SE="0.4463937715374166" STUDY_ID="STD-Toksvig_x002d_Larsen-1998" TOTAL_1="15" TOTAL_2="13" VAR="0.19926739926739928" WEIGHT="42.62410350161721"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.8317187197721192" CI_END="1.9017663500632258" CI_START="0.19629814148951613" DF="1" EFFECT_SIZE="0.6109936170408916" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="14" I2="45.406465020764315" ID="CMP-003.03.02" LOG_CI_END="0.2791571587047426" LOG_CI_START="-0.7070838121914793" LOG_EFFECT_SIZE="-0.21396332674336835" MODIFIED="2009-04-29 20:46:29 -0400" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.17592484142996212" P_Z="0.39509062477103285" STUDIES="2" TAU2="0.3080073496741178" TOTAL_1="65" TOTAL_2="63" WEIGHT="100.0" Z="0.8504218072552683">
<NAME>Intention-to-treat analysis (missing participants were categorized stable)</NAME>
<DICH_DATA CI_END="1.0656030513655157" CI_START="0.1240906778459671" EFFECT_SIZE="0.36363636363636365" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="0.027595455434811046" LOG_CI_START="-0.9062608430953362" LOG_EFFECT_SIZE="-0.43933269383026263" MODIFIED="2009-04-29 20:44:16 -0400" MODIFIED_BY="[Empty name]" ORDER="55" O_E="0.0" SE="0.5485518124198396" STUDY_ID="STD-Carlsson-2005" TOTAL_1="50" TOTAL_2="50" VAR="0.3009090909090909" WEIGHT="55.116747880914076"/>
<DICH_DATA CI_END="4.23886432923271" CI_START="0.3150156594459858" EFFECT_SIZE="1.1555555555555554" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.6272495165898051" LOG_CI_START="-0.5016678568708942" LOG_EFFECT_SIZE="0.06279082985945543" MODIFIED="2009-04-29 20:46:29 -0400" MODIFIED_BY="[Empty name]" ORDER="56" O_E="0.0" SE="0.6631316534019392" STUDY_ID="STD-Toksvig_x002d_Larsen-1998" TOTAL_1="15" TOTAL_2="13" VAR="0.4397435897435897" WEIGHT="44.883252119085924"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.9275530278827642" CI_END="1.2228176506954096" CI_START="0.24190745081927748" DF="1" EFFECT_SIZE="0.5438829843785741" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="14" I2="0.0" ID="CMP-003.03.03" LOG_CI_END="0.08736169889956441" LOG_CI_START="-0.6163507550367776" LOG_EFFECT_SIZE="-0.26449452806860657" MODIFIED="2009-04-29 22:00:35 -0400" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.33549972641205794" P_Z="0.14066252383489233" STUDIES="2" TAU2="0.0" TOTAL_1="59" TOTAL_2="57" WEIGHT="100.0" Z="1.4733283352387054">
<NAME>Available data analysis</NAME>
<DICH_DATA CI_END="1.1304397988776724" CI_START="0.13308975341781842" EFFECT_SIZE="0.3878787878787879" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="11" LOG_CI_END="0.05324743911712369" LOG_CI_START="-0.8758553795771621" LOG_EFFECT_SIZE="-0.41130397023001913" MODIFIED="2009-04-29 21:59:39 -0400" MODIFIED_BY="[Empty name]" ORDER="57" O_E="0.0" SE="0.5457595948341498" STUDY_ID="STD-Carlsson-2005" TOTAL_1="45" TOTAL_2="48" VAR="0.2978535353535354" WEIGHT="57.367102987116915"/>
<DICH_DATA CI_END="2.964381847087871" CI_START="0.2478404994527827" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.47193414512444604" LOG_CI_START="-0.6058277243856725" LOG_EFFECT_SIZE="-0.06694678963061322" MODIFIED="2009-04-29 22:00:35 -0400" MODIFIED_BY="[Empty name]" ORDER="58" O_E="0.0" SE="0.6330826571575395" STUDY_ID="STD-Toksvig_x002d_Larsen-1998" TOTAL_1="14" TOTAL_2="9" VAR="0.40079365079365076" WEIGHT="42.632897012883085"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2012-08-18 06:38:33 -0400" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="media - Copy.jpg" FILE_TYPE="JPG" ID="FIG-01" MODIFIED="2011-11-19 03:46:25 -0500" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION/>
<FILE>/9j/4AAQSkZJRgABAgAAAQABAAD/2wBDAAgGBgcGBQgHBwcJCQgKDBQNDAsLDBkSEw8UHRofHh0a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</FILE>
</FIGURE>
<FIGURE FILENAME="Figure 1.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2011-11-18 14:07:26 -0500" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION/>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAi4AAAGkCAIAAACZ6zmrAAAtRElEQVR42u2d6aGrIBBGb10WZD0W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</FILE>
</FIGURE>
<FIGURE FILENAME="Flowchart.png" FILE_TYPE="PNG" ID="FIG-03" MODIFIED="2012-02-21 17:47:22 -0500" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION>
<P>Study flow diagram.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAZAAAAKWCAYAAABnDs9MAAAc/0lEQVR42u3d7Y7zuI5F4b7/mz7z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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-04" MODIFIED="2012-08-18 06:38:33 -0400" MODIFIED_BY="[Empty name]" NO="4" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAzYAAAEACAMAAABWLRPqAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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==
</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-05" MODIFIED="2012-08-18 06:38:33 -0400" MODIFIED_BY="[Empty name]" NO="5" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAV8AAALDCAIAAAA9m5RzAAAbIElEQVR42u3dsa4kR9mH8ZFICDbY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=
</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-07-22 12:29:14 -0400" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2008-07-22 12:28:23 -0400" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2008-07-22 12:28:23 -0400" MODIFIED_BY="[Empty name]">Search strategy for CENTRAL</TITLE>
<APPENDIX_BODY MODIFIED="2008-07-22 12:23:17 -0400" MODIFIED_BY="[Empty name]">
<TABLE COLS="1" ROWS="2">
<TR>
<TH>
<P>CENTRAL</P>
</TH>
</TR>
<TR>
<TD>
<P>#1 arthritis[mesh]<BR/>#2 arthrit*:ti,ab<BR/>#3 osteoarthr*:ti,ab<BR/>#4 gonarthrosis:ti,ab<BR/>#5 arthralgia:ti,ab<BR/>#6 felty* next syndrome:ti,ab<BR/>#7 caplan* next syndrome:ti,ab<BR/>#8 sjogren*next syndrome:ti,ab<BR/>#9 sicca next syndrome:ti,ab<BR/>#10 still* next disease:ti,ab<BR/>#11 bechterew* next disease:ti,ab<BR/>#12 rheuma*:ti,ab<BR/>#13 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12<BR/>#14 knee[mesh]<BR/>#15 knee joint[mesh]<BR/>#16 knee*:ti,ab<BR/>#17 #14 OR #15 OR #16<BR/>#18 #13 AND #17<BR/>#19 knee osteoarthritis[mesh]<BR/>#20 #18 OR #19<BR/>#21 knee arthroplasty[mesh]<BR/>#22 knee prosthesis[mesh]<BR/>#23 knee*[tw] AND (arthroplast* OR implant* OR replace* OR prosthe* OR endoprosthe*):ti,ab<BR/>#24 #21 OR #22 OR #23<BR/>#25 "Prostheses and Implants"[mesh]<BR/>#26 #17 AND #25<BR/>#27 #24 OR #26<BR/>#28 cementation[mesh]<BR/>#29 "Bone cements"[mesh]<BR/>#30 "Durapatite"[mesh]<BR/>#31 cement* OR uncement* OR Hydroxyapatite OR Durapatite OR Ingrowth OR hybrid OR porous* OR coat* OR press-fit:ti,ab<BR/>#32 #28 OR #29 OR #30 OR #31<BR/>#33 #20 AND #27 AND #32</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2008-07-22 12:28:46 -0400" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2008-07-22 12:28:46 -0400" MODIFIED_BY="[Empty name]">Search strategy for MEDLINE (via Pubmed)</TITLE>
<APPENDIX_BODY MODIFIED="2008-07-22 12:26:22 -0400" MODIFIED_BY="[Empty name]">
<TABLE COLS="1" ROWS="2">
<TR>
<TH>
<P>MEDLINE (via PubMed)</P>
</TH>
</TR>
<TR>
<TD>
<P>#1 arthritis[mesh]<BR/>#2 arthrit*[tw]<BR/>#3 osteoarthr*[tw]<BR/>#4 gonarthrosis[tw]<BR/>#5 arthralgia[tw]<BR/>#6 felty* syndrome[tw]<BR/>#7 caplan* syndrome[tw]<BR/>#8 sjogren* syndrome[tw]<BR/>#9 sicca syndrome[tw]<BR/>#10 still* disease[tw]<BR/>#11 bechterew* disease[tw]<BR/>#12 rheuma*[tw]<BR/>#13 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12<BR/>#14 knee[mesh]<BR/>#15 knee joint[mesh]<BR/>#16 knee*[tw]<BR/>#17 #14 OR #15 OR #16<BR/>#18 #13 AND #17<BR/>#19 knee osteoarthritis[mesh]<BR/>#20 #18 OR #19<BR/>#21 knee arthroplasty[mesh]<BR/>#22 knee prosthesis[mesh]<BR/>#23 knee*[tw] AND (arthroplast* OR implant* OR replace* OR prosthe* OR endoprosthe*)[tw]<BR/>#24 #21 OR #22 OR #23<BR/>#25 "Prostheses and Implants"[mesh]<BR/>#26 #17 AND #25<BR/>#27 #24 OR #26<BR/>#28 cementation[mesh]<BR/>#29 "Bone cements"[mesh]<BR/>#30 "Durapatite"[mesh]<BR/>#31 cement* OR uncement* OR Hydroxyapatite OR Durapatite OR Ingrowth OR hybrid OR porous* OR coat* OR press-fit[tw]<BR/>#32 #28 OR #29 OR #30 OR #31<BR/>#33 #20 AND #27 AND #32<BR/>#34 randomized controlled trial[pt]<BR/>#35 controlled clinical trial[pt]<BR/>#36 randomized controlled trials[mh]<BR/>#37 random allocation[mh]<BR/>#38 double-blind method[mh]<BR/>#39 single-blind method[mh]<BR/>#40 clinical trial[pt] OR clinical trials[mh]<BR/>#41 ("clinical trial"[tw]<BR/>#42 (singl*[tw] OR doubl*[tw]<BR/>#43 trebl*[tw] OR tripl*[tw]) AND (mask*[tw] OR blind*[tw]))<BR/>#44 ("latin square"[tw])<BR/>#45 placebos[mh]<BR/>#46 placebo*[tw]<BR/>#47 random*[tw]<BR/>#48 research design[mh:noexp]<BR/>#49 comparative study[mh]<BR/>#50 evaluation studies[mh]<BR/>#51 follow-up studies[mh]<BR/>#52 prospective studies[mh]<BR/>#53 cross-over studies[mh]<BR/>#54 control*[tw]<BR/>#55 prospectiv*[tw]<BR/>#56 volunteer*[tw] NOT (animal[mh] NOT human[mh])<BR/>#57 #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #55 OR #56<BR/>#58 #33 AND #57</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2008-07-22 12:28:59 -0400" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2008-07-22 12:28:59 -0400" MODIFIED_BY="[Empty name]">Search strategy for EMBASE (via OVID)</TITLE>
<APPENDIX_BODY MODIFIED="2008-07-22 12:26:32 -0400" MODIFIED_BY="[Empty name]">
<TABLE COLS="1" ROWS="2">
<TR>
<TH>
<P>EMBASE (via OVID)</P>
</TH>
</TR>
<TR>
<TD>
<P>1. exp Arthritis/<BR/>2. arthrit$.tw.<BR/>3. osteoarthr$.tw.<BR/>4. gonarthrosis.tw.<BR/>5. arthralgia.tw.<BR/>6. (felty$ adj2 syndrome).tw.<BR/>7. (caplan$ adj2 syndrome).tw.<BR/>8. (sjogren$ adj2 syndrome).tw.<BR/>9. (sicca adj2 syndrome).tw.<BR/>10. still$ disease.tw.<BR/>11. bechterew$ disease.tw.<BR/>12. rheuma$.tw.<BR/>13. or/1-12<BR/>14. exp knee/<BR/>15. exp knee joint/<BR/>16. knee$.tw.<BR/>17. or/14-16<BR/>18. 13 and 17<BR/>19. exp Knee Osteoarthritis/<BR/>20. exp Knee Arthritis/<BR/>21. or/18-20<BR/>22. exp Knee Arthroplasty/<BR/>23. exp Knee Prosthesis/<BR/>24. (knee$ adj2 (arthroplast$ or implant$ or replace$ or prosthe$ or endoprosthe$)).tw.<BR/>25. exp Prosthesis/<BR/>26. exp IMPLANTATION/<BR/>27. 25 or 26<BR/>28. 17 and 27<BR/>29. or/22-24,28<BR/>30. exp CEMENTATION/<BR/>31. exp HYDROXYAPATITE/<BR/>32. (cement$ or uncement$ or Hydroxyapatite or Durapatite or Ingrowth or hybrid or porous$ or coat$ or press-fit).tw.<BR/>33. or/30-32<BR/>34. and/21,29,33<BR/>35. random$.ti,ab.<BR/>36. factorial$.ti,ab.<BR/>37. (crossover$ or cross over$ or cross-over$).ti,ab.<BR/>38. placebo$.ti,ab.<BR/>39. (doubl$ adj blind$).ti,ab.<BR/>40. (singl$ adj blind$).ti,ab.<BR/>41. assign$.ti,ab.<BR/>42. allocat$.ti,ab.<BR/>43. volunteer$.ti,ab.<BR/>44. crossover procedure.sh.<BR/>45. double blind procedure.sh.<BR/>46. randomized controlled trial.sh.<BR/>47. single blind procedure.sh.<BR/>48. or/35-47<BR/>49. exp animal/ or nonhuman/ or exp animal experiment/<BR/>50. exp human/<BR/>51. 49 and 50<BR/>52. 49 not 51<BR/>53. 48 not 52<BR/>54. 34 and 53</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-04" MODIFIED="2008-07-22 12:29:14 -0400" MODIFIED_BY="[Empty name]" NO="4">
<TITLE MODIFIED="2008-07-22 12:29:14 -0400" MODIFIED_BY="[Empty name]">Search strategy for LILACS</TITLE>
<APPENDIX_BODY MODIFIED="2008-07-22 12:27:30 -0400" MODIFIED_BY="[Empty name]">
<TABLE COLS="1" ROWS="2">
<TR>
<TH>
<P>LILACS</P>
</TH>
</TR>
<TR>
<TD>
<P>(((arthritis OR arthrit* OR osteoarthr* OR gonarthrosis OR arthralgia OR felty* syndrome OR caplan* syndrome OR sjogren* syndrome OR sicca syndrome OR still* disease OR bechterew* disease OR rheuma*) AND (knee OR knee joint OR knee*)) OR knee osteoarthritis) AND ((knee arthroplasty OR knee prosthesis OR (knee* AND (arthroplast* OR implant* OR replace* OR prosthe* OR endoprosthe*)) OR (prostheses and implants AND (knee OR knee joint OR knee*))) AND (cementation OR bone cements OR durapatite OR (cement* OR uncement* OR hydroxyapatite OR durapatite OR ingrowth OR hybrid OR porous* OR coat* OR press-fit)) AND ((Pt randomized controlled trial OR Pt controlled clinical trial OR Mh randomized controlled trials OR Mh random allocation OR Mh double-blind method OR Mh single-blind method) AND NOT (Ct animal AND NOT (Ct human and Ct animal)) OR (Pt clinical trial OR Ex E05.318.760.535$ OR (Tw clin$ AND (Tw trial$ OR Tw ensa$ OR Tw estud$ OR Tw experim$ OR Tw investiga$)) OR ((Tw singl$ OR Tw simple$ OR Tw doubl$ OR Tw doble$ OR Tw duplo$ OR Tw trebl$ OR Tw trip$) AND (Tw blind$ OR Tw cego$ OR Tw ciego$ OR Tw mask$ OR Tw mascar$)) OR Mh placebos OR Tw placebo$ OR (Tw random$ OR Tw randon$ OR Tw casual$ OR Tw acaso$ OR Tw azar OR Tw aleator$) OR Mh research design) AND NOT (Ct animal AND NOT (Ct human and Ct animal)) OR (Ct comparative study OR Ex E05.337$ OR Mh follow-up studies OR Mh prospective studies OR Tw control$ OR Tw prospectiv$ OR Tw volunt$ OR Tw volunteer$) AND NOT (Ct animal AND NOT (Ct human and Ct animal)))</P>
</TD>
</TR>
</TABLE>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>
<EXTENSION ID="FLOW_3" NAME="FIGURE" REVMAN_VERSION="5.1.0" TYPE="FLOWCHART">
<ALIAS ALIAS_ID="3">
<FLOWCHARTBOX TEXT="&lt;p&gt;3 studies included in quantitative synthesis (meta-analysis)&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;5 studies included in qualitative synthesis&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;18 full-text articles assessed for eligibility&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;551 records screened&lt;/p&gt;" WIDTH="120">
<FLOWCHARTBOX TEXT="&lt;p&gt;551 records after duplicates removed&lt;/p&gt;" WIDTH="200">
<FLOWCHARTBOX TEXT="&lt;p&gt;551 records identified through database searching&lt;/p&gt;" WIDTH="120"/>
<FLOWCHARTBOX TEXT="&lt;p&gt;0 additional records identified through other sources&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;533 records excluded&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
<OUT TEXT="&lt;p&gt;13 full-text articles excluded, with reasons&lt;/p&gt;" WIDTH="120"/>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</FLOWCHARTBOX>
</ALIAS>
</EXTENSION>
</EXTENSIONS>
</COCHRANE_REVIEW>